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Diseases such as cancer can develop asymptomatically, preventing 
opportunities for early detection. The drive for “liquid biopsies” that can detect 
biomarkers in a rapid, point-of-care setting has spurred innovation in nanoparticle-
based sensing schemes. One biomarker, cell-free circulating microRNA, has been a 
major target due to its diagnostic potential and difficulties in detecting it with standard 
assays. If cancer is detected, chemotherapy is often administered; unfortunately, 
chemotherapy can greatly decrease patient quality of life due to toxicity. Some side 
effects can be permanent and cumulative, as in the case of the drug doxorubicin. 
Sensors that can detect chemotherapy drugs in vivo would be useful as a research tool 
to better assess drug distribution in the organism and in cells. Clinically, an 
implantable cumulative sensor for doxorubicin could provide a record of lifetime 
exposure, minimizing chances of adverse effects.  
A potential nanomaterial for developing implantable sensors for biomarkers 
and chemotherapy drugs are single-walled carbon nanotubes. Carbon nanotubes are 
fluorescent in the near-infrared range, which is highly penetrant to tissue, and report 
their local environment via changes in their emission energy and intensity. Here, we 
have developed DNA-functionalized carbon nanotubes for the detection of 
oligonucleotide biomarkers, alkylating agents, and DNA-intercalating drugs like 
doxorubicin. We have discovered a method by which optical changes due to 
 
 
hybridization on the nanotube can be greatly enhanced, and applied it to the detection 
of microRNA in biofluids and in vivo. By adapting our understanding of this 
enhancement we were able to show directional control of nanotube solvatochromism 
to alkylating agents, which enabled control of sensing output signal. Mechanistic 
experiments allowed us to obtain new insight about the interaction of DNA-suspended 
nanotubes with anionic analytes, including oligonucleotides, to provide better 
selectivity. In detecting oligonucleotides in serum, we discovered that serum proteins 
can be denatured to selectively interact with nanotubes after hybridization to enhance 
sensing, and used this to detect viral RNA. Finally we developed a cumulative, 
implantable sensor for doxorubicin and other intercalating agents that enabled real-
time sensing in live mice. 
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1 
 
CHAPTER 1: UNDERSTANDING CARBON NANOTUBE OPTICAL 
SENSORS FOR APPLICATIONS IN BIOLOGY 
1.1 Abstract 
This doctoral dissertation is organized as largely independent chapters consisting of 
papers that have been published, submitted, or close to submission. Each chapter 
contains an introduction relating to the specific material contained within the chapter, 
sufficient for each chapter to be read and understood on its own. Overall, the thesis is 
unified by the use of carbon nanotubes as biological sensors. As will be described, 
they change their fluorescent emission wavelength and intensity in response to 
analytes. While carbon nanotube sensors have been demonstrated to be useful for 
biological sensing, they are also under intense study by physical scientists interested in 
one-dimensional materials. Their findings have important implications for developing 
and improving nanotube-based sensors for biology, in particular for understanding 
why and how an analyte of a given character produces an observed optical change. 
This understanding is essential for the rational design of sensors and the proper 
interpretation of optical changes. However, the different vocabulary and assumed set 
of requisite knowledge in the nanotube physical science literature makes it difficult to 
access. Additionally, the theory for how nanotube optical properties change in 
different environments is a work in progress in some respects, adding to the difficulty. 
The purpose of this introductory chapter is to provide pertinent fundamental 
information about carbon nanotubes in an accessible manner, and summarize the 
current understanding in how analytes elicit optical changes in nanotubes. 
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1.2 Carbon and carbon nanotubes 
Known since ancient times, carbon is truly an element that has changed the world1. 
Carbon is absolutely central to life as we know it, in both a fundamental biological 
sense and in a more abstract societal sense. Some forms of carbon have taken key 
roles in powering humanity, from industrial growth to transportation2. Other forms of 
carbon are hung ornately around necks and fingers, studded in ears or as part of hair 
accessories, incorporated into blades for cutting3, and have been presented countless 
times as tokens of love4. Carbon has made some people extremely wealthy, and 
dictated the policies of entire regions5. Carbon has also brought out the worst of 
humanity, fueling greed-based violence and being made into explosive compounds for 
propelling objects at high speed into other humans6. Carbon in a particular gaseous 
form has been especially problematic as of late7. Carbon has seen an entire field of 
science grown around her, organic chemistry, that has sullied the dreams of countless 
pre-med undergraduates8 but enabled others to synthesize new material to improve 
human health and convenience.  
 
But even more fundamental than organic chemistry, some forms of pure carbon have 
proven fascinating for their unusual properties. One such allotrope, carbon nanotubes, 
have been the subject of intense research9, and sometimes hype10, due to their 
potentially useful properties. The excitement surrounding carbon nanotubes was so 
great that they have entered the public lexicon through lay-person science articles. A 
carbon nanotube was even featured on the cover of the organic chemistry textbook I 
studied11 as an undergraduate. 
 
The electronic and optical properties of carbon nanotubes are truly remarkable. 
Carbon nanotubes consist of an ensemble of closely related structures, but small 
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differences in diameter and other geometry impart some with metallic properties and 
some with semi-conductor properties. Nanotubes can also be found inside of other 
nanotubes, like Russian nesting dolls, as so-called multi-walled carbon nanotubes. 
While multi-walled carbon nanotubes have some interesting applications12, what 
follows will be focused solely on single-walled carbon nanotubes (SWNT, SWCNT, 
carbon nanotubes, or nanotubes).  
 
In some iterations (as will be described), carbon nanotubes fluoresce in the near-
infrared spectral range. This is especially important for some biomedical applications, 
as the near-infrared red range falls in the “window of transparency13” where tissue can 
be maximally penetrated for deep imaging. Carbon nanotubes do not photobleach, but 
their emission intensity can be quenched or enhanced reversibly in some cases14. The 
emission wavelength of carbon nanotubes can also change in response to their 
environment. Tissue penetrant emission, resistance to photobleaching, and sensitivity 
to the local environment make nanotubes an exciting option for developing in vivo 
sensors based completely on optical excitation and emission—no batteries or wires 
required. 
 
A holistic view of the advantages of using carbon nanotubes to address biological 
problems are hidden somewhat behind nomenclature and models developed by 
physicists. Solid state physicists talk about wave vectors and reciprocal space in the 
way cancer biologists talk about c-Myc and transcriptomes—equally bewildering from 
each other’s point of view. What follows is an attempt to explain the electronic origins 
of the properties of carbon nanotubes in a qualitative way (more detailed explanations 
may be found elsewhere15-17). This is not meant to disparage the excellent work of 
many brilliant physicists and chemists, who have pieced together exact quantitative 
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relationships of all the variables and physical forces to describe the electronic states 
with great understanding18. Indeed, I am enamored of this work and rely on it via 
collaborators who have made fantastic progress in computationally simulating carbon 
nanotubes interacting with other molecules19. Rather, my goal is to establish a 
qualitative foundation for understanding one aspect of carbon nanotubes, their optical 
properties, in the context of sensing small molecule analytes. For this purpose, the 
level of quantitative detail that is known can become counterproductive. The 
following sections aim to explain, qualitatively and admittedly superficially, the 
electronic origins of the optical properties of nanotubes. This is important background 
for understanding the basis of nanotube-based sensor responses, and therefore correct 
usage and interpretation of sensing events.  
 
1.3 The origin and naming of carbon nanotubes 
Carbon nanotubes are composed of sp2 hybridized carbon that curls around into 
cylinders of diameters ranging from about 0.8 to 1.2 nm (depending on their synthesis) 
and can be of variable length. They are best conceptualized as a piece of 2-
dimensional graphene (an atomic layer of graphite) that has been rolled up into a tube. 
This is not how carbon nanotubes are made. They are typically “grown” around an 
iron metal nanoparticle catalyst under high pressure conditions using carbon monoxide 
(high pressure carbon monoxide, HiPco) or around a or Co-Mo catalyst under carbon 
vapor deposition (Co-Mo catalysis, CoMoCAT)20. Envisioning nanotubes as rolled-up 
graphene is useful for understanding nanotube nomenclature. The graphene may be 
folded in a number of ways to create nanotubes with different diameters and pitch. 
Indeed, carbon nanotubes are named according to vectors built on a hypothetical 
graphene grid. Any particular nanotube can be geometrically described by “rolling up” 
a single graphene strip along a chiral vector that can connect any two 
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crystallographically identical points. This chiral vector is defined by two component 
vectors, called the chiral index (n,m), that uniquely describes any particular carbon 
nanotube. From the chiral index, one can calculate the chiral vector, the nanotube 
diameter, the chiral angle, and the number of carbon atoms per unit cell by simple 
geometric arguments. Even more conveniently, the metallic or semiconductor 
character of any nanotube can be determined from the chiral index; a nanotube is 
metallic if (2n+m) is a multiple of 3. All other nanotubes are semiconductors. The 
armchair nanotubes, (n,n) are always metallic, while zigzag (n,0) nanotubes are only 
metallic when n=3. For example, the (4,1) nanotube is metallic, while the (8,3) 
nanotube is a semiconductor. Figure 1.1 contains a selected set of semiconducting 
nanotubes. 
 
 
Figure 1.1 Selected semiconducting nanotubes named by their chiral index in (n,m) 
notation. 
 
While metallic carbon nanotubes are useful for some applications, it is only the 
semiconducting nanotubes that have near-infrared fluorescence. At first glance, it 
seems incredible that pure carbon materials that differ in seemingly small ways, such 
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as diameter, can have such diverse physical properties. It is insightful to understand 
the origin of these differences in electronic, and thus optical, properties. 
1.4 Electronic properties of carbon nanotubes: the basics 
Carbon is at the top of column IV on the periodic table, and each atom contains six 
electrons occupying 1s2, 2s2, and 2p2 atomic orbitals. The two electrons occupying 1s2 
are strongly bound core electrons, and do not appreciably affect any solid state 
properties. The four electrons occupying 2s2 and 2p2 atomic orbitals are the weakly 
bound valence electrons responsible for forming covalent bonds. The energy 
difference between the lower 2s and upper 2p levels is relatively small; a consequence 
of this is that the wave functions of these four electrons can mix and produce 
hybridization states, enhancing binding energy to adjacent atoms. Three possible 
hybridization states are allowed: sp, sp2, and sp3. Graphite, fullerenes, and carbon 
nanotubes consist entirely of sp2 hybridized carbon, resulting in delocalized π orbitals 
perpendicular to the plane of the sigma bonds. These π electrons are ultimately 
responsible for the metallic or semiconductor properties of carbon nanotubes.  
 
Although the first experimental observation of carbon nanotubes was reported by 
Sumio Iijima in 199121, the theoretical framework of carbon nanotubes was already 
being pieced together based on the recent discovery of fullerenes by Harry Kroto, 
Richard Smalley, and Robert Curl (with the assistance of three graduate students, 
James Heath, Sean O’Brien, and Yuan Liu)22. Part of the theoretical framework had 
predicted that more than one “type” of carbon nanotube was possible. That is, carbon 
nanotubes with different diameters and pitch were possible, and would have different 
electronic properties. It was predicted that 1/3 of possible carbon nanotube structures 
would have a metallic electronic structure, and 2/3 would be semiconductors23, 24. 
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These predictions were based on the electronic structure of graphite23, 25 and the 
recently discovered fullerene26. The explanation for how this can be predicted will be 
the subject of the next few subsections. 
In our analysis, we will move from molecular orbital theory to a theory from solid 
state physics called band theory. Molecular orbital theory is powerful for small 
molecules, but for larger molecules a better understanding can emerge using the 
language and models from solid state physics. In considering carbon nanotubes, they 
have several convenient features that make this transition relatively painless. First, 
they are pseudo-1 dimensional. It’s easier to deal with electrons in one dimension 
rather than three. Second, it is only the π electrons that must considered. Third, they 
are qualitatively similar to graphite, with only some additional geometric 
considerations, meaning that the electronic structure of graphite can serve as a 
convenient foundation for the electronic structure of carbon nanotubes. 
 
1.4.1 From wave functions to density of states 
The advent of quantum mechanics introduced us to the wave function. The wave 
function contains all the information that can be known about a particle. It is from the 
wave function that atomic orbitals are calculated, and from atomic orbitals covalent 
bonds are described—this is, based on the probability density of the electron27. An 
interesting feature of the wave function is that two distinct wave functions can yield 
the same probability density. This becomes significant when two atomic orbitals must 
be considered interacting with each other. The wave function of the two atoms can 
combine to form a composite wave, where there is a nonzero probability of an electron 
between the two atoms (in phase), or can combine in a destructive way, where the 
wave functions subtract, leading to a point of zero probability for an electron (a node) 
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between the two atoms (out of phase). These two possible combinations correspond to 
the bonding orbital, which is lower energy, and the anti-bonding orbital, which is 
higher energy (Figure 1.2). 
 
 
 
 
 
 
 
 
 
Figure 1.2 In phase and out of phase wave functions combine to produce bonding 
and anti-bonding energy levels. 
As more atoms are added to this system, more combinations of states with varying 
degrees of in-phase and out-of-phase mixtures become available, producing a greater 
number of intermediate energy states (Figure 1.3a and b). The most stable 
combination, which is node-less, demarcates the lowest possible energy, while the 
least stable combination, with the maximum number of nodes (Figure 1.3, a), defines 
the highest possible energy. In solids, where the number of atoms approaches a huge 
number (1023) per microscopic unit, the number of discrete states between the most 
stable and least stable combination of wave functions becomes tremendous, and can be 
represented as a continuous band of energies (Figure 1.3, imagine energy states being 
added to b until it looks like c). Solid state physics treats the wave function in this 
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situation slightly differently. If all the atoms are the same, as in some simple crystals, 
then the translational symmetry can be used to make symmetry-adapted linear 
combinations of the wave function28. Symmetry adaptation in solids like this is called 
“forming a Bloch function.” If we use the letter k as an index (wavenumber) for the 
combination state that the wave function combines into, it’s possible to correspond the 
lowest energy wave function composite (no nodes) and the highest energy wave 
function composite (maximal number of nodes) within a certain range, called the first 
Brillouin zone29. Outside this range, the values simply repeat due to the translational 
symmetry of the solid. The number of values that k can take is equal to the number of 
translations in the crystal, which is approximately 1023. The formation of bands occurs 
for each quantum state, and are referred to as the 1s band, 2s band, etc. For most 
quantum states, there exists a gap between the energy bands, which are forbidden 
energies; however, some bands have energies that disperse so much they overlap with 
other bands.  
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Figure 1.3 How many wave functions produce nearly continuous energy states that 
can be represented as a band. a, orbital representation of the lowest energy and 
highest energy combinations. Dotted lines between these combinations represent all 
other intermediate energy combinations. b, a small set of the energy states. As more 
combinations are considered, more lines will be added until it is no longer to 
distinguish individual states by eye. c, the energy band representation of the energy 
states, treating it as if it were continuous. d, The energy of different wave function 
combinations E(k), indexed by k. 
 
This so called band theory of solids is the ideal framework for understanding the 
origins of metallic and semiconducting behavior30 in carbon nanotubes. In general, one 
must only consider the two outermost energy bands of a material. The lower, filled 
band (analogous to the HOMO) is called the valence band, and the upper, empty band 
(analogous to the LUMO) is called the conduction band. The separation of these two 
bands (if they don’t overlap) is called the energy gap. A generic metal would have an 
overlap of the valence and conduction band (Figure 1.4). If a potential difference is 
applied to the metal, only a small amount of energy is needed for electrons to reach 
empty energy states above it, allowing the electron to be mobile (and explaining why 
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metals are good conductors of electricity). In the case of a semi-conductor, there is an 
energy gap between the valence and conduction band. Because of the band gap, more 
energy must be applied to enable an electron to “jump” the forbidden energy levels in 
the band gap to enter the conduction band. In traditional semiconducting material, 
thermal energy can allow electrons to enter the conduction band, which explains why 
the conductivity of semiconductors increases with temperature. Insulating materials 
have a large band gap, meaning only very few electrons can enter the conduction band 
with added energy. 
 
 
 
 
 
 
 
 
 
Figure 1.4: Schematic of an insulator, semiconductor, and metal according to band 
theory. 
 
With this simplified framework, we can begin to partially understanding the electronic 
properties of carbon nanotubes. Conceptually, a carbon nanotube is simply a rolled up 
piece of graphene. Thus, the electronic properties will be that of graphene, with 
additional boundary conditions introduced by this rolling. In considering graphene, we 
only have to focus on the behavior of π energy bands, as these are the most important 
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electrons in determining physical properties. Graphene is technically a semi-metal, 
which according to the band theory of solids mean that their valence band and 
conduction band touch with an energy-gap of zero—not quite overlapping, but not 
quite a semiconductor either. For all intents and purposes though, we can consider the 
electronic behavior to be that of a metal.  
The electronic structure of graphene will form the basis for the electronic structure of 
nanotubes, so we begin by considering all the wave functions combinations that 
comprise the range of k, and subsequently defines the first Brillouin zone of graphene. 
In considering the Brillouin zone of graphene, it is useful to point out here the 
Brillouin zone is actually an abstraction. It results from a mathematical transformation 
from real space to “reciprocal space,” which makes a lot of sense due to a relationship 
between waves and energy that isn’t essential to explain in great detail. What is 
important to remember is that this abstraction contains the all the relevant 
composite wave function information that is used to define the electronic bands for 
the π electrons in graphene. And being a space, although abstract, it can be treated as 
a coordinate system. It turns out that in the Brillouin zone of graphene, there are 
locations where the dispersions of energy that define the bands “touch” (shown in 
Figure 1.5 as vertices of a hexagon), and render graphene with metallic properties. 
There are actually two inequivalent points, K and K’, but the distinction here is not 
essential. To calculate the band structure of carbon nanotubes, the idea is to “fold” the 
graphene into a tube and by doing so we introduce boundary conditions (quantized 
circumferential momentum) to the wave functions. This results in a set of discrete 
energy sub-bands that are essentially “slices” of the energy bands in graphene. To aid 
in this abstraction, these discrete sub-bands can be superimposed onto the original 
Brillouin zone of graphene to yield a series of parallel lines whose length, number, and 
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orientation depend on the particular geometry that the graphene has been folded into. 
These differences in folding correspond to the creation of different (n,m) type 
nanotubes. Thus, each (n,m) nanotube will have the electronic properties contained in 
the “slices” of the graphene band structure. Whenever the resulting allowed sub-bands 
includes a K or K’ point, and therefore has a band structure where the valence and 
conduction band touch, the nanotube will behave as a metal. When the K point is not 
included due to the particular boundary condition introduced by folding, the nanotube 
is a semiconductor with a small band gap that depends on the diameter. The valence 
band and conduction band energy gap will be defined by the sub-bands located closest 
to the K point.  
 
Figure 1.5 Deriving electronic properties of nanotubes. a, First Brillouin zone of 
graphene. K and K’ represent points where the valence and conduction band touch. b, 
First Brillouin zone of graphene with allowed (5,5) nanotube sub-bands due to folding 
(dark vertical lines). The sub-bands include the K point, making this nanotube a metal.  
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Understanding the electronic properties of carbon nanotubes as allowed “slices” of the 
graphene band structure using the first Brillouin zone is insightful but requires a high 
level of abstraction. A more intuitive understanding is to plot the band dispersions 
instead as density of states (DOS). The DOS plot is convenient because it does not 
require reciprocal space; the DOS is an average of the Brillouin zone over all k that 
give a molecular orbital at the specified energy level. In general, the DOS is highly 
dependent on the dimensionality of the material. Carbon nanotubes, being one 
dimensional, have large spikes in their density of states close the ends of bands, 
referred to as van Hove singularities. Inspection of the density of states for a particular 
nanotube type can also reveal if it is metallic or semiconducting. Metallic nanotubes 
have states that exist at every energy level, with no gaps. Semiconducting nanotubes 
have a gap were no electronic states exist; this is the band gap introduced earlier that 
defines semiconductors (Figure 1.6). These spikes, called Van Hove singularities, 
have been observed directly31 and have significant consequences in considering the 
optical properties of carbon nanotubes. 
 
1.4.2 Electronic properties: summary 
We have considered how the wave function, which contains all the information of a 
particle, can be applied to an electron involved in bonding. The wave function can 
combine with other wave functions to produce a bonding and anti-bonding orbital with 
different energies. For large systems approaching 1023 atoms, the combinations of 
wave functions can be described as a dispersion of wave function composites of nearly 
continuous energies delineated by a perfectly in-phase combination at the lowest 
energy extreme, and by a perfectly out-of-phase combination at the high energy 
extreme. This dispersion can be treated as an energy band for a quantum state. 
Because it is the π electrons that determine the properties of graphene, and thus carbon 
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nanotubes, we considered the dispersion of possible wave functions for the π electrons 
of graphene. In a convenient abstraction, we considered the possible wave functions of 
graphene in reciprocal space, called the first Brillouin zone. Here the extremes of the 
valence and conduction band touch at points of high symmetry, the K and K’ points, 
giving graphene (semi)metallic properties. We then saw that introducing 
circumferential constraints to the electronic structure of graphene when folding it into 
a one-dimensional tube results in a set of sub-band “slices” of graphene that, when 
superimposed on the original Brillouin zone of graphene, can predict if the particular 
nanotube will be metallic or semiconducting based on whether the sub-band slice 
contains the point where the valence and conduction bands touch. Different 
circumferential constraints from folding graphene into tubes with different diameter 
and pitch change the boundary conditions used to compute wave functions, and thus 
the allowed sub-bands of graphene that comprise the nanotube’s electronic structure. 
This is how the metallic or semiconducting character of a nanotube can be predicted. 
We also saw that nanotube electronic properties can also be conveniently described by 
density of states diagrams, which also show metallic or semiconducting behavior. 
These DOS diagram contain sharp van Hove singularities, which dominate the optical 
properties of nanotubes. 
 
1.5 Optical properties of carbon nanotubes 
The optical properties of nanotubes include absorption, fluorescence, and Raman 
scattering. For our application of carbon nanotubes as sensors, we will not be dealing 
with their Raman properties, although excellent reviews on this property exist32, 33. 
Absorbance and fluorescence phenomena from carbon nanotubes are best understood 
in terms of the density of states diagrams introduced earlier. We will consider both 
metallic and semi-conducting type nanotubes for this purpose. Figure 1.6 contains the 
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DOS for a generic metallic and semi-conducting nanotube. The valence band has been 
colored in red, while the conduction band is colored in blue. The van Hove 
singularities for both the valence band and the conduction band can be indexed by 
numbers starting in the center and moving downward or upward. 
Energy transitions happen between van Hove singularities. For example, light with 
energy equal to the gap between two van Hove singularities of matched numbers is 
able to promote an electron from the valence band van Hove singularity to the 
conduction band van Hove singularity. Transitions can happen from 1 to 1, 2 to 2, etc. 
but not from 1 to 2, 1 to 3, etc. Each type of transition is said to be E11, E22, etc. (read 
as “E-one-one, E-two-two”, and so forth). In the case of a metal, we may imagine light 
with energy equal to E11 promoting an electron to the conduction band. 
Spectroscopically, light will be absorbed maximally at this energy. However, because 
states exist contiguous with the valence band, the electron can non-radiatively decay 
back to the valence band (indicated by dotted arrow). An absorption event would also 
be detected with light equivalent to the energy of the E22; again, there will be a route 
to non-radiative decay, so no fluorescence will be observed. 
In considering a semi-conducting nanotube, the absorption will be detected similarly 
as the metallic tube. However, now there is an energy gap between the valence band 
and conduction band, with no path for non-radiative decay. Because of this band gap, 
the electron will release a photon with energy equal to the E11 to return to the valence 
band. An interesting case arises with excitation of a semi-conducting nanotube at the 
E22 transition. The excited electron now has a path to non-radiatively decay to the E11. 
Thus, excitation at the E22 will still only produce fluorescence at the E11 energy. 
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Figure 1.6: Density of states with van Hove singularities for metallic nanotubes and 
semiconducting nanotubes. Valence band is colored red, while the conduction band s 
blue. Non-radiative decay is represented by the dotted arrow. Absorption of a photon 
is represented by arrow point up, while emission of a photon is an arrow pointing 
down. 
The fluorescence of semiconducting nanotubes was predicted before they could be 
measured; indeed, it took nearly a decade after the discovery of carbon nanotubes to 
measure their fluorescence. The key step in enabling observation of nanotube 
fluorescence was to create a colloidally stable solution of single nanotubes.  As 
produced, carbon nanotubes form large aggregates as parallel bundles, with a van der 
Waals binding energy of approximately 500 eV per micron of tube contact34. This 
strong bundling interferes with the electronic structure provides non-radiative decay 
pathways to quench electronic excitation and prevent fluorescence. Metallic nanotubes 
in contact with semiconducting nanotubes can provide non-radiative pathways, 
masking fluorescence35, 36. Getting a solution of single nanotubes was no easy task, 
especially considering that covalent modifications could not be used, as too many sp3 
defects on the nanotube surface will also quench fluorescence37. Suspension of single 
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nanotubes was finally achieved by vigorous sonication of nanotubes in the presence of 
surfactant; the sonication physically debundled the nanotubes, while the surfactant 
coated the hydrophobic surface and prevented re-aggregation through electrostatic 
repulsion. Bundles of tubes that were suspended in surfactant micelles could be 
removed by centrifugation, leaving mostly single nanotubes in the supernatant. 
With this preparation of nanotubes, better absorption spectra could be obtained, and 
the nanotubes were found to have fluorescence from 800-1600 nm (the near-infrared 
spectral range). It was found that the wavelength of the absorbance peak in the spectral 
region of the first van Hove band gap, E11, was nearly identical to the wavelength of 
the emission peak, making it possible to assign the emission to semiconducting 
nanotubes34. Shortly thereafter, it became possible to identify (n,m) species based on 
their excitation and emission38. 
The optical properties of carbon nanotubes became a scientific pursuit in its own right 
as a one-dimensional system39. It was confirmed experimentally that the optical 
resonances in carbon nanotubes arise from excitons40, as was predicted by theory41, 
and many photophysical studies were performed to better understand this system42. 
Excitons are quasi-particles consisting of an electron associated with a positively 
charged hole. When the electron is excited to the conduction band, the “hole” it leaves 
in the valence band can be considered a particle with a positive charge whose 
magnitude is equivalent to the electron. The electron-hole pair stays associated via a 
Coulombic interaction, and is mobile along the nanotube surface. The excitonic origin 
of nanotube fluorescence has important ramifications15, 43, 44, including for their 
applications as sensors45, which will be examined in the next section. Because it is 
mobile on the nanotube surface, the exciton can often find defect sites on the surface 
that allow for non-radiative decay46. For understanding changes in carbon nanotube 
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emission wavelength and intensity as a result of analyte binding, the excitonic nature 
will provide an important framework.  
1.6 Carbon nanotubes as optical sensors  
Concurrent to the basic photophysical studies, exploration of carbon nanotube 
fluorescence in response to various perturbations was already underway. In the 
original report of nanotube fluorescence, it was observed that lowering pH quenched 
fluorescence, but could be reversed by restoring the pH toward neutral. Follow-up 
work implicated a critical role for molecular oxygen pre-adsorbing to the nanotube 
side wall47. Metallic nanotubes reacted first near neutral pH, followed by protonation 
of nanotubes with increasing band gap as the solution continued to drop in pH47. 
Further redox studies with organic acceptors found that nanotubes could act as an 
electron donor, bleaching the nanotube fluorescence and absorbance. This was 
selective, based on differences in electronic structure related to diameter and 
chirality48. Reversible quenching in a nanotube chirality-dependent manner suggested 
that nanotubes could become sensors for redox events. 
 
The use of carbon nanotubes as optical sensors has become a rich field, beginning with 
the detection of pH and redox changes. However, the use of carbon nanotubes as 
optical sensors is complicated by the inability to use covalent chemistry for 
functionalization, as too many sp3 defects along the nanotube sidewall will quench 
fluorescence due to non-radiative decay at the defect site. Thus, non-covalent 
functionalization schemes are required for their application as biosensors. Using such 
strategies, sensors have been developed for Beta-D-glucose30, DNA hybridization29, 
microRNA hybridization49, divalent metal cations31, assorted genotoxins32, 
nitroaromatics33, nitric oxide34, pH26, and the protein avidin35. More recently, specific 
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recognition of target analytes using changes in the corona phase of an adsorbed 
polymer has been developed36,37. A major challenge in developing non-covalent, 
colloidally stable sensors for use in biological systems is imparting appropriate 
specificity for the target analyte while resisting non-specific interactions with other 
biological material. 
In all cases, analyte binding induces a change in the nanotube fluorescence, either a 
shift in emission wavelength, change in emission intensity, or some combination 
thereof. The possible sensing mechanisms are often reported to be solvatochromism, 
charge-transfer, or doping and redox reactions. 
 
1.6.1 Solvatochromism 
Of the sensing mechanisms, solvatochromism is the most robust for sensing, 
especially in considering in vivo situations, due to the fact that changes in emission 
wavelength is an absolute measurement (in energy) while intensity is in arbitrary units. 
Solvatochromism in general refers to a change in color as a result from the dielectric 
environment due to solvation. Several theoretical treatments of solvatochromism in 
carbon nanotubes have been explored50-52. The situation that arises with carbon 
nanotubes can become complicated, as the suspending agent provides a 
microenvironment around the nanotube that is different from the bulk solvent (almost 
always water). However, experiments have been conducted with uncoated nanotubes 
suspended over a pillar, surrounded only by air53. Compared to surfactant suspended 
nanotubes, the emission peaks were blue-shifted by 28 meV on average54. Similarly, 
nanotubes grown over trenches were directly immersed in different solvents55. A 
potential confounding factor in these studies relates to mechanical strain and substrate 
contact, which could impact the nanotube fluorescence56. Other studies using 
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surfactant coated nanotubes have been conducted by changing the bulk solvent to 
liquids with different relative dielectric constants, such as hexane and o-
Dichlorobenzene57. Although organic solvents can affect the surfactant around the 
nanotube and thus the emission58, the authors found that the use of SDBS has minimal 
rearrangements and could be used for reasonable comparisons. The nanotubes showed 
significant sensitivity to the solvent dielectric environment; a change of the dielectric 
constant from 2 to 5 resulted in a drop of emission intensity of more than 50%. It was 
found that the peak position was most impacted though. Comparative studies between 
different surfactants have also proven insightful in establishing the effect of the 
solvent dielectric on nanotube emission wavelength59-61. 
 
There additionally is a strong chirality dependence on the degree and sensitivity to 
solvatochromism62-65. Even small, micro-dielectric environmental effects are sufficient 
to produce change in many cases66. In general, carbon nanotube emission peaks 
exhibit a red-shift and broadening with increasing solvent dielectric constants. The 
effect of increasing dielectric constant of the solvent causes the electron-electron and 
electron-hole exciton interactions to decrease in energy. The reduction in the exciton 
binding energy is expected to cause a blue-shift in the optical transition energy, while 
the reduction of electron-electron repulsion is expected to cause a red-shift. 
Experimentally, a red-shift is observed, because the repulsion energy of the electrons 
is larger than that of the exciton binding energy67.  
 
1.6.2 Charge-transfer and redox reactions 
The theory and experimental data relating the dielectric environment of the nanotube 
with the energy of the optical emission is an important framework for understanding 
the optical changes as sensing events for applied nanotube sensors. However, one 
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aspect that is not well explained is the photoluminescent intensity changes due to the 
solvent. Intensity changes in nanotubes have been best described so far by charge-
transfer events and redox reactions. 
 
In charge-transfer events, the analyte orbital overlaps with the nanotube or suspending 
agent’s orbital. Electron transfer leads to altered rates of exciton quenching due to 
changes in the ground or excited states48. Spectral evidence for this came from 
experiments with nitric oxide interacting with carbon nanotubes that suggest electron 
transfer from the valence band of the nanotube to the LUMO of the nitric oxide 
radical68. Evidence for transfer from an excited state came from experiments with dye-
ligand conjugates that quench the nanotube, but have a LUMO in the band gap of the 
nanotube, making a ground-state charge transfer impossible69.  
Redox reactions are thought to occur when the analyte changes the electron 
availability on the nanotube lattice, which could prevent or enhance exciton decay. 
Enhancement of intensity was shown with reducing agents such as dithiothreitol70, a 
vitamin E analog called Trolox, and β-mercaptoethanol. Remarkably, the nanotubes 
were nearly 10 times brighter in some cases. It was concluded that the enhancement 
was due to passivation of defects or oxygen adsorption on the nanotube surface by the 
reducing agents, which acted as electron donors at these sites. The role in mitigating 
the effect of pre-adsorbed oxygen was strengthened by the finding that the reducing 
agents restored fluorescence in nanotubes that were oxidized with methyl viologen70. 
Conversely, protonation of the nanotube side wall from acidic species 34, 47, 71, 72 creates 
a non-radiative recombination site by withdrawing electron density from the side 
wall73. 
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Recently, new insight in the impact of another quality of the solvent beside the 
dielectric constant has been found to play an important role in the nanotube optical 
response74. Using a novel polymer that suspends nanotubes stably in a range of 
solvents, the impact of solvent dielectric was better able to be assessed. Like other 
studies, it was found that the solvent dielectric greatly affects the wavelength of 
emission, and found that emission intensity was also affected. However, some 
irregularities suggested that the dielectric of the solvent alone was not sufficient in 
explaining the observed effects on emission intensity. For example, two solvent 
conditions that had only a small difference in their dielectric constant (D20 = 80 vs. 
9:1 ratio D20: DMF = 76) showed a large difference in emission intensity. One 
potential factor could be the electrophilicity of the solvent. It was hypothesized that 
strongly electrophilic solvents could behave like acidic protons in pulling away 
electron density and making a site for non-radiative decay of the exciton. The solvents 
were ranked by acceptor number, which is a relative measure of the electrophilic 
character of the solvent determined by the 31P NMR chemical shift induced by 
electron-withdrawing interactions of the solvent with the triethylphosphine oxide 
oxygen lone pair. A plot of the emission intensity with AN showed a monotonic trend. 
Conversely, a plot of the solvent donor number (DN), which measures the electron 
donating character of a solvent, showed the opposite effect on nanotube intensity. 
Solvents better able to donate electrons produced brighter emission intensity.  
 
1.6.3 An integrated view 
An integrated view of how nanotubes will respond to a given analyte from an 
excitonic perspective is beginning to emerge. The recent discovery that the solvent 
electrophilicity or donor ability can quench or enhance nanotube intensity according to 
similar mechanisms as protonation and reducing agents seemingly unites solvent 
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solvatochromism and redox reactions. It also resolves irregularities that have been 
observed in the past relating the dielectric environment with nanotube optical changes.  
Ultimately, we would like to be able to completely explain how the optical changes 
(emission wavelength and intensity) that arise upon analyte interaction with a 
nanotube results. An understanding of these forces may allow us to better predict how 
analytes will impact nanotube fluorescence, and aid in the design of better nanotube-
based sensors. So far, the prediction of how a given analyte will affect the nanotube 
emission must be based on how the dielectric environment will change, if there will be 
electron withdrawing or donating forces, and if the analyte’s orbital can overlap with 
the nanotube’s orbital to provide transfer to lower energy states for electrons.  
 
An added layer of difficulty toward this goal stems from the variety of materials that 
can be used to suspend carbon nanotubes. Interaction of analytes with the suspending 
material to change conformation, destabilize, or covalently modify are all expected to 
have large effects on the nanotube emission, and may complement or oppose the 
optical changes the analytes induces from direct interaction with the nanotube. To help 
reduce this complexity, this thesis has focused primarily on one type of suspending 
agent, single-stranded DNA, which has several favorable properties as explained in the 
following section. 
 
1.7 DNA-suspended carbon nanotubes as sensors  
The original report of nanotube suspension used a detergent called sodium dodecyl 
sulfate (SDS), a commonly used anionic detergent in molecular biology. Other 
surfactants and amphiphiles with different characters were also characterized in an 
attempt to improve dispersion efficiencies and explore new systems for study61. With 
an eye toward biological application, relatively “biocompatible” surfactants such as 
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the Pluronic series were also tested. Of all the things that can be used to make 
fluorescent suspensions of carbon nanotubes61, 75, 76, single-strand DNA was also 
considered. Using water soluble polymers such as single-strand DNA to disperse 
nanotubes was proposed early on77, and experimental success was obtained soon 
after78. Surprisingly, it has proven highly effective in nanotube chirality purification79. 
Using single-strand DNA to disperse nanotubes had many important implications for 
potential biomedical sensing applications. Being a biological molecule, single-strand 
DNA is inherently biocompatible in a way surfactants aren’t. Single-strand DNA is 
also relatively cheap and easy to produce, with nearly limitless combinations of four 
bases available. The sequence of DNA also carries biological information and inherent 
selectivity based on Watson-Crick base-pairing. Suspension of nanotubes with DNA 
often produces solutions with higher efficiency than other surfactants78. The 
suspensions are observed to be stable for months or longer at room temperature. DNA-
dispersed nanotubes quickly received the attention of many researchers for these 
reasons.  
 
Single-strand DNA has several characteristics that make it exceptionally well suited 
for suspending nanotubes. Single-strand DNA is a flexible polymer with a negatively 
charged phosphate backbone. The DNA bases are rich in π electrons and relatively 
hydrophobic80. This enables effective π-π stacking on the nanotube surface, directing 
the negatively charged phosphate backbone into the solvent. π-π interactions are 
caused by intermolecular overlap of p-orbitals in π-conjugated systems81. A loss of 
entropy upon confinement on the nanotube also plays a notable role82. Wrapping 
around the tube was confirmed in high-resolution AFM imaging that shows periodic 
bulges83. Many experiments were conducted to examine the role of the sequence in 
dispersion, and from this it was appreciated that polymers with alternating G and T 
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bases were well-suited for dispersion and separation60, 78, 79. Compared to other 
surfactants such as SDS and SDBS, nanotubes suspended with DNA are red-shifted by 
10-20 meV60, 84. This is due to incomplete coverage of the nanotube by DNA 
compared to surfactants, allowing more contact to the strong dielectric environment 
provided by water52. This free space has important implications as a sensor, because it 
is interaction with the nanotube surface that causes optical changes. High-resolution, 
tip-enhanced near-field optical microscopy was used to study the optical properties of 
single nanotubes with a spatial resolution of 15 nm. Doing this, it was possible to 
resolve photoluminescence variation along DNA-wrapped nanotubes. Two distinct 
emission bands were found, corresponding to DNA covered and uncovered portions. 
The shift between these two regions for the (6,5) nanotube was 18 meV85. 
Some of the first demonstrations of the sensing ability of DNA-suspended nanotubes 
came with the discovery that divalent ions can lead to greatly red-shifted emission 
from DNA-suspended nanotubes86. Other work from the Strano group demonstrated 
detection of specific oligonucleotides using DNA-suspended nanotubes87, 88. However, 
this approach failed to be generalizable to any target sequence89. Using DNA-
suspended nanotubes, it was later shown that multi-modal detection of analytes 
(genotoxins and reactive oxygen species) inside of cells could also be obtained90. A 
sensor for nitric oxide was also developed using (AT)15 suspended nanotubes91, 92. 
Another sequence, (AAAT)7, was used for detection of nitric oxide in an inflamed 
mouse liver93. Even some neurotransmitters could be detected with some DNA-
sequences94. Aptamers, which are conformations of DNA that can specifically 
recognize analytes, have also been used as part of carbon nanotube-based sensing 
schemes for insulin95. 
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1.8 Realizing the potential of carbon nanotube-based sensors: the challenges 
In the work that follows, great effort has been put forth in developing carbon-nanotube 
based sensors for clinical applications. A potential biomarker for disease, microRNA, 
and chemotherapy drugs were chosen as targets of detection due to the clinical utility 
of having implantable sensors for such analytes. A major challenge in building such 
sensors was imparting the appropriate specificity for target analytes, even in highly 
complex biological environments.  
 
A key step forward as will be described in great detail was the combination of DNA-
suspended nanotubes with another amphiphile. This combination enabled greatly 
enhanced and robust detection of target microRNA, even in complex biological 
environments and in vivo. At a more fundamental level, this helped clarify how 
changes at the nanotube surface translate into observed optical changes.  
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CHAPTER 2: A CARBON NANOTUBE REPORTER OF MIRNA 
HYBRIDIZATION EVENTS IN VIVO* 
 
2.1 Abstract 
MicroRNAs and other small oligonucleotides in biofluids are promising disease 
biomarkers, yet conventional assays require complex processing steps that are 
unsuitable for point-of-care testing or for implantable or wearable sensors. Single-
walled carbon nanotubes are an ideal material for implantable sensors, owing to their 
emission in the near-infrared spectral region, photostability and exquisite sensitivity. 
Here, we report an engineered carbon-nanotube-based sensor capable of real-time 
optical quantification of hybridization events of microRNA and other oligonucleotides. 
The mechanism of the sensor arises from competitive effects between displacement of 
both oligonucleotide charge groups and water from the nanotube surface, which result 
in a solvatochromism-like response. The sensor, which allows for detection via single-
molecule sensor elements and for multiplexing by using multiple nanotube chiralities, 
can monitor toehold-based strand-displacement events, which reverse the sensor 
response and regenerate the sensor complex. We also show that the sensor functions in 
whole urine and serum, and can non-invasively measure DNA and microRNA after 
implantation in live mice. 
 
 
 
 
 
                                                          
* Harvey et al. A Carbon nanotube reporter of miRNA hybridization events in vivo. 
Nature Biomedical Engineering (2017) 1, 0041 
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2.2 Introduction 
The detection of oligonucleotide hybridization is important for a broad range of 
applications, from devices based on dynamic DNA nanotechnology to clinical point-
of-care diagnostics. Oligonucleotides in biofluids such as serum, urine, and peritoneal 
fluid1, 2 are a promising source of biomarkers for a variety of pathologies, including 
cancer3, 4. Of potential biomarker oligonucleotides5-7, microRNA (miRNA) was found 
to be highly stable in body fluids, as many studies to date identify specific patterns of 
miRNA expression indicative of disease states3, 8-13. Devices that can measure changes 
in biomarker miRNA14 or cell-free DNA15 concentrations in biofluids such as urine, 
serum, or ascites in patients with risk factors for a disease or its relapse may improve 
early detection and treatment. Implantable or wearable devices that enable minimally-
invasive continuous biomarker monitoring may extend this strategy to detect 
biomarkers at the earliest possible stages of disease.  
 
The current standard for miRNA measurement, with limits of detection ranging from 
aM to fM16, is quantitative PCR (qPCR)17, but this method requires purification and 
amplification of miRNA that can introduce biases and variability18. Commercially 
available techniques that do not involve amplification, such as microarrays, suffer 
from poorer sensitivity (pM to nM) and high false positive rates16, 18. Detection 
strategies that avoid amplification, labeling, and purification from biofluids are under 
investigation19, 20, but in vivo detection strategies are sparse. The detection of nucleic 
acid biomarkers in real-time and in situ within living tissues and organisms remains an 
important challenge. 
 
Of potential materials for detecting nucleic acids, individually-dispersed 
semiconducting single-walled carbon nanotubes (SWCNTs) exhibit exciting properties 
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for use as optical biomedical sensors21, 22. Semiconducting carbon nanotubes are 
fluorescent in the near-infrared spectral region23, a wavelength range penetrant to 
tissue24, and they do not photobleach25. Their emission wavelength26 and intensity27 
are sensitive to the local environment, allowing perturbations at the nanotube surface 
to be transduced via modulation of their emission, with up to single-molecule 
sensitivity28. Up to 17 distinct nanotube (n,m) species (chiralities) with unique and 
resolvable emission wavelengths can be measured, potentiating multiplexed detection 
schemes29.  
 
Herein, we describe a label-free approach to detect hybridization events of miRNA 
and other oligonucleotides transiently and in vivo. We designed a sensor which 
transduces the hybridization of small DNA and RNA oligonucleotides into spectral 
changes of carbon nanotube photoluminescence, and we determined its mechanism of 
action via experiments and molecular dynamics simulations to be a competitive 
response to local dielectric and electrostatic factors. Using this understanding, we 
designed a scheme wherein amphiphilic moieties undergo triggered assembly on the 
nanotube surface upon binding of target miRNA, resulting in a markedly enhanced 
spectral response. We showed that the sensor enables multiplexed detection using 
different nanotube chiralities and real-time monitoring of toehold-mediated DNA-
strand displacement, which caused a reversal of the signal response. The sensor was 
highly resistant to non-specific interactions with biological molecules, allowing for 
direct detection in urine and serum. Finally, we showed the first in vivo optical 
detection of target DNA and miRNA by encasing the sensor within an implantable 
device through which we detected hybridization non-invasively via near-infrared 
fluorescence in live mice.  
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2.3 Results and Discussion 
2.3.1 Development of sensor 
We synthesized a DNA-nanotube complex consisting of a single oligonucleotide 
sequence with two domains—one to impart nanotube colloidal stability (nanotube-
binding sequence) and a second with a complementary sequence to a target 
oligonucleotide (miRNA capture sequence). For the miRNA capture sequence, we 
chose a specific 23-mer miRNA (miR-19) as a model target due to its role in 
oncogenesis30. Figure 2.1 shows the synthesis scheme. A screen of potential nanotube-
binding sequences found (GT)15, known to efficiently encapsulate nanotubes31, to 
provide superior resistance to non-complementary oligonucleotides (Figure 2.2). The 
purified DNA-nanotube construct was found to be highly photoluminescent and is 
herein referred to as the GT15mir19 sensor. 
 
 
 
Figure 2.1 Construction scheme of the miRNA sensor complex. A single DNA 
oligonucleotide containing a nanotube-binding sequence (blue) and miRNA capture 
sequence (orange) which is non-covalently bound to the carbon nanotube surface. 
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Figure 2.2 Selectivity assessment of different nanotube binding domains. 
Wavelength shift of modified sensors after addition of non-complementary control 
(R23) or miR-19 DNA. a, Sensor composed of the (GT)15 nanotube binding sequence 
(GT15mir19). b, Sensor composed of the (GT)6 nanotube binding sequence 
(GT6mir19). c, Sensor composed of the (AT)15 nanotube binding sequence 
(AT15mir19). d, Sensor composed of the (TAT)6 nanotube binding sequence 
(TAT6mir19). Error bars represent standard deviation for n = 3 technical replicates. 
 
The optical response of the GT15mir19 sensor was then tested using both a DNA-
based and RNA-based analyte miR-19 sequence, as well as a length-matched, 
randomly generated, non-complementary control (R23). After incubation with miR-19 
or R23, eleven different nanotube chiralities were measured via two-dimensional 
excitation/emission photoluminescence spectroscopy32 (“PL plots”, Figure 2.3). Each 
nanotube emission peak exhibited a shift in wavelength which was specific to the 
miR-19 target sequence over the R23 control (Figure 2.4). In general, nanotube 
emission peak wavelengths blue-shifted and intensity increased upon introduction of 
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the target oligonucleotide (Figure 2.5); excitation peaks (E22 transitions) also blue-
shifted (Figure 2.6). 
 
 
 
Figure 2.3. Photoluminescence excitation/emission plots of the GT15mir19 sensor a, 
in buffer only, b, after interrogation with miR-19 DNA, c, after interrogation with 
miR-19 RNA, d, after interrogation with R23 DNA, e, after interrogation with R23 
RNA.  
 
Figure 2.4 Response of the GT15mir19 sensor to analyte DNA or RNA with the 
miR-19 sequence, or a control sequence (R23). Response of nanotube emission is 
shown for each nanotube chirality. Positive wavelength shift denotes a red-shift in the 
emission peak, and negative numbers denote a blue-shift 
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Figure 2.5. Intensity response of the GT15mir19 sensor. a, Response after addition 
of miR-19 DNA analogue or random sequence DNA control. b, Response after 
addition of miR-19 RNA or random sequence RNA control. Error bars represent 
standard deviation for n = 3 technical replicates. 
 
 
 
Figure 2.6. Plots of excitation and emission wavelength shifts calculated from 
photoluminescence plots. a, Responses to miR-19 DNA analogue and random 
sequence DNA control (R23). b, Responses to miR-19 RNA and random sequence 
RNA control (R23). Error bars represent standard deviation for n = 3 technical 
replicates. 
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To verify that hybridization to the GT15mir19 sensor occurred upon introduction of 
the target, we designed a hairpin oligonucleotide which would make binding of the 
target more apparent by atomic force microscopy (AFM). The oligonucleotide was 
composed of the miR-19 or R23 sequence, a short spacer, and a 52-nucleotide hairpin 
region (diagram in Figure 2.7). After incubation with the miR-19-hairpin, the average 
height of the sample increased by ~0.6 nm, as measured by AFM in dry conditions 
(Figure 2.7). Upon imaging in aqueous conditions, we observed distinct protrusions 
from the nanotubes which were absent in the R23 hairpin-treated sample and buffer 
controls (Figure 2.8). Based on this pattern and other AFM studies33, we estimate that 
the GT15mir19 sensor presents 5-10 binding sites per 100 nm of nanotube. Our 
preparation method yielded nanotubes with a mean length of 166 nm (SD 149nm)34; 
thus we calculate that an average single nanotube could potentially bind approximately 
8-17 copies of miRNA.  
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Figure 2.7. Atomic force microscopy of the GT15mir19 complex under dry 
conditions. a and b, Sequences of the hairpin RNAs miR-19HP and R23HP, 
respectively, and AFM height profiles after incubation. Green bases are 
complementary to the GT15mir19 capture sequence, red bases are random sequence 
control, and purple bases are thymine spacers. c, Images of single nanotubes from 
miR-19HP and R23HP images. d, Average height of nanotubes after addition of miR-
19HP or R23HP, calculated from n = 1332 nanotubes. Error bars represent standard 
error of the mean. 
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Figure 2.8 Atomic force microscopy images in aqueous conditions of the sensor 
complex upon incubation with non-complementary (R23HP) or complementary 
(miR-19HP) hairpin DNA. 
 
Because the mechanism of nanotube spectral changes induced by oligonucleotide 
hybridization is poorly understood, we designed a set of experiments to better 
understand the structural changes of the sensor induced by hybridization. We first 
investigated whether the hybridized duplex remained near the nanotube surface after 
the binding of target miRNA. We developed an assay using an organic fluorophore 
conjugated to the miRNA capture sequence under the premise that the fluorophore 
intensity would increase upon hybridization if the fluorophore desorbed from the 
nanotube surface, as organic fluorophores are known to quench upon interaction with 
the nanotube surface via an energy transfer mechanism35. We suspended nanotubes 
with the sequence GT6mir19, (shortened due to synthesis constraints) containing the 
Cy5 dye conjugated to the 3' end of the miR-19-binding domain. Upon addition of 
miR-19 to the modified complex, we found that Cy5 fluorescence increased over time, 
while the R23 sequence caused no change in Cy5 fluorescence (Figure 2.9). To 
validate GT6mir19-Cy5 as a proxy for the GT15mir19 sequence, we measured the 
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nanotube emission upon introduction of the miR-19 sequence to the fluorophore-
labeled complex. Again, we saw blue-shifting upon hybridization with the target 
oligonucleotide, suggesting the same sensor function despite the shortened nanotube-
binding domain (Figure 2.10). In agreement with the Cy5 fluorescence change, we 
found nanotube fluorescence emission to blue-shift at a slower rate compared to 
GT6mir19 without Cy5 (Figure 2.10). We interpret this relatively slow rate as a result 
of the affinity of Cy5 for the nanotube surface, based on π stacking interactions 
between the Cy5 dye, which is rich with π electrons, and the graphitic π electrons of 
the nanotube. The fluorophore de-quenching and AFM together suggest a final 
hybridized structure consisting of a partial duplex dissociating from the nanotube 
surface.  
 
Figure 2.9 Intensity of Cy5 emission from the GT15mir19-Cy5-nanotube complex 
after introducing miR-19 DNA or R23 DNA. 
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Figure 2.10 Near-infrared emission wavelength response of the modified sensor 
complex, GT6mir19-Cy5, used for the fluorophore dequenching experiment. The 
sensor was interrogated with miR-19 (blue), R23 (red), or buffer only (green). The 
emission wavelength response of three nanotube chiralities, (10,2), (9,4), and (8,6), are 
shown. Error bars represent standard error of the mean for n = 3 technical replicates. 
 
Using all-atom molecular dynamics simulations, we assessed whether the GT15mir19 
sequence could remain stable on the nanotube upon partial hybridization. The pre-
hybridized sequence was placed in the vicinity of the (9,4) nanotube with explicit 
water and counterions, and a simulation was run for 250 ns (details in methods). The 
single-stranded portion of the oligomer bound to the nanotube and the hybridized 
construct remained stable on the nanotube surface for the remainder of the simulation 
(Figure 2.11 “Hyb”). A second simulation was run in absence of the hybridization 
strand. During the simulation, the entire oligomer bound to the surface and wrapped  
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the nanotube, with the nucleobases orienting closely to the nanotube surface in a 
parallel orientation (Figure 2.11, “Unhyb”).  
 
Figure 2.11 Snapshot images of molecular dynamics simulations of the GT15mir19 
sensor (Unhyb) and GT15mir19 sensor hybridized with miR-19 (Hyb) after 
equilibrating for 250 ns. Teal color denotes the (GT)15, nanotube-binding sequence, 
and orange denotes the miR-19 capture sequence. The purple strand denotes miR-19. 
 
The simulations allowed the quantification of nucleobase adsorption to the nanotube 
surface. We measured the radial distance of the nucleobases from the nanotube surface 
and their stacking angles relative to the nanotube surface (Figure 2.12). We observed 
that all bases of the (GT)15 nanotube-binding domain remained adsorbed on the 
nanotube surface, whereas only 1-2 terminal bases of the double-stranded miR-
19/miRNA capture sequence adsorbed to the nanotube surface. In the simulation 
without the complementary strand, all bases of the (GT)15 nanotube binding domain 
adsorbed to the nanotube surface, as well as most of the bases of the miR-19 miRNA 
capture sequence (Figure 2.12). 
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Figure 2.12. Structural parameters of the GT15mir19 sensor complex computed for 
the (9,4) nanotube via molecular dynamics simulations. a, Distribution of radial 
distance and b, stacking angle relative the nanotube for nucleobases from the GT15 
nanotube binding domain and miR-19 miRNA capture sequence domain when 
hybridized to target miR-19. c, Distribution of radial distance and d, stacking angle 
relative to the nanotube for nucleobases from the hybridized target miR-19 when 
hybridized with the miRNA capture sequence. e Distributions of radial distance from 
the nanotube of the miR-19 miRNA capture sequence when target miR-19 is not 
hybridized. f, Stacking angle of miR-19 miRNA capture sequence when target miR-19 
is not hybridized. 
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We assessed the thermodynamic concerns regarding the stability of the hybridized 
duplex in the presence of the nanotube. Molecular dynamics simulations of hybridized 
miR-19, without the (GT)15 nanotube binding domain, in the presence of the nanotube 
were run using several different initial conditions (Figure 2.13). In all simulations, no 
de-hybridization of the duplex was observed, suggesting that the nanotube would not 
destabilize the hybridized duplex. To understand how the partial hybridized state of 
the DNA is stable on the nanotube (or preferred over single strand adsorption on the 
nanotube), we conducted a free energy analysis. We used the two schemes shown in 
Figure 2.14 to estimate the difference in free energy of ssDNA adsorption and dsDNA 
hybridization at the nanotube surface. As parameters needed for such a calculation are 
available from Jung et al.36 for a 17-mer duplex strand, we focus our analysis for this 
particular DNA length and sequence. For case A, one ssDNA is already adsorbed on 
the nanotube surface and its complementary partner ssDNA is introduced in the 
solution like the experimental setup reported in this paper. The change in free energy 
upon hybridization is approximately -135 kcal/mol (at (300 K, 1 bar), which clearly 
indicates that hybridization is preferred over adsorption. Similar analysis for case B, 
where both strands are initially adsorbed on the nanotube surface, the change in free 
energy upon hybridization (again using values reported by Jung et al.) is 
approximately +9 kcal/mol. This indicates that when both strands are initially 
adsorbed (Figure 2.14 Case B), ssDNA adsorption is slightly more favorable than 
dsDNA hybridization. In our experimental setup of miR-19 hybridization on the 
nanotube, we expect the case A to be the relevant one as complementary strand is 
introduced after ssDNA and surfactant are allowed to adsorb on the nanotube surface. 
Thus, our analysis findings are consistent with the observed hybridization leading to 
the function of biosensor / reporter. 
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The analysis suggests that hybridization of the dsDNA is favored if the analyte strand 
is not initially adsorbed on the nanotube surface, as is the case in our experiments.  
Figure 2.13 Starting configurations of molecular dynamics simulations involving 
the duplex miRNA capture sequence + miR-19 without the GT15 nanotube binding 
domain. a, miRNA capture sequence/miR-19 duplex initially configured parallel to 
the axial vector of the nanotube b, miRNA capture sequence/miR-19 duplex initially 
configured perpendicular to the axial vector of the nanotube. 
 
Figure 2.14 Two calculations of hybridization free energy of DNA on the nanotube 
surface. Graphics are illustrative examples of the reference states and Gbinding values 
are taken the work by Jung et al.36 Case A depicts the scenario where single stranded 
DNA on a nanotube hybridizes with complementary DNA in solution. Case B depicts 
the scenario were both strands are first adsorbed to the nanotube surface. 
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We also analyzed the molecular dynamics simulations to gain a quantitative 
understanding of the carbon nanotube spectral response upon hybridization. On 
comparing the water density as a function of distance at the end of the two simulations, 
we found a slight increase in the water concentration near the nanotube in the 
hybridized structure (Figure 2.15a). In addition, we found that the density of 
phosphate ions as a function of distance from the nanotube decreased upon 
hybridization (Figure 2.15b). While an increase in local water density is known to 
cause red-shifting37 of the nanotube emission wavelength, a decrease in local anionic 
charge density in the local environment of the nanotube was found to cause a blue-
shifting response, according to recent work34. As the nanotube emission exhibited a 
net blue-shift upon hybridization, we thus conclude that the effect of the removal of 
phosphate charges from the nanotube surface out-competed the effects of increased 
local water density.  
 
Figure 2.15 Water and phosphate density from the nanotube surface. a, Density of 
water as a function of radial distance from the nanotube, calculated for both 
simulations. b, Density of phosphate groups as a function of radial distance from the 
nanotube, calculated for the final frame of both simulations. 
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2.3.2 Effects of amphipathic molecules on sensor response 
As the simulations showed an increase in available nanotube surface area upon 
hybridization, we hypothesized that additional small amphipathic molecules might 
assemble on this newly exposed nanotube surface to enhance the optical response. 
Low concentrations of several candidate surfactants (Table 2.1) were tested to 
determine whether they changed the optical response of the GT15mir19 sensor. 
Several classes of amphipathic molecules were introduced to the GT15mir19 sensor to 
assess their potential to modulate the optical response to hybridization. Selected 
molecules included ionic surfactants, non-ionic triblock copolymers, non-ionic 
surfactants, PEG-functionalized lipid, and BSA due to their variety of steric and 
electrostatic properties (Table 2.1). After treatment for 4 hours with each amphipathic 
molecule, but before addition of target oligonucleotide, emission spectra were 
measured to assess the effect of each molecule in the absence of target miRNA. The 
impact on center wavelength and intensity are shown for the (7,5) nanotube, which 
was similar to the responses of other chiralities (Figure 2.16). All molecules either 
elicited a blue-shift to varying degrees or had no apparent effect. SDC was an outlier 
in that the intensity was enhanced 2-3 fold. While other molecules were found to also 
enhance intensity to different degrees, none matched the effect of SDC. 
 
Table 2.1 Panel of amphipathic molecules tested. 
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Figure 2.16 Baseline response to amphipathic molecules. a, Mean peak wavelength 
and b, intensity values of the GT15mir19 complex after incubation with amphipathic 
molecules. Data is shown for the (7,5) nanotube species. Error bars represent standard 
deviation from three technical replicates. 
 
For each set of surfactant-treated nanotubes, complementary and non-complementary 
target oligonucleotides were introduced and incubated for 4 hours. Each amphipathic 
molecule was tested at a final concentration of 0.2% wt/vol with 2 mg/L of 
GT15mir19. Endpoint data showed that SDBS and IGEPAL provided the greatest 
enhancement of target miRNA-induced blue-shifting, followed by SDS, Brij52, and 
lipid-PEG to a smaller extent (Figure 2.17). The presence of Pluronic, SDC, and 
Triton X-100 resulted in no apparent blue-shift of the sensor upon introduction of 
target miRNA, although we note that SDC and Triton X-100 substantially blue-shifted 
the nanotube before target oligonucleotides were added. The initial blue-shift suggests 
that these amphiphiles likely coated the nanotube so efficiently as to displace water 
from the nanotube surface and prevent the capture sequence of the GT15mir19 
oligonucleotide from interacting with the nanotube surface prior to hybridization. 
There are no obvious patterns relating the structure of the amphiphiles to the 
modulation of the response to miRNA, although there are certain factors that can be 
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noted. It is not surprising that SDC caused an initial blue-shift and prevented the 
response to miRNA, for example, because it is a very strong surfactant that is known 
to efficiently suspend nanotubes and enhance nanotube emission. Pluronic and Triton 
X-100 are fairly large/bulky surfactant molecules which may have similarly prevented 
interactions of the capture sequence with the nanotube surface. We also note the 
structural similarity between SDBS and IGEPAL, the two surfactants that resulted in 
the largest hybridization-induced enhancements. The supramolecular interactions of 
the surfactant molecules with each other and the nanotube surface are complex and 
warrant further study in this context. 
 
Figure 2.17 Change of the GT15mir19 sensor response to miRNA upon 
interrogation with a panel of amphiphilic molecules. a,Wavelength shift from buffer 
control and b, intensity fold enhancement over buffer control are shown following incubation 
with the target oligonucleotide or non-complementary control after 4 hours. 
 
The study found that a low concentration (0.2% wt/vol, or 5.7 mM) of sodium 
dodecylbenzenesulfonate (SDBS), a mild surfactant known to associate with 
nanotubes38, resulted in an increase in the degree of hybridization-dependent blue-
shifting and intensity enhancement by an order of magnitude (Figure 2.18). In the 
SDBS-supplemented buffer-only condition and in the presence of the R23 control, the 
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emission bands broadened slightly but did not increase or shift appreciably. Upon 
hybridization in the presence of SDBS, all nanotube chiralities exhibited a greatly 
enhanced blue-shift (Figure 2.19), even those that that did not blue-shift in the absence 
of SDBS (Figure 2.4). A significant blue-shift in the excitation wavelength was also 
observed (Figure 2.20). The magnitude of blue-shifting and intensity enhancement 
(Figure 2.21) upon hybridization of DNA and RNA were identical. In the absence of 
the target oligonucleotide, the GT15mir19 sensor emission remained stable over a 
wide-range of SDBS concentrations (Figure 2.22). To further assess the specificity of 
the sensor response, we introduced an ensemble of randomly generated 
oligonucleotides. A random library of 23 nt oligonucleotides, with a diversity of 
approximately 423 different sequences, was introduced to the GT15mir19 sensor, 
resulting in no response (Figure 2.23). In the presence of the random library, the 
GT15mir19 sensor maintained sensitivity to miR-19.  
 
 
Figure 2.18 Photoluminescence spectra of the GT15mir19 sensor on hybridization 
with miR-19 in the absence (Top) or presence (Bottom) of SDBS, normalized to the 
buffer condition . 
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Figure 2.19 Response of the sensor complex to analyte DNA or RNA with the miR-
19 sequence, or a control sequence (R23), in the presence of SDBS, for each 
nanotube chirality. 
 
 
 
Figure 2.20 Excitation and emission wavelength shifts of the GT15mir19 sensor, 
calculated from photoluminescence excitation/emission (PL) plots. a, Absolute 
wavelength shifts of the sensor upon introduction of miR-19 RNA or random 
sequence RNA control (R23). b, Change in excitation and emission energy in response 
to miR-19 RNA or random sequence RNA control (R23). Red = nanotube chiralities 
that satisfy (2n+m) mod 3 = 1 (mod 1). Blue = nanotube chiralities that satisfy (2n + m) 
mod3 = 2 (mod2). The Pearson correlation coefficient for the x vs. y values of each 
graph is indicated. Error bars represent standard error of the mean for n = 3 technical 
replicates. 
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Figure 2.21 Change in intensity of the GT15mir19 sensor in the presence of 0.2% 
SDBS. Intensity was calculated from photoluminescence excitation/emission plots and 
normalized to buffer only control. Error bars represent standard error of the mean for n 
= 3 technical replicates. 
 
Figure 2.22 Emission response of the GT15mir19 sensor to different SDBS 
concentrations, in the absence of analyte. a, Emission wavelengths of 11 nanotube 
chiralities after an overnight incubation with SDBS. b, Intensity change in response to 
SDBS. Dotted lines indicate critical micelle concentration (CMC, 1.6 mM), and the 
concentration of SDBS used in most experiments of this work (5.7 mM, 0.2% w/v). 
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Figure 2.23 Response to random sequence controls. Wavelength response of the 
GT15mir19 sensor in the presence of random permutations of DNA 23 nucleotides in 
length (random seqs.) alone, random seqs. with miR-19 DNA, and random seqs. with 
miR-19 RNA. The responses of three different nanotube chiralities are shown. Error 
bars represent standard error of the mean for n = 3 technical replicates. 
 
2.3.3 SDBS-induced spectroscopic changes 
Previous work has shown that the optical transition energies for DNA-wrapped 
nanotubes are red-shifted by 10-20 meV (14-22 nm, depending on chirality) and 
quenched as compared to nanotubes suspended entirely with small molecule anionic 
surfactants like SDS or SDBS39-41. A proposed mechanism has attributed this finding 
to incomplete coverage of the nanotube surface by DNA, which allows for greater 
accessibility of water, resulting in an increased polarity of the local solvent 
environment (higher local dielectric constant) in the immediate vicinity of the 
nanotube41. In the current work, we observed a blue-shifted shoulder in the spectrum 
of the GTmir19 sensor in the absence of the complementary miR-19 strand upon 
introduction of SDBS. In light of previous findings, this spectral change suggests that 
SDBS binds to the exposed surfaces on the DNA-suspended nanotube, causing the 
displacement of water from the nanotube surface, which produces a slight blue-shift in 
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the emission. When target RNA or DNA hybridizes and the duplex dissociates from 
the surface, bare nanotube surface is exposed, allowing SDBS to bind and become the 
dominant factor determining of the nanotube emission peak wavelength, and intensity. 
The net effect was a dramatic blue-shift (4-17 nm, depending on the nanotube chirality) 
and intensity increase (1.3 -2.2 fold) from the assembly of supramolecular complexes 
of SDBS, triggered by the introduction of target RNA or DNA.  
 
From spectroscopic studies of the GT15mir19 sensor response, we observed a blue 
shift in nanotube excitation wavelengths, suggesting that the binding of miR-19 RNA 
and DNA affects the ground state absorption energies in addition to the excited state. 
Figure 2.20a shows the correlation between the excitation wavelength shift and the 
emission wavelength shift for the ensemble of chiralities, yielding a Pearson 
correlation coefficient of 0.87744 (p=0.00188). When plotted as change in energy 
(Figure 2.20b), the Pearson correlation coefficient is similar 0.90656 (p=0.0007). The 
environmental effects on nanotube optical properties have been shown to depend at 
least in part on the mod type of the nanotube42. On stratifying the nanotubes by mod 
type, defined for any nanotube as mod(n-m,3), we found that mod2 nanotubes 
exhibited an emission energy modulation that increased nearly linearly (R2=0.9272) 
with nanotube diameter (Figure 2.24a). Interestingly, for the mod2 nanotubes, the 
intensity enhancement did not show the same linear relationship with nanotube 
diameter, although all nanotubes increased in intensity. A maximum was found for 
nanotubes ~0.9 nm in diameter (Figure 2.24b). A slight difference also became 
apparent between the responses to target DNA and RNA, with RNA eliciting a slightly 
enhanced intensity increase for small diameter nanotubes and a slightly dampened 
enhancement for larger diameter nanotubes. This small, diameter-dependent difference 
63 
 
may be related to the difference in binding strength and hydration between DNA-DNA 
hybrids and DNA-RNA hybrids43, 44. 
 
Figure 2.24 Diameter dependence of emission energy change and intensity change. 
a, Change in emission energy of the GT15mir19 sensor as a function of nanotube diameter, for 
mod2 nanotubes. b, Change in GT15mir19 sensor emission intensity, as a function of 
nanotube diameter, for mod 2 nanotubes. Error bars represent standard error of the mean for n 
= 3 technical replicates 
 
We present our model of SDBS-mediated hybridization-dependent signal 
enhancement in Figure 2.25, wherein hybridization triggers SDBS assembly on the 
newly-exposed nanotube surface.  
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Figure 2.25 Cartoon depicting the proposed mechanism of SDBS-mediated 
enhancement of the blue shifting response upon hybridization. 
 
2.3.4 Detection limit, kinetics, and breadth of applicability 
Given the variety of potential miRNA biomarkers, we sought to assess the modularly 
of the sensor. The miRNA capture sequence was substituted with several sequences 
specific to 9 different serum or urine miRNA biomarkers, as well as a sequence not 
found in humans (C. elegans miR-39) used for standardization in clinical 
applications45 (Table 2.2). Each GT15mirX sensor was treated with SDBS and 
interrogated with its respective miRNA target sequence, resulting in a wavelength 
shift which was comparable to that of the original miR-19 sensor, with slight 
sequence-to-sequence variations (Figure 2.26 and Figure 2.27). Intensity was similarly 
enhanced (Figure 2.28). In all of the sensors, no appreciable responses from the 
control sequence (R23) were observed.  
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Table 2.2 Disease-relevant miRNA biomarkers 
 
 
 
Figure 2.26 Optical responses of the sensor composed of different capture 
sequences to recognize the specified miRNA sequences (DNA analogues), shown for 
the (7,5) chirality. 
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Figure 2.27 Emission wavelength response of GT15mirX sensors to their 
complementary miR biomarker sequence or R23 non-complementary control (DNA). 
The responses of four nanotube chiralities are shown. Error bars represent standard 
error of the mean for n = 3 technical replicates. 
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Figure 2.28 Intensity response of the GT15mirX sensors after the introduction of 
target miR sequences or R23 non-complementary control. The response of the (7,5) 
nanotube is shown, normalized to the buffer only control. Error bars represent 
standard error of the mean for n = 3 technical replicates. 
 
To determine if the SDBS-GT15mirX sensor could discriminate among similar 
sequences, three related sequences from the miR-200 family were selected. The miR-
200 family plays an essential role in the epithelial-to-mesenchymal transition (EMT)46 
in cancer. Focusing on the wavelength response of the (9,4) nanotube chirality, we 
observed a high degree of discrimination between the three sequences after one hour 
of incubation (Figure 2.29). Complete time-course data for both the (9,4) and (8,6) 
nanotubes (Figure 2.30 and 2.31, respectively) revealed that the intensity increase 
provided near-perfect discrimination in most cases. Although the SDBS-GT15mirX 
sensor responded to target miRNA via both wavelength shifting and intensity changes, 
we assessed detection limits, kinetics, and other sensor characteristics using the 
wavelength response, due to the inherent quantifiability and internal standard provided 
by this mode.  
 
68 
 
Figure 2.29 Intensity response of the GT15mirX sensors after the introduction of 
target miR sequences or R23 non-complementary control. The response of the (7,5) 
nanotube is shown, normalized to the buffer only control. Error bars represent 
standard error of the mean for n = 3 technical replicates 
 
 
 
Figure 2.30 Kinetic response of the GT15mirX sensor to three closely-related 
sequences for the (9,4). The response of the (9,4) chirality is shown. a and b, 
wavelength shift and intensity change of the sensor specific for miR-141 
(GT15mir141). c and d, wavelength shift and intensity change over time for sensor 
specific for miR-200b (GT15mir200b). e and f, wavelength shift and intensity fold 
change over time for sensor specific for miR-429 (GT15mir429). Error bars represent 
standard error of the mean for n = 3 technical replicates. 
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Figure 2.31 Kinetic response of the GT15mirX sensor to three closely-related 
sequences for the (8,6). The response of the (8,6) chirality is shown. a and b, 
wavelength shift and intensity fold change over time for sensor specific for miR-141 
(GT15mir141). c and d, wavelength shift and intensity fold change over time for 
sensor specific for miR-200b (GT15mir200b). e and f, wavelength shift and intensity 
fold change over time for sensor specific for miR-429 (GT15mir429). Error bars 
represent standard error of the mean for n = 3 technical replicates. 
 
To determine the limit and range of detection, a dose-response curve of the sensor was 
constructed over several orders of magnitude of miR-19 concentrations. At a minimal 
sensor concentration of 0.02 mg/L, the limit of detection of miRNA was between 10 
and 100 pM (500 attomoles to 5 femtomoles) (Figure 2.32). Signal saturation occurred 
at a high concentration between 1 and 10 nM. The dynamic range was tuned by 
adjusting the concentration of the GT15mir19 sensor to cover at least 5 orders of 
magnitude, from 10 pM to 1 uM (Figure 2.33). We calculated the number of binding 
sites using the mass of DNA used to suspend 1 mg of nanotubes (see Methods). We 
estimated that 2.117 nM of miR-19 binding sites were available in a solution of 0.02 
mg/L of the GT15mir19 sensor, consistent with the observed saturating range of 
concentrations (between 1 and 10 nM).  
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Figure 2.32 Dose-response curve of the GT15mir19 sensor, shown for the (7,6) 
nanotube species. 
 
Figure 2.33 Dose-response curves of the GT15mir19 sensor response, using three 
different sensor concentrations. Table indicates observed limit of detection (LOD), 
calculated number of binding sites, and measured saturating range of the sensor. Error 
bars represent standard error of the mean for n = 3 technical replicates. 
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The kinetics of both DNA and miRNA detection were assessed via transient 
measurements. The kinetics of eleven different nanotube chiralities were measured by 
excitation/emission spectroscopy (Figure 2.34). Within 10 minutes of introducing the 
analyte to the sensor, significant blue-shifting was discerned. The rate of blue-shifting 
behaved with pseudo-first order kinetics and showed no obvious dependence on 
nanotube structure (Figure 2.35). The sensor kinetics were consistently faster for DNA 
(1.8x on average), as compared to RNA (Figure 2.36). We ascribe this difference to 
the longer persistence length and higher rigidity of single-stranded RNA as compared 
to single-strand DNA47. 
 
 
Figure 2.34 Kinetic data for all measured chiralities of the GT15mir19 sensor after 
addition of miR-19 DNA or miR-19 RNA. Data was acquired in 10-minute intervals. 
All data is fitted to an exponential decay, 𝑦 = 𝑦0 𝑒−𝑘𝑘. 
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Figure 2.35 Comparison of the response rate of the GT15mir19 sensor to DNA or 
RNA versions of the target, for eleven different nanotube chiralities. a, Rate constant 
K of the GT15mir19 wavelength response after addition of miR-19 DNA or RNA, 
arranged according to nanotube diameter. b, Comparison of rate constants of each 
nanotube chirality, in response to miR-19 DNA and miR-19 RNA. 
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Figure 2.36 Kinetics of the sensor response upon interrogating with miR-19 RNA or 
the DNA analogue, fitted with the exponential function, 𝒚 = 𝒚𝟎 𝒆−𝒌𝒌. R2=0.97 and 
0.99 for DNA and RNA, respectively. 
 
To test if the composition of the miRNA capture sequence influenced sensor kinetics, 
we compared the response rates for the sensor using 8 different miRNA capture 
sequences (Figure 2.37). On comparing the sensor kinetics as a function of guanine 
content, we found a significant correlation, with Pearson coefficients of -0.74195 
(p=0.035) for the (9,4) nanotube and -0.77215 (p=0.0248) for the (8,6) nanotube 
(Figure 2.38). This result may be explained by the high affinity of guanine for the 
nanotube surface, which was determined previously via both molecular dynamics and 
ab initio calculations48 to fall in the order: G > A > T > C. Thus, the affinity of guanine 
to the nanotube surface may slow the hybridization process. The content of other 
nucleotide bases, as well as the overall ΔG of hybridization, did not show any 
statistically significant correlations (Figure 2.39 and 2.40).  
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Figure 2.37 Kinetics of the wavelength response of GT15mirX sensors after addition 
of target miR biomarker sequences. a, Response of the (9,4) nanotube chirality. b, 
Response of the (8,6) nanotube chirality. Smooth curves are fitted exponential decays, 
𝑦 = 𝑦0 𝑒−𝑘𝑘. 
 
 
 
 
 
 
 
 
Figure 2.38 GT15mirX sensor response rates vs. guanine content of the miRNA 
capture sequences. a, Response of the (9,4) nanotube chirality. b, Response of the 
(8,6) nanotube chirality. Pearson correlation coefficients are indicated. 
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Figure 2.39 GT15mirX sensor response rates of the (9,4) vs. thymine, adenosine, 
and cytosine content of the miRNA capture sequence, or free energy of 
hybridization of the miRNA capture sequence. Response of the (9,4) chirality was 
measured. No statistically significant correlations were found. 
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Figure 2.40 GT15mirX sensor response rates of the (8,6) vs. thymine, adenosine, 
and cytosine content of the miRNA capture sequence, or free energy of 
hybridization of the miRNA capture sequence. Response of the (8,6) chirality was 
measured. No statistically significant correlations were found. 
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To better understand how the length and thermodynamics of hybridization relate to the 
optical response of the nanotube, we conducted several experiments using modified 
analyte oligonucleotides. We interrogated the G15mir19 sensor using analyte 
sequences between 10 and 23 nucleotides long which were complementary to either 
the 3′ terminal end of the miRNA capture sequence, or the middle of the sequence, as 
depicted in Figure 2.41. We found that, in general, a shorter analyte sequence resulted 
in a smaller blue-shifting response of the nanotube, down to approximately 10 
nucleotides, where there was virtually no response (Figure 2.42). Additionally, the 
magnitude of the blue-shifting response was consistently smaller when the analyte 
sequence was designed to hybridize to the middle of the capture sequence. This 
difference may be explained by the affinity of the capture sequence to the nanotube, as 
suggested by the results of the fluorophore quenching experiment, MD simulations, 
and free energy analyses48.  
 
Figure 2.41 Cartoon illustrating truncated analyte sequences complementary to the 
middle or 3’ end of the capture sequence.  
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Figure 2.42 Emission response of the sensor to a series of truncated sequences 
(length specified in the x axis) designed to hybridize to either the middle or 3’ end of 
the capture sequence. 
 
To assess its broad applicability for the detection of different nucleic acid types, we 
assessed whether the sensor could detect oligonucleotides longer than miRNA 
sequences. First, we assessed how the GT15mir19 sensor would respond to a long 
oligonucleotide designed to contain a complementary sequence flanked by non-
complementary sequences. On interrogating the sensor with R23-mir19-R23, a 69-bp 
oligonucleotide with 23 complementary bases in the middle of the sequence, the 
sensor emission red-shifted—opposite of the expected blue-shifting response—even in 
the presence of SDBS (Figure 2.43, shown for the (8,6) chirality). We therefore 
hypothesized that, when R23-mir19-R23 hybridizes to the recognition sequence, the 
R23 portion at the 5′ end may disrupt the sensor function by increasing the phosphate 
content near the nanotube surface to cause a red-shift of the nanotube emission. To test 
this hypothesis, we designed two long oligonucleotide sequences, R23-mir19 and 
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mir19-R23, placing the R23 portion at either the 3′ end or 5′ end. The proposed 
orientation upon binding and predicted spectral shifts are shown in Figure 2.44a—the 
two sensors were hypothesized to give the opposite spectral responses. Upon 
interrogating the sensor, the R23-mir19 oligonucleotide produced a red-shifting 
response, and the mir19-R23 oligonucleotide produced a blue-shift, as predicted 
(Figure 2.44b). The magnitude of the blue-shift in response to mir19-R23 was smaller 
than that produced by the miR-19 control, suggesting that the unhybridized single-
stranded nucleotides may bind to the nanotube surface, diminishing the response. This 
hypothesis warrants further study. Regardless, we conclude that sensors based on the 
GT15 nanotube binding domain and a general capture sequence can be extended to 
detect longer nucleic acid sequences, but the orientation of the oligonucleotide is 
critical for eliciting a desired spectral response. 
 
 
Figure 2.43 Assessing the effect of hybridization location. a, Cartoon illustrating a 
modified analyte sequence and expected configuration upon binding to the 
GT15mir19 sensor. b, Spectral response of the (8,6) nanotube species upon 
introduction of long analyte sequences to the sensor 
 
 
80 
 
Figure 2.44 Effect of overlap orientation on wavelength shift. a, Cartoons depicting 
experiment designed to assess orientation of partial complementary sequences, as well 
as predicted sensor responses. b, Response of the (8,6) nanotube species upon 
interrogating the GT15mir19 sensor sensor with the partial complementary 
oligonucleotides. All error bars represent standard deviation for n = 3 technical 
replicates. 
2.3.5 Measurements of single sensor complexes 
We assessed the sensor function on the single-nanotube level via spectral imaging. 
The sensor was deposited on a lysine-coated glass surface with sodium dodecyl sulfate 
(SDS). We then used hyperspectral microscopy29 to spectroscopically image the (9,4) 
nanotube (Figure 2.45a). The blue-shifting of single nanotubes was apparent upon 
interrogating the sensor with miR-19 RNA, but not upon introducing R23 RNA 
(Figure 2.45b-d). Using the number of binding sites per nanotube length determined 
from AFM measurements (Figure 2.7), we attempted to estimate the number of copies 
of miRNA detected per nanotube. Because a diffraction-limited spot could contain a 
nanotube up to ~600nm long49, we estimate a range of detection between 1-60 miRNA 
molecules.  
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Figure 2.45 Single nanotube response to miRNA hybridization. a, Broadband near-
infrared image of the GT15mir19 sensor adsorbed to a glass surface. b, Change in 
emission wavelength of individual (9,4) nanotubes after incubation of the surface-
bound complexes with miR-19 RNA or R23 RNA at room temperature (unpaired, 
two-tailed t test, p=0.0014, n = 24). c, Representative spectra of the same sensor 
complex in the buffer-only condition and 50 min after introducing miR-19. d, 
Representative spectra of the same sensor complex in the buffer-only condition and 50 
min after introducing the R23 control sequence. 
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2.3.6 Sensor multiplexing 
We assessed the potential for the multiplexed detection of several miRNA sequences 
via the use of different nanotube chiralities. Two nanotube preparations enriched for 
different nanotube chiralities were suspended with binding sequences for either miR-
19 or miR-509. A preparation enriched in large diameter species, (Nano-C APT-200) 
was suspended by the GT15mir19 sequence, and a CoMoCAT preparation enriched in 
small diameter species was suspended using the GT15mir509 sequence. 
Excitation/emission plots found that the GT15mir19 sensor, encapsulating the APT-
200 nanotubes, effectively lacked the (6,5) species (Figure 2.46a), while the 
GT15mir509 sensor, encapsulating the narrow-diameter enriched CoMoCAT 
preparation, lacked the (8,6) species (Figure 2.46b). Absorbance spectra verified the 
differential enrichment of nanotube chiralites between these samples (Figure 2.47). 
After mixing the two nanotube preparations, each miRNA sequence added 
individually was recognized by the appropriate nanotube chirality (Figure 2.48). When 
miR-19 and miR-509 were added together, the spectral shift almost identically 
recapitulated the shifts seen when either miRNA was added alone.  
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Figure 2.46 Photoluminescence excitation/emission plot of the GT15mir19 sensor 
synthesized using a large-diameter nanotube preparation. b, Photoluminescence 
excitation/emission plot of the GT15mir509 sensor synthesized using a small-diameter 
preparation of carbon nanotubes. Red circles highlight the differences in chiralities 
present. 
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Figure 2.47 Normalized absorbance spectra of GT15mir19 oligonucleotide-
suspended APT-200 from Nano-C and GT15mir509 oligonucleotide-suspended 
CoMoCAT SG65i grade. 
 
 
 
Figure 2.48 Responses of the two sensors mixed together, upon introducing miR-19 
alone, miR-509 alone, or both analytes simultaneously. Error bars represent standard 
deviation for n = 3 technical replicates. 
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2.3.7 Toehold-mediated strand displacement 
We asked whether the spectral response of the sensor could be reversed via toehold-
mediated strand displacement. Strand displacement reactions occur through the use of 
“toeholds,” single-strand overhangs on duplexed DNA that facilitate binding of a 
complementary strand, which is thermodynamically favored due to complete 
complementarity, and is thus able to displace the shorter bound strand50. We truncated 
the miRNA capture sequence of the GT15mir19 sensor to leave a 6 nucleotide 
overhang51 after hybridization with the target strand to test whether the addition of a 
removing strand (RS) to bind the toehold and displace the target would reverse the 
spectral shift, according to the proposed scheme in Figure 2.49a. Upon addition of 
miR-19 to the modified GT15mir19 sensor, the nanotube emission blue-shifted and 
the intensity increased as expected (Figure 2.49b and 2.49c). After 5 hours, the 
removing strand was added, at which point the blue-shifting ceased and the emission 
began to undergo a steady red-shift (Figure 2.49b). The emission intensity exhibited a 
similar reversal (Figure 2.49c). We note that the signal reversal was slower than 
detection in the forward direction, which is likely due to the energetic barrier for the 
truncated capture sequence to displace SDBS from the nanotube surface.  
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Figure 2.49 Monitoring toehold-mediated strand displacement. a, Cartoon depicting 
the experiment, wherein the GT15mir19 sensor contains a truncated miRNA-capture 
sequence (orange domain). Upon hybridization with miR-19, a 6-nucleotide toehold 
remains on the miRNA sequence (purple strand). The removing strand (red), which is 
complementary to the entire miRNA sequence, is introduced to remove miR-19. b, 
Kinetic response of the GT15mir19-sensor wavelength upon addition of the target 
miRNA sequence, and after introducing the removing strand (RS), at the time denoted 
by the arrow. c, Kinetic response of the GT15mir19 sensor intensity, measured during 
the same experiment. Error bars represent standard deviation for n = 3 technical 
replicates. 
 
2.3.8 Detection of miRNA in biofluids  
We sought to assess the ability of the GT15mir19 sensor to detect miRNA binding 
events in common biofluids—urine and serum—due to their clinical value as sources 
of microRNA biomarkers8. The GT15mir19 sensor and SDBS were introduced 
concomitantly to whole urine from 5 healthy donors before interrogating with miR-19 
RNA. The wavelength shifting response was clearly detectable against controls down 
to 1 nM of miRNA, and intensity enhancement gave a similar sensitivity, between 1 
and 10 nM (Figure 2.50, Figure 2.51). Variation from sample-to-sample was minimal. 
In whole serum, we found that target miR-19 DNA was similarly detectable in the 
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presence of SDBS (Fig 2.52). When target miR-19 RNA was introduced to the sensor, 
we found only a small response at the highest tested concentration (Fig 2.52). We 
hypothesized that the RNA detection was complicated by RNases in the serum which 
might degrade the analyte sequence, as reported elsewhere for synthetic RNA 
sequences52. We therefore introduced proteinase K, a detergent-stable protease used to 
deactivate RNase, into the serum. Introduction of proteinase K allowed the detection 
of miR-19 RNA with the same sensitivity as for the DNA analogue (Figure 2.52). 
When proteinase K was introduced 12 h after mixing miR-19 with serum, the 
sensitivity of the response to miR-19 RNA was not improved, suggesting that the 
RNA had been destroyed. To verify broad applicability with this method, we also used 
miR-21 as a target, due to its significance as a serum colorectal cancer biomarker53. 
We similarly tested GT15mir21 sensor in whole serum treated with proteinase K and 
found that miR-21 RNA could be detected directly in minimally-treated serum via 
both blue-shifting and intensity enhancement (Figure 2.53).  
 
Figure 2.50 Response of the GT15mir19 sensor emission wavelength to miR-19 
spiked into urine from 5 healthy donors. The (7,6) nanotube chirality was measured. 
Error bars represent standard deviation of technical triplicates. b, Intensity response of 
the sensor in urine. Error bars represent standard deviation of technical triplicates. 
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Figure 2.51 Sensor response in urine from individual healthy donors. a, Wavelength 
shift as a function of miR-19 RNA or non-complementary control R23 concentration 
for each individual donor. b, Intensity fold enhancement as a function of added miR-
19 RNA or non-complementary control R23 concentration. Error bars represent 
standard deviation of three technical replicates. 
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Figure 2.52 Study of the sensor response in serum. a, Wavelength shift of the 
GT15mir19 sensor in whole serum with 0.2% SDBS and upon addition of proteinase K. The 
response of the (8,6) nanotube is shown. b, Intensity change in the same conditions. Error bars 
represent standard deviation of three technical replicates. 
 
 
 
Figure 2.53 Detection of miR-21 in serum. (Left) Wavelength response of the 
nanotube sensor complex to miR-21 and miR-19 miRNA in fetal bovine serum (FBS). 
Error bars represent standard deviation of technical triplicates. (Right) Intensity 
response of the GT15mir21 sensor after introducing the miR-21 RNA oligonucleotide in 
serum with proteinase K. Error bars represent standard deviation of three technical replicates. 
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2.3.9 Detection of miRNA detection in vivo 
We further explored the potential of the sensor to detect miRNA in vivo via a 
minimally-invasive implantable device. We loaded the SDBS-treated GT15mir19 
sensor into a semipermeable membrane capillary with a MWCO of 500 kDa (Figure 
2.54a). To determine whether this cutoff would to prevent the diffusion of the 
GT15mir19 sensor complexes outside of the membrane, we calculated the molecular 
weight of the GT15mir19 sensor. We estimated that the sensor complexes composed 
of the narrowest diameter (0.8 nm) and average length of 166nm fall within the range 
of 701 kDa to 839 kDa. The molecular weight of the sensor was estimated using the 
lower limit of the nanotube diameters to be 0.8 nm, wherein there are 20 carbons 
around the nanotube circumference. Thus, 80 carbon atoms are present for every 0.283 
nm in nanotube length. Taking the average length of the nanotube, as measured via 
AFM, to be 166 nm, the resulting molecular weight of the nanotube is 564 kDa. The 
molecular weight of the GT15mir19 DNA sequence is 16.5 kDa. From AFM 
measurements, we estimated 5-10 copies of DNA per 100 nm, and thus 8.3 to 16.6 
copies per 166 nm, adding 137 kDa to 275 kDa to the total complex. Thus, for an 
average length GT15mir19 sensor with diameter near the lower limit, the molecular 
weight would be between 701 kDa and 839 kDa. 
 
We surmised that the miR-19 miRNA, with a molecular weight of 7.055 kDa, would 
pass through the membrane. We also assessed the likelihood that the enhanced signal 
response provided by SDBS would continue after device implantation. We thus filled 
the semi-permeable capillary with SDBS-pretreated GT15mir19 sensor and placed it 
in buffer dialysate for 6 hours. The buffer was changed and the sensor response was 
assessed with miR-19 every 2 hours (Figure 2.54b and c). We found that the 
91 
 
GT15mir19 sensor exhibited a nearly identical blue-shifting response after 6 hours of 
dialysis, suggesting that the SDBS remained associated with the sensor even under 
these conditions.  
 
Figure 2.54 Implantable device testing in vitro. a, Semi-permeable membrane 
encapsulating the GT15mir19 sensor for implantation. b, Persistence of wavelength 
shifting of the GT15mir19 sensor upon dialysis of SDBS. c, Emission wavelength 
response of the sensor, interrogated after the indicated dialysis time. Buffer changes 
are indicated by the arrows. c, Average emission wavelength the sensor in response to 
miR-19 DNA and buffer control at all time points. 
 
We tested the sensor response in vivo after surgically implanting the membrane into 
the peritoneal cavity of NU/J (nude) mice. The membrane was placed medially over 
the intestines and sutured to the parietal peritoneum to immobilize the device. We first 
tested whether DNA could be detected intraperitoneally by injecting 1 nanomole of 
miR-19 DNA, R23, or the vehicle control. The mice exhibited no obvious adverse 
effects or changes in behavior following the implantation or injection. After 90m, the 
mice were anesthetized using isofluorane. A fiber optic-based probe system was 
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developed to excite an 0.8 cm2 area with a 730 nm CW laser (Figure 2.55a), collect the 
emitted near-infrared light through the same fiber bundle, disperse the light with a 
Czerny-Turner spectrograph, and detect the light via a 1D InGaAs array (Figure 
2.55b). Using the nanotube emission signal collected from the mouse, we found that 
the target miR-19 DNA exhibited a significant blue-shifting response as compared to 
controls (Figure 2.56a). The experiment was repeated using the RNA version of the 
analyte, resulting in a similar response (Figure 2.56b). We tested the implantable 
device in vitro by immersing the filled capillary into buffer containing RNA, finding 
that the threshold of detection was below 10 pmol (Figure 2.57). To determine the 
limit of detection in vivo, we injected 500 pmol, 100 pmol, or 50 pmol of miR-19 
RNA intraperitoneally into mice implanted with the devices. After 120 min, 
significant wavelength shifting responses were measured down to 100 pmol (Figure 
2.58). The devices were removed from the animals and measured ex vivo, resulting in 
similar results (Figures 2.59). We suspect the higher limit of detection of the device in 
vivo as compared to in vitro was due to the degradation of microRNA in the peritoneal 
fluid as well as fluid exchange out of the peritoneal cavity. The measurement of 
endogenous microRNA targets, which are highly stable due in part to their association 
with proteins such as Ago254, 55, may help improve sensor performance in future 
investigations. 
 
Figure 2.55 Optical probe system for animal studies. a, Diagram of NIR probe 
apparatus for illuminating and measuring the sensor response in vivo. b, Image of NIR 
probe system measuring the nanotube response within a live mouse. 
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Figure 2.56 Response of the implanted sensor device to miR-19 DNA within the live 
mouse (3-4 measurements per mouse; 3 mice per group). The (9,4) nanotube species 
was measured (p<0.0001, Dunnet’s multiple comparison test, ordinary one-way 
ANOVA). Response of the implanted sensor device to 1 nanomole of miR-19 RNA 
within live mice. The (8,6) nanotube chirality was measured; 3-4 spectra per animal 
were taken; 3 animals were measured per group (p<0.0001, Dunnet’s multiple 
comparison test, ordinary one-way ANOVA). 
 
Figure 2.57 Dose-response curve of the GT15mir19 sensor capillary device 
measured in vitro. 
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Figure 2.58 Response of the implanted sensor device to 500, 100, and 50 pmol of 
miR-19 RNA or R23 RNA injected into mice intraperitoneally (3-4 measurements 
per animal; 3 animals per group), shown for the (8,7) nanotube species. 50 pmol R23 
was slightly red-shifted compared to buffer control. Error bars represent standard 
deviation. Statistical significance was calculated with Dunnet’s multiple comparison 
test. Ordinary ANOVA was used to compare the mean of each group to the mean of 
the buffer control. Sidak’s multiple comparison test with an alpha of 0.05 was used to 
compare miR-19 groups. 
 
Figure 2.59 Emission from the implantable devices ex vivo. Ex vivo measurements 
from device removed from one animal in each group after injection of buffer, 500 
pmol miR-19 RNA, or 500 pmol R23 RNA. Error bars represent standard error of the 
mean for 3-4 measurements. 
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2.4 Outlook 
Herein, we engineered a label-free, amplification-free optical sensor for the 
quantitative detection of oligonucleotide hybridization events in vitro and non-
invasively in vivo. The sensor mechanism, resulting from competitive effects of the 
displacement of both electrostatic charge and water from the carbon nanotube surface, 
has implications for the improvement of carbon nanotube-based optical and electronic 
sensors. We also gained a clear understanding over the effects of length, mismatches 
in sequence, and orientation of longer oligonucleotides on the optical response of the 
carbon nanotube, providing a basis for continued optimization. The GT15mirX sensor 
enabled detection via single-molecule sensor elements and multiplexing using multiple 
nanotube chiralities. The monitoring of toehold-based strand displacement events 
portends use in nucleic acid-based logic circuits56 and also allowed the reversal of the 
sensor response and regeneration of the sensor complex, which may potentially be 
exploited for continuous use.  
 
Using the current iteration of the sensor, in vitro applications such as point-of-care 
diagnostics may provide the most immediate route to clinical use. We found that the 
sensor can directly detect oligonucleotides in heterogeneous biofluids such as urine 
and serum with minimal pre-treatment, potentially circumventing biases and 
variability related to typical pre-analytical steps required for RT-qPCR45. Regarding 
sensor parameters pertinent to clinical measurements, Weber et al.8 surveyed the 
microRNA content in 12 body fluids, providing useful quantitative information to 
estimate the physiological range of microRNA. In urine, the median concentration of a 
microRNA species is on the scale of tens of pM8, while in plasma and peritoneal fluid 
it is in the hundreds of pM8. Other quantitative sensors57 found biofluid microRNA 
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concentrations in the high femtomolar range, suggesting that the dynamic range may 
fall between about 10 fM and 100 pM. The current limit of detection of our sensor in 
bulk solution is in the picomolar range, although the threshold of detection and 
dynamic range depends on several factors, including binding site coverage, which 
have not yet been modulated in the development process. We also demonstrated the 
ability to measure single-nanotube responses representing 1-60 copies of microRNA 
binding, suggesting developments that might attain sensitivities down to 10’s of copies 
of microRNA, potentially rivaling the most sensitive techniques52, 58, 59.  
 
An implantable optical sensor device for the non-invasive detection of biomarkers 
such as miRNA may potentially be used in conjunction with wearable devices to 
facilitate the optical readout and data recording. Our sensor implant quantified miRNA 
down to 100 pmol in vivo, although further optimization of the sensitivity and other 
parameters is warranted. While in vitro experiments suggest the current version of the 
sensor to be robust over at least several hours, more testing is needed to determine 
stability over longer periods. Investigations are also needed to ensure that 
oligonucleotides can be detected in their physiological states. For example, miRNA is 
often found associated with the small protein Ago254, which makes it physiologically 
stable. Functionally, Ago2 binds to microRNA in a conformation to favor 
hybridization with target sequences, especially over an 8 nucleotide section called the 
seed sequence60, 61, but steric hindrance or charge interactions of the protein with 
miRNA could slow access to the protein-bound sections of the strand. Future iterations 
of a sensor may include locked nucleic acids62 or peptide nucleic acids63 to enhance 
binding affinities to short, unbound sections of miRNA. Future studies are also needed 
to investigate device form factors for implantation and data collection strategies, such 
as sensor interrogation using wearable devices.  
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2.5 Methods 
2.5.1 DNA-suspension of carbon nanotubes 
Carbon nanotubes produced by the HiPco process (Unidym, Sunnyvale, CA), 
CoMoCAT process (SG65i grade, Sigma-Aldrich, St. Louis, MO, US), or a 
combustion process (APT-200, Nano-C,Westwood, MA) were mixed with DNA 
oligonucleotides (IDT DNA, Coralville, IA) at a 2:1 mass ratio in 1 mL of saline-
sodium citrate (SSC) buffer and ultrasonicated for 30 minutes at 40% amplitude 
(Sonics & Materials, Inc.). The complete list of DNA sequences used for suspension 
can be found in the Appendix. Following ultrasonication, the dispersions were 
ultracentrifuged (Sorvall Discovery 90SE) for 30 minutes at 280,000 x g. The top 80% 
of the supernatant was collected. Absorbance spectra were acquired using a 
UV/Vis/nIR spectrophotometer (Jasco V-670, Tokyo, Japan). The concentration was 
calculated using the extinction coefficient Abs910 = 0.02554 L mg-1cm-1. To remove 
free DNA, 100 kDa Amicon centrifuge filters (Millipore) were used. The DNA-
nanotube complexes were re-suspended in saline-sodium citrate buffer (G Biosciences, 
St. Louis, MO).  
 
2.5.2 Fluorescence spectroscopy of carbon nanotubes in solution 
Fluorescence emission spectra from aqueous nanotube solutions were acquired using a 
home-built apparatus consisting of a tunable white light laser source, inverted 
microscope, and InGaAs nIR detector. The SuperK EXTREME supercontinuum white 
light laser source (NKT Photonics) was used with a VARIA variable bandpass filter 
accessory capable of tuning the output 500 – 825 nm with a bandwidth of 20 nm. The 
light path was shaped and fed into the back of an inverted IX-71 microscope 
(Olympus) where it passed through a 20x nIR objective (Olympus) and illuminated a 
50-100 µL nanotube sample in a 96-well plate (Corning). The emission from the 
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nanotube sample was collected through the 20x objective and passed through a 
dichroic mirror (875 nm cutoff, Semrock). The light was f/# matched to the 
spectrometer using several lenses and injected into an Isoplane spectrograph 
(Princeton Instruments) with a slit width of 410 µm which dispersed the emission 
using a 86 g/mm grating with 950 nm blaze wavelength. The spectral range was 930 – 
1369 nm with a resolution of ~0.7 nm. The light was collected by a PIoNIR InGaAs 
640 x 512 pixel array (Princeton Instruments). A HL-3-CAL-EXT halogen calibration 
light source (Ocean Optics) was used to correct for wavelength-dependent features in 
the emission intensity arising from the spectrometer, detector, and other optics. A 
Hg/Ne pencil style calibration lamp (Newport) was used to calibrate the spectrometer 
wavelength. Background subtraction was conducted using a well in a 96-well plate 
filled with DI H2O. Following acquisition, the data was processed with custom code 
written in Matlab which applied the aforementioned spectral corrections, background 
subtraction, and was used to fit the data with Lorentzian functions. 
 
2.5.3 Atomic force microscopy 
The GT15mir19 sensor was incubated overnight at 20 mg/L with 10 uM of the miR-
19-hairpin or 10 uM of the R23-hairpin in saline sodium citrate diluted 20x in 20 mM 
HEPES + 5 mM MgCl2. The sample was plated on a freshly cleaved mica substrate 
(SPI) for 4 minutes before washing with 10 mL of dH2O and blowing dry with argon 
gas. An Asylum Research MFP-3D-Bio instrument was used with an Olympus 
AC240TS AFM probe in AC mode. Data was captured at 2.93 nm/pixel XY resolution 
and 15.63 pm Z resolution. For AFM under aqueous conditions, 20 mg/L of the 
GT15mir19 sensor was incubated with 10 uM of the miR-19-hairpin, R23-hairpin, or 
buffer overnight. All three conditions were spin-filtered 3x with 100 kDa Amicon 
centrifuge filters, and resuspended with 5 mM NiCl2, 20 mM HEPES pH 6.7 buffer. 
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The samples were plated onto freshly cleaved mica for 2 minutes before gently 
washing with the same buffer. Samples were imaged in a droplet of the buffer using an 
Asylum Research Cypher ES + BlueDrive AFM with an Olympus AC55 probe and 
imaged using BlueDrive excitation at the ambient temperature of 31°C within the 
AFM enclosure. All three samples were imaged with the same probe, consecutively, 
with the same scan settings, starting with the miR-19-hairpin sample, followed by the 
R23-hairpin control and the buffer control. 
 
2.5.4 Hybridization experiments in buffer conditions and biofluids 
Hybridization experiments were conducted with 2 mg/L of the GT15mir19 sensor in 
saline-sodium citrate buffer at room temperature. Target DNA or RNA was introduced 
to reach a final concentration of 1 uM. Samples were incubated for 4 hours, unless 
otherwise noted. Free energy of hybridization was predicted using OligoAnalyzer 3.1 
(IDT). Kinetics experiments were measured every 10 minutes using custom LabView 
code. Hybridization experiments with sodium dodecylbenzenesulfonate (SDBS) were 
conducted using a final concentration 0.2% wt/v. SDBS was added to the GT15mir19 
sensor and allowed to equilibrate overnight at room temperature before target 
oligonucleotides were added. Toehold-mediated strand displacement experiments 
were performed with 1 uM of target miR-19 DNA, and 10 uM of the removing strand, 
composed of an ssDNA oligonucleotide with the complementary sequence to miR-19. 
Hybridization experiments in urine were conducted in samples from 5 healthy 
volunteers and stored on ice until the experiment. Concentrated GT15mir19 was added 
to each sample to final concentration of 0.2 mg/L and SDBS to final concentration of 
0.2%. Concentrated DNA and RNA target were added to the indicated concentrations 
and incubated at room temperature overnight. Serum experiments used fetal bovine 
serum (Life Sciences) with GT15mir19 added to final concentration 0.2 mg/L and 
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SDBS at 0.2%. Where indicated, proteinase K (New England Biolabs) was added to a 
final concentration of 0.5 mg/mL. Spectra was acquired after overnight incubation at 
room temperature. 
 
2.5.5 Single-nanotube measurements 
Single-nanotube measurements were performed by incubating SDS-treated 
GT15mir19 sensor (0.2% SDS in SSC buffer) on a poly-D-lysine coated glass bottom 
plate (Mattek, Ashland, MA) for 10 minutes before gently washing with 0.2% SDS in 
SSC buffer. A final volume of 1 mL SDS-buffer was left in the plate during 
hyperspectral imaging measurements of the surface-bound nanotubes. A small volume 
(1 uL) of 1 mM solutions of miR-19 RNA or R23 RNA were then mixed with the 
buffer. Hyperspectral imaging measurements were repeated after 15 minutes and 50 
minutes. Single nanotube emission spectra were collected via a custom near-infrared 
hyperspectral microscope, as described previously29. Data was processed with ImageJ 
software. Peaks were fit to Voigt functions using custom Matlab code to obtain center 
wavelength values.  
 
2.5.6 Molecular dynamics simulations 
Molecular dynamics (MD) simulations were conducted using the (9,4) nanotube 
chirality in explicit water. The DNA molecule for GT15mir19 (without 
complementary strand) was generated as an unstructured single stranded DNA and 
placed near the (9,4) nanotube, followed by a sufficiently long equilibration MD 
simulation enhanced with a replica-exchange based method64, 65 to let the entire strand 
adsorb on (9,4) nanotube surface. Analysis of an additional 250 ns long MD 
simulation is presented in the results. The DNA molecule for GT15mir19 hybridized 
with the complementary strand was created in a partially double stranded form. miR-
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19 was generated in the double stranded form using NAB program of AmberTools66 
and was appropriately bonded via phosphodiester bond to the ss(GT)15 segment of the 
GT15mir19 DNA. The ss(GT)15 nanotube binding portion of the first strand was 
adsorbed to the nanotube. The entire DNA and nanotube construct was solvated in a 
10.65 x 10.65 x 14.7179 nm water-box containing approximately 55,000 water 
molecules and 74 sodium counter-ions, placed randomly, to balance the negative 
charges from phosphates on the DNA. The total system was approximately 170,000 
atoms. The nanotube extended to the edges of the water box and was kept frozen in 
place during the entire equilibration and simulation time. The nanotube atoms were 
modeled as sp2 hybridized carbon. All structures were visualized in VMD67. 
 
The Gromacs 4.6.7 simulation package68, 69 was used with the Charmm36/TIP3P 
nucleic acid/water model70. Long-range electrostatics were calculated using the 
particle mesh Ewald method with a 0.9 nm real space cutoff71. For van der Waals 
interactions, a cutoff value of 1.2 nm was used. The energy minimized simulation box 
was then subjected to 100 ps equilibration in an NVT (T=300 K) ensemble where the 
number of water molecules were fine-tuned to make average pressure approximately 
equivalent to atmospheric pressure. Further equilibration runs were performed for 100-
200 ns in NVT (T=300 K) ensemble. The movie and analysis used the 250 ns 
production run, followed by equilibration. Systems were propagated with stochastic 
Langevin dynamics with a time step of 2 fs. The trajectories were saved every 10 ps, 
yielding a total of 25,000 snapshots for production analysis. VMD Movie Maker was 
used to create the movie of the trajectory. Homemade python scripts calling 
MDAnalysis module72 were used for all other analysis presented. 
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2.5.7 Quantification of DNA on the nanotube complex 
The GT15mir19 sequence was used to suspend nanotubes as described earlier. After 
each of 4 centrifugation filter steps using the Amicon centrifuge filter (100 kDa 
MWCO), the concentration of the filtered DNA was measured using Abs260 on a 
NanoDrop spectrophotometer (ThermoScientific, Waltham, MA). The pellet from 
centrifugation was also filtered to measure free DNA. The final mass of DNA from the 
combined values was calculated from the concentration and subtracted from the initial 
value. From three suspensions, we found that 3.5 (+/-1.8) mg of DNA suspended 1 mg 
of nanotube, matching previous reports of 2.5 to 5 mg of DNA per 1 mg of nanotube73. 
 
2.5.8 Device implantation and in vivo spectroscopy 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee at Memorial Sloan Kettering Cancer Center. KrosFlo Implant Membranes 
(500 kD MWCO) were obtained from Spectrum Labs (Rancho Dominguez, CA). The 
membrane was cut to about 1 cm in length and filled with approximately 15 uL of 2 
mg/L GT15mir19-nanotubes. Each end was heat sealed. A total of 36 NU/J (nude) 
mice (Jackson Labs) were anesthetized with 2% isoflurane and implanted with the 
membrane. Nine mice were divided into three cohorts of three mice to receive miR-19 
DNA, R23 DNA, or buffer vehicle via an intraperitoneal injection of 1 nanomole in 1 
mL sodium saline citrate buffer. An identical experiment was performed with miR-19 
RNA, R23 RNA, or buffer vehicle at 1 nanomole, 500 picomole, 100 picomole, or 50 
picomole in 1 mL sodium saline citrate buffer The mice were removed from 
anesthesia and allowed to regain consciousness. After 90 or 120 minutes, mice were 
anesthetized and measured using a custom-built reflectance probe-based spectroscopy 
system. The system consisted of a continuous wave 1 watt 730 nm diode laser 
(Frankfurt). The laser light was injected into a bifurcated fiber optic reflection probe 
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bundle. The sample leg of the bundle included one 200 µm, 0.22 NA fiber optic cable 
for sample excitation located in the center of six 200 µm, 0.22 NA fiber optic cables 
for collection of the emitted light. Emission below 1050 nm was filtered using 
longpass filters, and the light was focused into the slit of a Czerny-Turner 
spectrograph with 303 mm focal length (Shamrock 303i, Andor). The slit width of the 
spectrograph was set at 410 µm. The light was dispersed using a 85 g/mm grating with 
1350 nm blaze wavelength and collected with an iDus InGaAs camera (Andor). 
Spectra were fit to Voigt functions using custom Matlab code. 
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CHAPTER 3: CONTROL OF CARBON NANOTUBE SOLVATOCHROMIC 
RESPONSE TO CHEMOTHERAPEUTIC AGENTS 
 
3.1 Abstract 
Alkylating agents such as cisplatin play an essential role in chemotherapy regimens, 
but initial and acquired resistance in many cancer types often dampen therapeutic 
response. Poor understanding of the mechanisms of resistance highlight the need for 
quantitative measurements of alkylating agent distribution at both tissue and sub-
cellular levels. Sensors for use in live animals and cells would allow for more effective 
study of drug action and resistance. Toward this end, single-walled carbon nanotubes 
suspended with single-strand DNA have suitable optical properties for in vivo sensors, 
such as near-infrared emission and sensitivity to the local environment via 
solvatochromic responses. Currently, solvatochromic changes of such sensors have 
been limited by the chemical nature of the analyte, making it impossible to control the 
direction of energy emission changes. Here, we describe a new approach to control the 
direction and magnitude of solvatochromic responses of carbon nanotubes. We found 
that the alkylation of DNA on the nanotube surface can result in small changes in 
DNA conformation that allow the adsorption of amphiphiles to produce large 
differences (> 14 nm) in response to different drugs. The technique surprisingly 
revealed differences among drugs upon alkylation. The ability to control carbon 
nanotube solvatochromism to desired changes may potentially expand the application 
of nanotube-based optical sensors for new classes of analytes. 
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3.2 Introduction 
As a class of chemotherapy drugs, alkylating agents have essential roles in many 
cancer treatment protocols to date due to their cytotoxic effects on dividing cells1. The 
mechanism of action is partly due to alkylation of DNA in the nucleus, which affects 
replication and induces apoptosis2. The platinum analogs, such as cisplatin and 
carboplatin, are not true alkylating agents but are often grouped with these drugs due 
to a similar putative mechanism of cytotoxicity3. Cisplatin is relatively unreactive in 
chloride ion-rich environments because a chloride must leave and be replaced by 
water to produce the reactive intermediate4. A lower concentration of chloride in the 
cytoplasm (~4 mM) facilitates formation of the reactive intermediates2, where they 
preferentially react with the nucleophilic N7 position of guanine, producing 1,2-
intrastrand GpG crosslinks as the major DNA adduct5. Cisplatin has significant 
antitumor activity in a broad range of solid tumors, and it is curative in the treatment 
of testicular cancer3. However, initial and acquired resistance to cisplatin in some 
cancer types is a major clinical limitation6. The mechanisms that lead to resistance are 
only partially understood. Attempts to develop improved platinum-based therapies 
have been met with limited success7.  
Current methods for detecting cisplatin distribution require invasive and destructive 
measurement of platinum accumulation in tissues ex vivo8-13. Similar issues exist for 
other small alkylating agents. An implantable sensor for active alkylating drugs such 
as cisplatin could be useful in understanding drug reactivity and distribution in vivo. 
Such a sensor could also be used to elucidate mechanisms of acquired resistance and 
screen reactivity and efficacy of new platinum compounds.  
As a nanoscale sensing element, single-walled carbon nanotubes have advantages due 
to their photostable emission in the near-infrared spectral range14 that is responsive to 
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the local environment via solvatochromic changes15-17. Up to 17 distinct chiralities 
with unique spectral properties can be measured18. Carbon nanotubes non-covalently 
functionalized with single-stranded DNA have found unique success in applications 
toward optical biomedical sensors19 for the measurement of small molecules, proteins, 
and biological processes20-23 as well as implantable devices for in vivo uses24, 25. 
Previous work has found that alkylating agents can elicit a solvatochromic red-shift 
upon incubation with DNA-suspended nanotubes26.  
In general, carbon nanotube optical sensors are based on an interaction with the target 
analyte that leads to modulation of the local dielectric environment, which can elicit a 
change in emission intensity or a solvatochromic shift in the emission wavelength. The 
emission can shift towards higher energies (relative blue shift) or towards lower 
energies (relative red shift). Heretofore, it has not been possible to control the 
direction of solvatochromic shifting (toward red or blue) to a particular analyte. 
Exercising control over the direction and magnitude of solvatochromic shifting to a 
particular analyte is important for expanding the application of nanotube-based 
sensors where a desired optical output is necessary, such as larger responses to confer 
greater sensitivities, or as part of a multiplexing scheme that could be used to identify 
multiple analytes25, 27. 
Herein, we describe a method to control the direction of solvatochromic shifting of 
carbon nanotube emission in response to a class of analytes, alkylating 
chemotherapeutic drugs. Using this method, we discovered that it exacerbates the 
optical response to small chemical differences between drug compounds. While 
previous work found that the alkylation of DNA on single-walled carbon nanotubes 
results in a small solvatochromic shift of the nanotubes towards longer wavelengths, 
we found that the perturbation with a small molecule amphiphile, sodium 
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dodecylbenzene sulfonate (SDBS) can cause large drug-mediated shifts towards 
shorter wavelengths. Interestingly, the resulting responses were strikingly different, 
depending on the alkylating drug. Notably, the responses to platinum compounds, 
which previously elicited small red-shifting responses, were exacerbated. Also, 
although cisplatin and transplatin both produced red-shifts in nanotube emission with 
approximately the same kinetics, the exposure to the amphiphile resulted in transplatin 
blue shifting the emission to a significantly greater degree. We attribute these 
phenomena to alkylating agent-induced distortions to the DNA that are drug-
dependent, resulting in exposure of the nanotube surface to different degrees. The 
method produced large differences in drug-induced nanosensor responses.  
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3.3 Results and discussion 
Using single-walled carbon nanotubes (HiPco preparation) suspended with the DNA 
oligonucleotide with the sequence (GT)15 , we measured the response of all chiralities 
to cisplatin. Upon treating the nanotubes with cisplatin (1000 uM) in HEPES (20 mM) 
buffer for 12 hours, we assayed the sample via two-dimensional excitation/emission 
photoluminescence spectroscopy (PL plots, Figure 3.1)28 and found that, for all 
measured chiralities, there was a consistent red-shift in emission ranging from about 2 
nm to 4 nm. Some chiralities additionally showed a red-shift in excitation, indicating 
that for some chiralities, alkylation also induced a change in the ground state 
absorption energies (Figure 3.2). Because all nanotube chiralities behaved similarly, 
we moved our focus to a purified chirality, (GT)20-suspended (8,4) nanotubes29. PL 
plots of purified (GT)20 revealed a high degree of purity, and the emission behaved 
similarly by red-shifting upon the addition of cisplatin (Figure 3.3.). A dose-response 
measurement of (GT)20-suspended (8,4) nanotubes with cisplatin showed clear 
cisplatin dose-dependent red-shifting (Figure 3.4). The kinetics were similarly 
dependent on concentration (Figure 3.5). 
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Figure 3.1 Two-dimensional excitation/emission photoluminescence plots (PL plots) 
of (GT)15-suspended HiPCO nanotubes (2 mg/L) in buffer only conditions (top plot) 
and after 12h with 1000 uM cisplatin (bottom plot). Color bars indicate the emission 
intensity in arbitrary units. 
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Figure 3.2 Emission and excitation wavelength responses to cisplatin. The emission 
wavelengths of the nanotube emission bands from the PL plots in Figure S1 were 
subtracted. Peaks were fit to Lorenztian functions. The x-axis lists nanotube species 
according to their chiral indices. Error bars represent standard deviation of technical 
replicates. 
Figure 3.3 Two-dimensional excitation/emission photoluminescence plot of (top 
panel) purified (GT)20-suspended (8,4) nanotubes in buffer and (bottom panel) with 
1000 uM cisplatin (bottom plot). Vertical black line is a visual reference to compare 
center wavelengths.  
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Figure 3.4 Dose-dependent wavelength shifts of (GT)20-suspended (8,4) nanotubes 
after overnight equilibration with the indicated concentration of cisplatin. 
Differences are based on untreated control samples. Error bars represent standard 
deviation of technical replicates. 
 
Figure 3.5 Dose-dependent red-shifting kinetics of (GT)20-suspended (8,4) 
nanotubes during the first three hours after addition of drug. Spectra were acquired 
every 10 minutes following addition of the indicated concentration of cisplatin. 
Wavelength shifts are presented as difference from buffer treated control sample. 
Error bars represent standard deviation of technical replicates 
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To determine whether the observed red-shifting of the nanotube from added cisplatin 
was due to alkylation of the DNA and not due to non-specific interactions, we 
measured the extent of red-shifting as a function of added sodium chloride. Using 
(GT)20-suspended (8,4) nanotube samples at 2 mg/L, we varied the sodium chloride 
concentration of the buffer before adding 500 uM cisplatin to each sample. After 
incubation overnight, we observed a linear decrease in the extent of red-shifting as the 
concentration of sodium chloride was increased. Above approximately 80 mM NaCl, 
red-shifting was barely detectable (Figure 3.6). Linear regression applied between 0-
80 mM NaCl (R2 = 0.9885) produced a slope of -0.06177 (Figure 3.7), denoting that, 
for every 10 mM increase in sodium chloride, the maximal red-shift decreased by 
about 0.6 nm. This behavior was consistent with the chloride-dependent reactivity of 
cisplatin, and suggests that a covalent reaction (alkylation) is responsible for the red-
shift. Lastly, we investigated whether the red-shift was due to aggregation of 
nanotubes upon reaction with cisplatin. We immobilized (GT)15-suspended nanotubes 
in 3% agarose gel and found that the addition of cisplatin (500 uM) still resulted in a 
red-shift (Figure 3.8) with similar kinetics (Figure 3.9), suggesting that aggregation 
was not a major causative factor of the red-shifting response. 
Figure 3.6 Response of the nanotube emission as a function of sodium chloride. 
(GT)20-suspended (8,4) were incubated with the indicated concentration of sodium 
chloride overnight and incubated with 500 uM cisplatin or buffer control for an 
additional 12h. Error bars represent standard deviation of technical replicates. 
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Figure 3.7 Linear regression of nanotube emission red-shifting as a function of 
sodium chloride from 0 to 80 mM NaCl. Black solid line represents the linear fit with 
equation y=-0.06177x + 5.33, and dotted black line represents 95% confidence 
interval of the fit. Error bars represent standard deviation of technical replicates. 
 
Figure 3.8 Wavelength shifts of (GT)15-suspended nanotubes at 2 mg/L immobilized 
in 3% agarose gel and treated with 100 uM cisplatin overnight. Wavelength shifts 
relative to buffer treated control are reported for four nanotube chiralities. Error bars 
represent standard deviation of 3 agarose gel replicates. 
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Figure 3. 9 Kinetics of the emission response of (GT)15-suspended nanotubes at 2 
mg/L immobilized in 3% agarose gel and treated with 100 uM cisplatin at time 0. 
Spectra were acquired every 10 m. Two nanotubes chiralities, (9,4) and (8,6), were 
measured simultaneously under 730 nm excitation. Wavelength shift was computed 
from buffer only control. Error bars represent standard deviation of 3 gel preparations. 
 
We investigated the effects of amphiphilic molecules on the nanotube response upon 
alkylation. We hypothesized that the alkylation of cisplatin changes the DNA 
conformation on the nanotube in a manner that decreases DNA surface coverage. A 
previous screen of amphiphiles found that SDBS blue-shifts DNA-suspended 
nanotubes in a manner consistent with nanotube surface accessibility25. Thus, we 
tested if SDBS could modulate the wavelength shifting response of cisplatin. Upon 
reaction of (GT)20-suspended (8,4) nanotubes with cisplatin in the presence of SDBS, 
a blue shift was observed, instead of the usual red shift (Figure 3.10a). The spectra 
were fit to Lorenztian functions to quantify the changes in center wavelength and 
intensity, showing clear differences (Figure 3.10b). While the wavelength exhibited a 
clear dependence on SDBS the intensity was largely unaffected. Based on this data, 
we developed a model of how SDBS allows solvatochromic control of the nanotube 
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(Figure 3.10c). Cisplatin reacts with guanine bases to distort the DNA conformation 
and expose more of the nanotube surface to water, leading to the observed red-shift in 
emission15. In the presence of SDBS, this same conformational change allows greater 
exposure of the nanotube surface to the surfactant, which adsorbs to the nanotube 
surface, producing a blue shift in emission. 
Figure 3.10 Control of solvatochromic shift. a, Normalized emission spectra of: (top 
panel) (GT)20-suspended (8,4) nanotubes in buffer (black dotted line) and the 
nanotubes with 500 uM cisplatin (red line), and (bottom panel) (GT)20-suspended (8,4) 
nanotubes in buffer with 0.2% SDBS (black dotted line), and 0.2% SDBS plus 500 
uM cisplatin (blue line). b) Change in the (top panel) emission wavelength and 
(bottom panel) intensity of (GT)20-suspended (8,4) nanotube emission after incubation 
with cisplatin and/or 0.2% SDBS. c) Illustration of hypothesized mechanism of 
solvatochromic shift control. Cisplatin distorts the DNA allowing more water to 
access the nanotube surface, while SDBS displaces water upon binding to the 
nanotube. 
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To better understand the role of SDBS in modulating the solvatochromic response to 
cisplatin, we devised an additional experiment to remove cisplatin after alkylation. We 
exposed (GT)15-suspended nanotubes to cisplatin (Figure 3.11a, step 1), before 
dialyzing against a 500 kDa MWCO membrane to remove unbound cisplatin (Figure 
3.11a, step 2). After three dialysis steps, (2-3 hours each, with overnight dialysis on 
the third step), we found that the red-shift persisted relative to a control dialysis 
experiment without cisplatin (Figure 3.11b). We interpret this result to mean that 
cisplatin-induced distortion of the DNA persisted throughout the dialysis process. 
Upon introducing SDBS outside of the dialysis bag (Figure 3.11a, step 3), we 
observed a blue-shift (Figure 3.11a, step 4). This blue-shift, relative to the cisplatin-
free dialysis control, reached a maximum after 90 minutes (Figure 3.11b) and largely 
recapitulated the shift in the presence of cisplatin (Figure 3.10). We conclude that 
SDBS does not affect the reactivity of cisplatin with DNA on the nanotube, and that 
the effect of SDBS is due to the cisplatin-induced modulation of DNA conformation 
on the nanotube which exposes the nanotube surface.  
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Figure 3.11 Dialysis experiment involving cisplatin and SDBS interactions with the 
DNA-nanotube complex. a) Sequence of experimental steps of dialysis experiment. (1) 
Cisplatin was introduced to (GT)15-encapsulated nanotubes in a dialysis membrane, 
resulting in a red-shift in emission. (2) The dialysate was changed to remove un-
reacted cisplatin, but the red-shift persisted. (3) SDBS was added to the dialysate. (4) 
The nanotube emission blue-shifted after the addition of SDBS. b) Response of the 
(9,4) nanotube emission, compared to an identically-treated control without cisplatin, 
corresponding to the experiment outlined in panel a. Numbers indicate corresponding 
step in the experimental outline. 
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A panel of alkylating agents with applications in chemotherapy was used to assess the 
generalizability of this phenomenon. Figure 3.12a depicts the chemical structures of 
the five alkylating agents tested: (1) cisplatin, (2) transplatin, (3) carboplatin, (4) 
mechlorethamine, and (5) melphalan. When an equimolar (100 uM) amount of each 
alkylating agent was added to (GT)20-suspended (8,4) nanotubes, a consistent red-shift 
of approximately 2 nm was observed for all alkylating agents except carboplatin 
(Figure 3.12b). Carboplatin is a second generation platinum analogue that displays less 
nephrotoxicity than cisplatin, but also significantly less reactivity 30, 31, which may 
explain the lack of an effect on the nanotubes. When we tested the panel of alkylating 
agents in the presence of SDBS, all agents that previously red-shifted instead blue-
shifted to varying degrees (Figure 3.12b). Carboplatin again showed no change with 
SDBS, consistent with the hypothesis that a reaction-induced distortion of the DNA is 
necessary for SDBS to elicit a blue-shift. The other platinum-based drugs exhibited 
large blue-shifting responses, however. Strikingly, transplatin induced a blue-shifting 
response of over 14 nm (Figure 3.12b), and it also resulted in a substantial increase in 
intensity of the nanotube, as compared to the other agents (Figure 3.12c).  
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Figure 3.12: Solvatochromic response to a panel of alkylating agents. a) Chemical 
structures of alkylating chemotherapy drugs tested: (1) cisplatin, (2) transplatin, (3) 
carboplatin, (4) mechlorethamine, (5) melphalan. b) Wavelength shifting response of 
(GT)20-suspended (8,4) nanotubes after incubation with the indicated alkylating agent 
in buffer only (red) and in the presence of 0.2% SDBS. Wavelength shifts are reported 
relative to nanotubes in buffer only. c) Intensity response of the nanotubes under the 
same conditions. Error bars represent standard deviation of technical triplicates. 
 
The large difference in transplatin activity versus cisplatin warranted further 
investigation. Transplatin, a stereoisomer of cisplatin, differs only in the spatial 
relationship of the two chloride leaving groups (Figure 3.13a), but provides no clinical 
benefit despite its reactivity towards DNA32, 33. The type of DNA adduct transplatin 
forms is thought to be non-toxic to cells compared to that formed by cisplatin32. Given 
the contrast between these two agents, we hypothesized that transplatin was making an 
adduct that distorted DNA on the nanotube to a greater extent than cisplatin. When 
tested in buffer-only conditions, we found that the red shifts induced by cisplatin and 
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transplatin on (GT)20-encapsulated nanotubes were similar (Figure 3.13b), and with 
similar kinetics (Figure 3.13c). This is consistent with previous work showing that 
cisplatin and transplatin form monofunctional adducts with DNA at approximately the 
same rate34. When the identical kinetics experiment is done in the presence of SDBS, a 
rapid blue-shift is observed for transplatin compared to cisplatin, which takes several 
hours and is not apparent on this timescale (Figure 1.13d). In contrast, after two hours, 
transplatin has almost maximally blue-shifted the nanotube response. Near-infrared PL 
plots revealed that there was a significant chirality dependence on the rate of blue-
shifting, with the two smallest diameter nanotubes ((6,5) and (8,3)) shifting at the 
fastest rates (Figure 3.14). Although the kinetics and magnitude of red-shifting were 
nearly identical for cisplatin and transplatin in buffer conditions, the addition of SDBS 
revealed that transplatin resulted in changes of the DNA conformation of a 
fundamentally different character that revealed a larger degree of nanotube surface, 
leading to a greater blue-shifting response. We summarize these findings in an 
illustration in Figure 3.15. The conformational changes induced by cisplatin and 
transplatin were optically indistinguishable in normal buffer conditions, but the 
differences become apparent in the presence of SDBS, revealing that the DNA 
distortions induced by cisplatin and transplatin were indeed different. 
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Figure 3.13 Comparison of nanotube response to cisplatin and transplatin. a) 
Chemical structures of cisplatin and transplatin, with the configuration of the chloride 
leaving groups highlighted in red. b) Response of (GT)15 encapsulated (9,4) in the 
presence of 100 uM cisplatin or transplatin in buffer, at 12h. c) Kinetic response of the 
(9,4) nanotube emission wavelength in the presence of cisplatin or transplatin, in 
buffer-only conditions. d) Kinetic responses as in panel c but in the presence of 0.2% 
SDBS. Error bars represent standard deviation. 
 
Figure 3.14 Kinetics of emission response of several nanotube chiralities. Two-
dimensional excitation/emission photoluminescence spectroscopy (PL) plots were 
acquired after addition of 100 uM to (GT)15-suspended nanotubes in the presence of 
0.2% SDBS. The emission wavelength shifts of 11 different nanotube species were 
calculated as differences from buffer treated controls in 0.2% SDBS. 
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Figure 3.15 Illustration of the proposed mechanism of the difference in nanotube 
emission response upon interaction with cisplatin or transplatin. a) Cisplatin and 
transplatin react with DNA on the nanotube to introduce distortions that are different 
but yield identical optical changes. b) The distortion in the transplatin-bound complex 
allows a greater amount of SDBS to bind to the nanotube surface, producing a larger 
blue-shift for transplatin-induced distortions. 
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3.4 Conclusions 
We found a method to control the direction of solvatochromic shifting to a class of 
analytes and probe the structural changes to DNA on the nanotube surface. Alkylating 
agents such as cisplatin covalently react with DNA on carbon nanotubes to induce 
conformational changes that increase accessibility of water to the nanotube surface, 
leading to red-shifting. Based on this mechanism, we found that the addition of SDBS, 
an amphiphilic surfactant, causes the nanotube to instead blue-shift upon reaction of 
the drugs to the nanotube-bound DNA. Dialysis experiments suggested that SDBS was 
a passive reporter of the changes induced by the alkylating agents, providing 
mechanistic insight into the origin of the solvatochromic changes. To our knowledge, 
this is the first report describing directional control of carbon nanotube solvatochromic 
shifts in response to a target analyte. The ability to control the direction of 
solvatochromic shifts of nanotubes in response to a target analyte has important 
implications for the future application of sensors where certain output is necessary or 
desired, such as part of a multiplexed sensing scheme. Finally, we found that cisplatin 
and transplatin produce different DNA distortions on the nanotube that are optically 
indistinguishable in buffer only conditions, but apparent only in the presence of SDBS. 
Such insights will continue to improve application of carbon nanotube sensors for the 
detection of active chemotherapeutic drugs and other analytes. 
 
3.5 Materials and Methods 
3.5.1 DNA-suspension of carbon nanotubes 
Carbon nanotubes produced by the HiPco process (Unidym, Sunnyvale, CA) were 
mixed with DNA oligonucleotides (IDT DNA, Coralville, IA) at a 2:1 mass ratio in 1 
mL of HEPES (20 mM) buffer (Thermo Fisher Scientific Waltham, MA) and 
ultrasonicated for 30 minutes at 40% amplitude (Sonics & Materials, Inc.). The DNA 
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sequences used for suspension were (GT)15, (AT)15, (TAT)6, (GTT)3G, (CCG)2CC, 
(TGTT)2TGT, (GGGGT)6, all purchased from IDT (Coralville, IA). Following 
ultrasonication, the dispersions were ultracentrifuged (Sorvall Discovery 90SE) for 30 
minutes at 280,000 x g and the top 80% of the supernatant was collected. Absorbance 
spectra were acquired using a UV/Vis/nIR spectrophotometer (Jasco V-670, Tokyo, 
Japan). The concentration for HiPco samples was calculated using the extinction 
coefficient Abs910 = 0.02554 L mg-1cm-1. Excess DNA was removed via 100 kDa 
Amicon centrifuge filters (Millipore). The DNA-nanotube complexes were re-
suspended in HEPES (20 mM) buffer (Thermo Fisher Scientific Waltham, MA). 
Purified (GT)20-suspended (8,4) nanotubes were prepared as described29.  
  
3.5.2 Fluorescence spectroscopy measurements of carbon nanotubes 
Fluorescence emission spectra from aqueous nanotube solutions were acquired with a 
home-build spectroscopy system as described25. Briefly, carbon nanotube samples 
were assayed in a 96 well plate format on an inverted microscope using a tunable 
white-light laser (NKT Photonics) coupled to a variable bandpass filter. Emission light 
was directed into a spectrometer with a focal length of 320 mm and aperture ratio of 
f/4.6 (Princeton Instruments IsoPlane SCT 320) and InGaAs array camera (Princeton 
Instruments 640 × 512 pixel NIRvana). For all experiments, measurements were taken 
in triplicate across three wells. Concentrated sodium dodecylbenzenesulfonate (Sigma-
Aldrich) was prepared in HEPES (20 mM) buffer and added to samples where 
indicated to a final concentration of 0.2% wt/vol; control samples had an equivalent 
volume of buffer added. Cisplatin, melphalan, mechlorethamine, carboplatin (all from 
Sigma-Aldrich) and transplatin (Acros Organics) were all prepared in HEPES (20 mM) 
buffer, except melphalan which was prepared in DMSO (Acros Organics). Control 
samples received an equivalent volume of buffer or DMSO. Experiments involving 
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dialysis used KrosFlo Membranes (500 kD MWCO) from Spectrum Labs (Rancho 
Dominguez, CA) filled with 15 uL of 2 mg/L sample and dialyzed in 2 mL of HEPES 
(20 mM) buffer dialysate. Experiments with nanotube immobilized in gels were 
prepared as described35 in 3% low melt agarose gels directly into wells of a 96 well 
plate. Following spectra acquisition, custom code written in Matlab applied spectral 
corrections and background subtraction as described25. Corrected spectra were used to 
fit the data with Lorentzian functions. Error bars and linear fits were computed with 
GraphPad Prism 6. 
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CHAPTER 4: ELECTROSTATIC SCREENING MODULATES ANALYTE 
BINDING AND EMISSION OF CARBON NANOTUBES 
 
4.1 Abstract 
Nanoparticle-based sensing schemes are promising approaches for rapid and selective 
detection of biomarkers in biological materials. Many nanoparticles have intrinsic 
charge, and are thus susceptible to electrostatic interactions that can enhance or 
attenuate sensing. Single-strand DNA suspended carbon nanotubes are advantageous 
for use in sensing applications, but the polyanionic nature of the DNA backbone 
suggests that electrostatic interactions could greatly impact sensor performance. Here, 
using a combination of experimental and computational approaches, we have found 
and characterized a critical role of the solvent salt conditions in determining the extent 
of optical changes due to anionic analyte interaction with DNA-suspended nanotubes. 
Using a well-characterized model anionic analyte, we found that monovalent salts 
enabled greater optical changes in a highly-dose dependent manner, but not with a 
neutrally charged analyte. Molecular dynamics simulations were used to derive a 
quantitative understanding of this mechanism from a free energy standpoint. We also 
show that salt can be manipulated to enhance the sensitivity of detection for a 
polyanionic analyte, single-strand DNA, using a DNA-suspended nanotube-based 
sensor. These results suggest that electrostatic screening is an important parameter for 
intrinsically charged nanoparticle sensors, and may be tuned with added salt for 
controlled response to targets. 
 
 
143 
 
4.2 Introduction 
Early and accurate detection of biomarkers has driven the development of 
nanoparticle-based biosensors with the goal of providing selective, sensitive, and rapid 
detection with minimal sample preparation1. Nanoparticle-based solutions have 
several advantages as sensors owing to their high volume to surface ratio, amenability 
to derivation, multiplexing capacity, and the unique physical properties that emerge at 
the nanoscale2. For cancer, several protein-based biomarkers have been FDA-
approved or cleared3. Other emerging biomarkers include oligonucleotides such as 
circulating microRNA4 and circulating tumor DNA5. The variety of different 
biomarkers has led to a diverse set of recognition moieties and signal transduction 
elements to be developed6. Some recognition moieties are based explicitly on 
electrostatic attraction7, 8 to take advantage of the unique charge character of some 
analytes. Many surface-enhanced Raman scattering based probes and sensors were 
found to depend on the pH and zeta potential values of the nanoparticle solutions9, 
emphasizing the importance in controlling electrostatic interactions in this system. A 
colorimetric sensor for mercury ions based on different sized silver nanoparticles 
functionalized with adenine nucleotides showed great variations in detection 
sensitivity based on electrostatic repulsion between nanoparticles10.  
 
One promising nanomaterial for sensing, semiconducting single-walled carbon 
nanotubes, have been pursued as biomedical sensors due to their outstanding optical 
properties11; they fluoresce in the near-infrared spectral range and do not photobleach. 
Changes in the local dielectric environment around the nanotube surface can elicit a 
solvatochromic shift12, 13, forming the theoretical and physical basis for their use as 
sensors14, 15. To make use of their optical properties as sensors, single-walled carbon 
nanotubes can be made into a colloidal dispersion with single-stranded DNA , where π 
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stacking enables DNA bases to adsorb to the nanotube surface while the negatively 
charged phosphate backbone prevents re-aggregation16. DNA-suspended nanotubes 
provide several advantages as sensors, such as biocompatibility17, stability18, high 
yields16, and relatively facile purification of spectrally distinct chiralities16, 19 which 
may enable highly multiplexed sensing schemes. 
 
Recently, the role of the electrostatic charge in DNA-nanotube dispersions has been 
shown to be important for manipulating nanotube chirality purification19, optical 
behavior, and sensing20. The negatively charged phosphate backbone prevents re-
aggreation of the nanotubes, but may also impact charged analyte detection. Our group 
has recently shown that hybridization of complementary oligonucleotide sequences 
with DNA-suspended nanotubes can lead to structural changes that alter the charge 
distribution on the nanotube surface, and thus the emission character21. By combining 
the anionic amphiphile sodium dodecylbenzenesulfonate (SDBS) with DNA-
suspended nanotubes, we found that the emission character provided by both agents is 
present. Hybridization-induced removal of DNA from the nanotube surface led to 
greater SDBS emission character, greatly blue-shifting the emission21. Furthermore, 
the magnitude of blue-shifting corresponded with the length of DNA removed from 
the nanotube surface, with longer sequences leading to greater blue-shifting due to the 
larger nanotube surface exposed for SDBS binding. Thus, for DNA-suspended 
nanotubes, SDBS-induced blue-shifting can serve as a quantitative optical assay of 
accessibility to the nanotube surface.  
 
Using SDBS as a model anionic analyte, we set out to assess the impact of different 
conditions that could affect SDBS accessibility to the DNA-functionalized nanotube 
surface. Recent work has shown that monovalent salts such as NaCl are important in 
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determining DNA-nanotube interactions with each other and thus stability22-24. We 
hypothesized that charge-charge repulsion between the negatively charged DNA 
phosphate backbone and SDBS is a dominate force controlling accessibility of SDBS 
to the nanotube surface, despite the significant hydrophobic region of SDBS available 
to bind the nanotube. The addition of salts to screen this charge should then enable 
more SDBS binding, and thus greater blue-shifting. However, testing this hypothesis 
could be complicated by DNA-conformational changes, since the salts may also 
screen intramolecular repulsion forces along the negatively charged phosphate 
backbone12, 25 and in this way change analyte accessibility in a more general way.  
Herein, using (GT)15 DNA suspended nanotubes, we probed the salt-dependent 
accessibility of SDBS to the nanotube surface by measuring the magnitude of SDBS-
induced blue-shifting under different salt conditions. To parse the importance of 
potential conformational changes of the (GT)15 DNA on the nanotube surface in 
response to added salts, we additionally tested an electrically neutral molecule, PEG-
cholesterol, which blue-shifts nanotubes similarly to SDBS. Using molecular 
dynamics simulations, we were able to quantitatively assess potential DNA-changes 
due to salt content, as well as the influence of NaCl on the free energy of adsorption of 
SDBS to DNA-suspended nanotubes. Finally, we extend our study to a polyanionic 
analyte target, single-strand DNA, using a (GT)15-based oligonucleotide sensor as 
described21, and found that the threshold of detection could be improved with added 
salt. From these studies, we conclude that electrostatic screening of the DNA-
suspended nanotube by monovalent ions is a primary determinant of interaction with 
negatively charged analytes, and that the magnitude of nanotube optical response can 
be tuned depending on the salt concentration. Our findings have implications for the 
rational design of DNA-suspended carbon nanotube sensors for charged analytes, 
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where varying the monovalent ion content of the sensing environment can facilitate or 
abrogate detection of an anionic analyte. 
 
4.3 Results and discussion 
We first asked whether the anionic amphiphile SDBS would produce a blue-shift in 
the emission of carbon nanotubes under different salt conditions. The effect of NaCl 
alone on nanotube emission, using (GT)15-suspended nanotubes in HEPES buffer, was 
determined by measuring the spectra in 100 mM NaCl. No appreciable shifting in 
emission wavelength was observed, and intensity changes were insignificant (Figure 
4.1a). In SDBS concentrations of 0.2% wt/vol (5.7 mM), we found a large salt-
dependent difference in the nanotube emission spectra (Figure 4.1b), including a 
distinct blue-shifting behavior (Figure 4.1c, d) and intensity increase in the high-salt 
condition.  
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Figure 4.1 Salt dependence on carbon nanotube emission response to anionic 
amphiphile. a, Representative spectra from (GT)15-suspended nanotubes in 100 mM 
sodium chloride (red) or in NaCl-free HEPES buffer (blue).b, Representative spectra 
from (GT)15-suspended nanotubes in 0.2% wt/vol sodium dodecylbenzenesulfonate 
(SDBS) and 100 mM sodium chloride (red) or NaCl-free HEPES buffer (blue). c, 
Center wavelength of the (9,4) nanotube emission in the indicated salt conditions upon 
addition of 0.2 % wt/vol SDBS or buffer control d, Center wavelength values of the 
(8,6) nanotube emission in the indicated salt conditions after addition of 0.2 % wt/vol 
SDBS. Error bars represent standard deviation of technical replicates. 
 
 
We next assessed how the concentration of NaCl affected the magnitude of SDBS-
induced blue-shifting behavior of the nanotubes by escalating the NaCl concentration 
from 0 mM to 100 mM in 10 mM increments, keeping the concentration of SDBS 
constant at 0.2% wt/vol. After allowing the samples to come to equilibrium (48h 
incubation), we found that the magnitude of emission wavelength shifting varied 
nearly linearly with the NaCl concentration, up to approximately 50 or 60 mM NaCl 
for most measured chiralties (Figure 4.2a). The nanotube emission intensity exhibited 
a similar dose-dependent increase over the buffer-only control (Figure 4.2b). 
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Figure 4.2 NaCl dependent optical effects from SDBS. a, Wavelength shifting 
response of five nanotube chiralities in SDBS as a function of NaCl concentration. b, 
Intensity fold change of five nanotube chiralities in SDBS as a function of NaCl 
concentration. Error bars represent standard deviation of technical replicates. 
 
We then assessed how changes in the salt concentration affected the kinetics of SDBS-
induced blue-shifting of the nanotube emission. We measured the emission spectra of 
the nanotubes every 10 minutes over three hours in escalating salt concentrations. The 
equilibration time was slow, generally taking several hours. However, over the first 
three hours, the curves were approximately linear, enabling the use of linear 
regressions to calculate the slope and estimate the early rate of shifting for three 
chiralities of nanotubes (R2 > 0.9) (Figure 4.3). Each chirality showed a nearly linear 
increase in the rate of blue-shifting as the salt concentration was increased (Figure 4.4). 
We conclude that increasing NaCl concentration increases the rate at which SDBS-
mediated blue-shifting occurred. 
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Figure 4.3 Wavelength shift from added SDBS over time for the three indicated 
nanotube chiralities in the indicated NaCl concentration. Kinetics of SDBS-induced 
blue-shifting of the (10,2), (9,4) and (8,6) nanotube chiralities with increasing NaCl 
concentration as indicated by color. Solid lines represent fits from linear regressions, 
error bars represent standard deviation of technical triplicates. 
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Figure 4.4 Rate of shifting due to SDBS as a function of NaCl concentration for the 
three indicated chiralities. The rate of SDBS-induced blue-shifting of the (10,2), (9,4), 
and (8,6) nanotube as a function of NaCl concentration. Solid line represents the fit 
from a linear regression, and dotted lines represent the 95% confidence interval. Error 
bars in all instances represent the standard deviation of technical triplicates. 
 
To test if the NaCl-dependent effects on SDBS-induced blue-shifting could be 
extended to divalent ions, we repeated the kinetics experiment with MgCl2. To match 
the total salt charge, MgCl2 was added at half the molar concentration used for NaCl. 
By itself, MgCl2 red-shifted the nanotubes and partially quenched the fluorescence 
(Figure 4.5). Kinetics of the SDBS-mediated blue-shifting were measured in 0, 12.5, 
25, and 50 mM MgCl2; however, MgCl2 appeared to prevent any significant SDBS-
induced blue-shifting (Figure 4.6). The effect of divalent ions on SDBS accessibility 
may have been complicated by the previously reported de-stabilizing effects of 
divalent ions on the DNA-suspended nanotubes25. 
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Figure 4.5 Effect of divalent ions on the nanotube spectra. Emission spectra of 
(GT)15 DNA-suspended nanotubes after introducing 0, 12.5, 25, and 50 mM MgCl2.  
 
Figure 4.6 SDBS-induced shifting over time with MgCl2. Emission wavelength shift 
from control of DNA-encapsulated nanotubes after addition of SDBS in the indicated 
MgCl2 condition over time. Data from the (9,4) and (8,6) nanotube chiralities are 
shown. Error bars represent standard deviation of technical replicates. 
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Because the data implicates electrostatic screening effects from monovalent ions as a 
possible determinant of SDBS-induced blue-shifting, we next tested if KCl, which is 
often used to improve charge screening in DNA-related assessments such as PCR26, 
would also enhance SDBS-induced blue-shifting on an equi-molar basis. Indeed, at 
both 50 mM and 100 mM KCl, we observed SDBS-induced blue-shifting, often with a 
greater magnitude as compared to NaCl (Figure 4.7). The greater magnitude of blue-
shifting suggests that potassium may interact with DNA on the carbon nanotube to 
screen charges better than sodium, allowing more SDBS to access the nanotube 
surface.  
Figure 4.7 Comparison of NaCl and KCl for five chiralities. Emission wavelength 
changes of the (7,6) nanotube chirality after equilibration with 0.2% SDBS in the 
indicated concentration of NaCl or KCl. Error bars represent standard deviation of 
technical triplicates. 
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Although the enhancement effect of monovalent ions appears to be due to electrostatic 
screening between the negatively charged DNA phosphate backbone and the 
negatively charged SDBS, we hypothesized that monovalent ions could also affect the 
conformation of (GT)15 on the nanotube. Intramolecular electrostatic screening among 
adjacent phosphates could be responsible for changes in DNA conformation that leads 
to greater SDBS accessibility. To test this, we used a neutral molecule, polyethylene 
glycol (PEG)-modified cholesterol, that also blue-shifts the nanotube emission upon 
interaction with the surface. We reasoned that, if charge screening affected the DNA 
conformation to expose the nanotube surface to enhance analyte binding, then PEG-
cholesterol-dependent blue-shifting should exhibit sensitivity to NaCl. Two 
concentrations of PEG-cholesterol were introduced to (GT)15-suspended nanotubes in 
either buffer alone or with 100 mM NaCl. For both concentrations of PEG-cholesterol 
tested, the presence of NaCl did not affect the magnitude of blue-shifting for nearly all 
nanotube chiralities measured (Figure 4.8). Intensity enhancement was also not 
affected (Figure 4.9). These data suggest that monovalent ions do not change intrinisc 
sensitivity to analytes via DNA rearrangment but act extrinsically by a screening 
effect between the DNA and the charged analyte. We present our model of salt-
dependent accesibility in Figure 4.10. In the absence of salt, the electrostatic repulsion 
between the negatively charged phosphate backbone of the DNA and the anionic 
sulfate group limits the amount of SDBS that can adsorb to the nanotube, resultuing in 
only a minor blueshift. In the presence of monovalent ions, charge screening enables 
greater SDBS access, leading to a larger blue-shift. 
 
 
 
154 
 
 
Figure 4.8 Neutral analyte effect on wavelength in salt. Emission wavelength 
changes of DNA-encapsulated nanotubes after addition of the indicated concentration 
of polyethylene glycol (PEG)-modified cholesterol and incubation overnight in 0 mM 
or 100 mM NaCl solvent conditions. The (6,5), (7,5) (10,2), (7,6), (9,4), and (8,6) 
nanotube chiralities are shown. Error bars represent standard deviation of technical 
triplicates. 
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Figure 4.9 Neutral analyte effect on intensity in salt. Intensity fold change of DNA-
wrapped nanotubes after addition of the indicated concentration of polyethylene glycol 
(PEG)-modified cholesterol and incubation overnight in 0 mM or 100 mM NaCl 
solvent conditions. The (6,5), (7,5), (10,2), (7,6), (9,4), and (8,6) nanotube chiralities 
are shown. Error bars represent standard deviation of technical triplicates. 
 
Figure 4.10 Model depiciting the hypothesized mechanism for monovalent salt-
dependent anionic analyte binding to (GT)15 DNA-suspended nanotubes. Example 
spectra corresponding to the hypothesized structures in each condition of baseline 
nanotube emission (black) and emission after treatment with SDBS (blue). 
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We ran serial molecular dynamics simulations to investigate our proposed model. We 
first quantitatively assessed the effect of salt on the DNA encapsulating the nanotube 
by introducing a (GT)15-suspended (9,4) nanotube to three different salt concentrations, 
0 mM, 100 mM, and 500 mM, in a in a 8.0 nm x 8.0 nm x 9.8119 nm cubic box 
solvated in explicit water (approximately 20,000 molecules, see Methods). We ran the 
simulation for 200 ns, after which we assessed ion and water densities on the nanotube 
surface under each condition (Figure 4.11). We reasoned that changes in phosphate 
and water densities would indicate a major disturbance to the DNA on the nanotube. 
In all cases, no differences in these parameters were observed, agreeing with 
experimental data showing no optical changes due to NaCl alone (Figure 4.1). A 
concentration-dependent increase in sodium density around the DNA phosphate 
groups was observed in the simulations, consistent with our proposed screening model 
in Figure 4.10. 
Figure 4.11 Molecular dynamics of DNA-suspened nanotubes in salt.Water, 
phosphate, chloride, and sodium density at different distances from the DNA-
suspended (9,4) nanotube surface calculated from molecular dynamics simulations 
performed with 0 mM NaCl (black), 100 mM NaCl (red), and 500 mM NaCl (blue) in 
a 8.0 nm x 8.0 nm x 9.8119 nm cubic box solvated in explicit water (approximately 
20,000 molecules) for 200 ns. Six simulations were performed at each salt 
concentration. 
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We next conducted molecular dynamics simulations to assess the effects of SDBS on 
the DNA-wrapped nanotube in the absence of salt. The surfactant was introduced to 
the vicinity of the (9,4) (GT)15 DNA-encapsulated nanotube. After 200 ns of 
simulation time, we observed SDBS adsorbing to the bare surface of the nanotube 
without apparent displacement of the DNA (snapshot in Figure 4.12). From the 
simulation, we quantified phosphate, sulfate, sodium, and chloride ion density as well 
as water density (Figure 4.12). Notably, the density of phosphate at all radial distances 
showed no change versus the SDBS-free control, indicating that DNA remained bound 
to the surface and was not displaced by SDBS, despite the increase in sulfate 
concentration near the surface. We also found that the water density near the nanotube 
surface decreased when SDBS was added. We therefore conclude that the expulsion of 
water by SDBS, and the resulting decrease in the local dielectric constant, most likely 
explains how SDBS experimentally elicits a blue-shift. This result agrees nicely with 
the experimental findings of the emission response of DNA-suspended nanotubes to 
SDBS, which show broadened spectral peaks which seem to retain the characteristics 
of both DNA-suspended nanotubes and SDBS-suspended nanotubes21. Sodium 
accumulation near the surface of the nanotube was largely unaffected by SDBS 
adsorption. 
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Figure 4.12 Molecular dynamics of DNA-suspened nanotubes with SDBS. 
Trajectory snapshots and density concentrations of selected parameters from 
molecular dynamics simulations of a (GT)15 DNA suspended nanotube with 100 mM 
SDBS. Snapshots depict SDBS adsorption to the bare nanotube surface of a (GT)15 
DNA suspended nanotube. Phosphate, sodium, water, chloride, and sulfate densities 
are quantified as a function of radial distance with no SDBS (black) and 100 mM 
SDBS (red). 
 
We aimed to quantitatively examine SDBS interactions with the DNA-wrapped 
nanotube under different salt conditions. We used molecular dynamics simulations to 
calculate changes in the free energy of adsorption of SDBS to the (GT)15-suspended 
(9,4) nanotube. We first placed a single SDBS molecule in the vicinity of the DNA-
suspended nanotube at various salt concentrations (Figure 4.13). In this case, we found 
that there was no salt-dependent change in the free energy of SDBS adsorption (Figure 
4.13a and c, single SDBS). Based on the trajectory snapshot, there appeared to be a 
large area of bare-nanotube surface accessible to SDBS, which we conclude may have 
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allowed for adsorption with minimal electrostatic interactions with the DNA. In a 
simulation with excess SDBS, which better represents the experimental conditions, 
increasing salt concentration resulted in a lower free energy of adsorption (Figure 
4.13b and c, excess SDBS). In this simulation, SDBS exhibited greater coverage of the 
DNA-suspended nanotube. This increased coverage may have induced greater 
electrostatic barriers between the SDBS and the DNA-encapsulated nanotube, 
potentially explaining the effect of salt on SDBS adsorption in this case.  
Figure 4.13 Molecular dynamics simulations of anionic amphiphile adsoprtion to 
DNA-encapsulated nanotubes. a, Simulation snapshot and corresponding plot of free 
energry (FE) of adsorption of a single molecule of SDBS (green) on the (9,4) nanotube 
species bound by the (GT)15 DNA sequence (purple) in the three indicated salt 
conditions. Vertical dotted line indicates the radial distance with the most negative FE. 
b, Simulation snapshot and FE of adsorption of SDBS (green and orange) added in 
excess, in the indicated salt conditions. The green SDBS indicates the molecule used 
to calculate the free energy of adsorption. c, Adsorption free energies calculated for 
dilute and concentrated SDBS at radial distances corresponding with the vertical 
dotted lines in parts a and b. Error bars represent standard deviation of the mean from 
three simulations. 
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The simulation results and experimental data suggest that charge-charge repulsion 
between the DNA on the nanotubes and the SDBS is a primary factor affecting the 
accessibility of the amphiphile. The simulation and cholesterol data suggest that NaCl 
does not significantly alter the DNA conformation, but it allows sodium ions to 
effectively screen the charges to lessen repulsion and allow SDBS to access the 
nanotube surface. The simulations also suggest that salt may screen charges from 
SDBS already adsorbed to the nanotube, which may become significant as more 
SDBS adsorbs. No clear secondary surfactant structures, such as hemi-micelles27, were 
observed to form on the nanotube surface, consistent with studies describing random 
adsorption of other surfactants to nanotubes28.   
To investigate whether charge screening would affect the detection of other analytes, 
we tested how salt would affect detection of nucleic acid hybridization. We previously 
developed a complex consisting of a nanotube encapsulated by a single-stranded DNA 
oligonucleotide consisting of a “nanotube-binding” (GT)15 domain and an “analyte-
binding” domain of 23 nucleotides complementary to a target oligonucleotide21. The 
hybridization results in a partial desorption of the pair from the nanotube that causes a 
blue-shifting of the nanotube emission wavelength. For the analyte, we used a DNA 
analogue of a microRNA (miR-19) and chose the suitable complementary sequence as 
the “analyte-binding” domain on the nanotube. Focusing on the (9,4) chirality, we 
introduced several concentrations of miR-19 in the presence of 0 mM NaCl or 150 
mM NaCl and assessed emission wavelength (Figure 4.14a). In the no-salt condition, 
miR-19 DNA did not elicit a response. In the presence of 150 mM NaCl, we observed 
a blue shift down to a concentration of 100 nM miR-19 DNA, suggesting that 
hybridization did not occur in the absence of NaCl. We next tested if NaCl can be 
adjusted to improve the detection of low concentration targets. We hypothesized that 
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hybridization, and thus the magnitude of blue-shifting, could be enhanced by further 
increasing the NaCl concentration to overcome electrostatic repulsion. Using the (7,5) 
chirality, which only slightly blue-shifts upon addition of 100 nM miR-19 DNA in 150 
mM NaCl, we repeated the hybridization experiment in escalating salt conditions. We 
found an enhancement of the blue-shifting response up to about 750 mM NaCl, after 
which the sensor function started to become adversely affected (Figure 4.14b). A non-
complementary, length matched oligonucleotide control, R23, did not produce a blue-
shifting response at any NaCl concentration. Our results are in agreement with other 
work that showed DNA hybridization of 24 base-pair sequences in solution is 
optimally enhanced at 800 mM NaCl29. We present a model of charge screening 
leading to enhanced hybridization in Figure 4.14c.  
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Figure 4.14 Salt-dependent optical detection of a polyanionic analyte, single 
stranded DNA. a, Wavelength shift of an oligonucleotide sensor, GT15mir19, as a 
function of target oligonucleotide (miR-19 DNA) concentration in 0 mM NaCl or 150 
mM NaCl. b, Wavelength shift of GT15mir19 with 10 nM miR-19 or 10 nM non-
complementary control (R23) with escaltating NaCl concentration. c, Model of 
hyopthesized mechanism for target oligonucleotide interaction with DNA-suspended 
nanotube sensor (GT15mir19) under zero salt conditions (left) and with salt (right). 
Observed spectral shifts in each condition are represented by generic spectra where 
black represents the baseline spectra and blue represents spectra after hybridization. 
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4.4 Conclusion 
The impact of electrostatic interactions between nanoparticles and analytes can play a 
critical role in the success30 or failure31 of a nanoparticle sensor. Nanoparticles with 
intrinsic surface charge, such as gold nanoparticles functionalized with 
oligonucleotides, are especially sensitive to the solvent salt conditions32. Many 
biomarkers have multivalent charges, such as oligonucleotides, making electrostatic 
interactions of nanoparticles and analytes an integral part of successful sensing 
schemes. Carbon nanotubes functionalized with DNA have an intrinsic negative 
charge, but the impact of electrostatic repulsion with potential analytes has not been 
well addressed. Using an experimental and computational approach, we have found an 
important role for NaCl in determining the sensitivity of DNA-suspended nanotubes to 
anionic analytes. The role of NaCl in enabling SDBS-dependent blueshifting, for 
example, was striking; the magnitude of SDBS-induced blue-shifting for the (9,4) 
nanotube chirality was nearly quadrupled by the addition of NaCl. From an 
applications standpoint, controlling the salt content of the sensing environment could 
provide a simple route to tune the magnitude and kinetics of an optical response to 
anionic analytes. 
 
Because the DNA is non-covalently associated with the carbon nanotube, there is a 
certain degree of freedom in conformations that the DNA can take on the surface. As a 
polyanionic molecule, we reasoned that electrostatic screening from added salts could 
change intrinsic sensitivity to analytes via a DNA conformation change, complicating 
experimental system. This does not appear to be the case, as a neutrally charged 
analyte interacted with the nanotube independent of the salt concentration. Molecular 
dynamics simulations strengthened this view, as no major DNA rearrangement was 
observed in our simulations. The effect of salt on the free energy of absorption of 
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SDBS in the simulations provide quantitative insight in how analyte binding may be 
controlled by changing the salt concentration of the sensing environment. This strong 
control of analyte binding through changes in the salt concentration may have 
important consequences for other intrinsically charged nanoparticles, and represents 
an important parameter that must be considered in future point-of-care applications. 
 
4.5 Materials and Methods 
4.5.1 DNA-suspension of carbon nanotubes 
Carbon nanotubes produced by the HiPco process (Unidym, Sunnyvale, CA) were 
mixed with (GT)15 or (GT)15-TCAGTTTTGCATAGATTTGCACADNA 
oligonucleotides (IDT DNA, Coralville, IA) at a 2:1 mass ratio in 1 mL of 20 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES, Thermo Fisher Scientific) 
buffer or deionized water for hybridization experiments and ultrasonicated for 30 
minutes at 40% amplitude (Sonics & Materials, Inc.). Following ultrasonication, the 
dispersions were ultracentrifuged (Sorvall Discovery 90SE) for 30 minutes at 280,000 
x g. The top 80% of the supernatant was collected. Absorbance spectra were acquired 
using a UV/Vis/nIR spectrophotometer (Jasco V-670, Tokyo, Japan), and the 
concentration was calculated using the extinction coefficient Abs910 = 0.02554 L mg-
1cm-1. To remove free DNA, 100 kDa Amicon centrifuge filters (Millipore) were used. 
The DNA-nanotube complexes were re-suspended in 20 mM HEPES buffer or 
deionized water. 
 
165 
 
4.5.1 Salt-dependent effects on analyte accessibility 
For all experiments, DNA-suspended nanotubes were used at a final concentration of 
0.2 mg/L diluted from a stock solution in either 20 mM HEPES or deionized water. 
Concentrated stock solutions of sodium chloride, potassium chloride, and magnesium 
chloride (Thermo Fisher Scientific) were prepared in 20 mM HEPES and diluted to 
the indicated concentration in the figures. A stock solution of sodium 
dodecylbenzenesulfonate (SDBS) in 20 mM HEPES buffer was used to produce a 
final concentration of 0.2% wt/vol where indicated. Cholesterol-PEG 600 (Sigma-
Aldrich) was reconstituted to a stock of 5.73 mM in phosphate buffered saline. 
Hybridization experiments were performed in deionized water or PBS, with additional 
NaCl spiked in to indicated final concentration using a concentrated stock solution. 
The target sequence, miR-19, is TGTGCAAATCTATGCAAAACTGA and non-
complementary control strand, R23, is TCGGTCAGTGGGTCATTGCTAGT. 
 
4.5.2 Fluorescence spectroscopy of carbon nanotubes in solution 
Fluorescence emission spectra from aqueous nanotube solutions were acquired using a 
home-built apparatus consisting of a tunable white light laser source, inverted 
microscope, and InGaAs nIR detector. The SuperK EXTREME supercontinuum white 
light laser source (NKT Photonics) was used with a VARIA variable bandpass filter 
accessory capable of tuning the output 500 – 825 nm with a bandwidth of 20 nm. The 
light path was shaped and fed into the back of an inverted IX-71 microscope 
(Olympus) where it passed through a 20x nIR objective (Olympus) and illuminated a 
50-100 µL nanotube sample in a 96-well plate (Corning). The emission from the 
nanotube sample was collected through the 20x objective and passed through a 
dichroic mirror (875 nm cutoff, Semrock). The light was f/# matched to the 
spectrometer using several lenses and injected into an Isoplane spectrograph 
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(Princeton Instruments) with a slit width of 410 µm which dispersed the emission 
using a 86 g/mm grating with 950 nm blaze wavelength. The spectral range was 930 – 
1369 nm with a resolution of ~0.7 nm. The light was collected by a PIoNIR InGaAs 
640 x 512 pixel array (Princeton Instruments). A HL-3-CAL-EXT halogen calibration 
light source (Ocean Optics) was used to correct for wavelength-dependent features in 
the emission intensity arising from the spectrometer, detector, and other optics. A 
Hg/Ne pencil style calibration lamp (Newport) was used to calibrate the spectrometer 
wavelength. Background subtraction was conducted using a well in a 96-well plate 
filled with DI H2O. Following acquisition, the data was processed with custom code 
written in Matlab which applied the aforementioned spectral corrections, background 
subtraction, and was used to fit the data with Lorentzian functions. Graphs and linear 
fits were performed in GraphPad Prism 6. 
 
4.5.3 Molecular dynamics simulations  
We first performed 200 ns serial molecular dynamics (MD) simulations of a (GT)15 
suspended, (9,4) nanotube to determine unbiased density distributions of unbiased salt 
and other molecule concentrations. A total of six simulations were performed at three 
different salt concentrations (0, 100, and 500 mM) and two different SDBS 
concentrations (0 and 100 mM). Simulation boxes contained a (9,4) chirality carbon 
nanotube in a 8.0 nm x 8.0 nm x 9.8119 nm cubic box solvated in explicit water 
(approximately 20,000 molecules). The exact number of water molecules in each case 
was fine-tuned to adjust the average pressure to approximately atmospheric pressure. 
The nanotube extended to the edges of the water box and was kept frozen in place 
during the course of the simulation. The DNA molecule was initially generated using 
the NAB program of AmberTools33. After placing the DNA near the nanotube, 
sufficiently long equilibrations were performed until the distance between nanotube 
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and DNA remained constant. The nanotube atoms were modelled as sp2 hybridized 
carbon. DNA/water is represented with CHARMM36/TIP3P force field34. Parameters 
for linear non-branched SDBS was obtained from a study by MacKerell and co-
workers (He et al., 2010), which follows general parameterization strategy for 
CHARMM force field35. The systems were propagated using stochastic Langevin 
dynamics with a friction coefficient of 1 ps-1 and time step of 2 fs using GROMACS 
4.6.7 simulation package36, 37. Long-range electrostatics were treated with particle 
mesh Ewald method with a 0.9 nm real space cut-off distance and van der Waals 
interactions were calculated following a 1.2 nm cut-off distance38. Each simulation 
box was pre-equilibrated with 10-20 ns NVT (T=300K simulations). Further 
production simulations were run for 200 ns for each case, where we collected the 
density profiles afterwards using custom python scripts calling the MDAnalysis 
module39. All visualizations were performed using VMD program40. 
We next performed enhanced sampling simulations to quantify the adsorption free 
energy of SDBS using two different SDBS concentration conditions. In one case the 
simulation box contained the addition of a single SDBS molecule to the (GT)15 
suspended nanotube; the other case contained addition of excess SDBS to the (GT)15 
suspended nanotube. For each SDBS concentration, three different salt conditions 
were simulated using an umbrella sampling technique41 where we defined the 
adsorption with a reaction coordinate of the radial distance between the center of mass 
of SDBS and the nanotube. In the excess SDBS case, a single SDBS molecule is 
pulled along the radial direction as well. A total of 16 umbrella windows at radial 
distances of 0.65, 0.85, 1.10, 1.25, 1.45, 1.65, 1.85, 2.05, 2.25, 2.45, 2.65, 2.85, 3.05, 
3.25, 3.45, 3.65 nm were used with a spring constant of 400 kJ/mol/nm. Each umbrella 
is simulated for 30 ns in parallel, allowing an exchange between adjacent replicas42 to 
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further enhance the sampling. Initial 10 ns is discarded as equilibration from each 
window. The WHAM code by Grossfield43 was used to compute resultant free 
energies. Errors are the standard blocked errors using 2 equal non-overlapping blocks.  
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CHAPTER 5: DETECTION OF VIRAL RNA BASED ON DENATURED-
PROTEIN ENHANCED OPTICAL SENSING 
 
5.1 Abstract 
Direct optical detection of virus or virus-associated components directly in patient 
serum could facilitate diagnostics and guide clinicians to selecting optimal treatment. 
Detection of viral RNA is one option, but the RNA is contained within a protein 
capsid and occasionally lipid bilayer, requiring a lysis step to liberate the RNA. 
Single-walled carbon nanotubes have recently been shown to be a viable option for the 
detection of small oligonucleotides such as microRNA in biofluids like urine and 
serum. Here we have found that the optical changes of the nanotube due to 
hybridization can be enhanced by protein denatured with a common surfactant, 
sodium dodecyl sulfate (SDS). While SDS alone does very little to the nanotube, and 
protein rich solutions like serum ruined the functionality of the sensor, the 
combination produced an unexpected enhancement in solvatochromism upon 
hybridization with target oligonucleotide. We found the mechanism to be due to 
hydrophobic patches of the denatured protein chain interacting with the nanotube 
surface after hybridization. Because the sensor works best in protein denaturing 
conditions, we demonstrate potential clinical use by treating an intact lentivirus model 
with SDS and a nanotube sensor for a region of the viral genome and showing specific 
hybridization.  
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5.2 Introduction 
As biomarkers, cell-free oligonucleotides in biofluids such as serum offer the potential 
to diagnose, monitor, and stratify disease states based on specific expression patterns, 
changes, or mutations1-3. Indeed, realizing such potential has been the subject of recent 
work focusing on “liquid biopsies4,” which aims to use such accessible biomarkers to 
complement or even obviate the need for an invasive, traditional biopsy. In particular, 
circulating microRNA has been identified as a promising target2, but circulating tumor 
DNA5 and other cell-free DNA6 fragments are also of great interest. While the focus 
of cell-free oligonucleotide detection has been for cancer, many other diseases of 
interest also show specific expression patterns of oligonucleotides7. In additionally, 
detection of exogenous DNA and RNA strands such as those found in viruses is also 
highly desirable8. Rapid, quantitative detection of viral oligonucleotides without the 
need for purification, amplification, or labeling of the oligonucleotide could help 
diagnose infectious disease before symptoms appear, monitor the course of the disease, 
and also characterize viral subtypes and clades9. A simple point-of-care option such as 
this would be especially valuable in developing countries prone to infectious disease 
outbreak9, such as Ebola10. Because the viral genome is typically sequestered inside a 
protein capsid and in some cases an additional lipid bilayer, a point-of-care sensor 
would have to be compatible with lysing conditions to liberate the viral 
oligonucleotides. In addressing the need for such point-of-care options, diverse 
solutions based on nanomaterials are being developed, which have recently been 
reviewed elsewhere11. 
Single-strand DNA-suspended single-walled carbon nanotubes represent one such 
class of nanomaterials being pursued as an optical sensor12, and have recently been 
shown to be able to detect biomarker oligonucleotides such as microRNA directly in 
biological fluids such as serum and urine13. Carbon nanotube-based sensors are 
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fluorescent in the near-infrared range14 and do not photobleach15, with many chiralities 
present defined in part by unique excitation and emission spectra16. Changes in the 
local dielectric environment, such as upon interaction with an analyte17, leads to 
solvatochromic changes (relative blue- or red-shifting of the emission wavelength) in 
the nanotube emission18, forming the basis for their use as optical sensors19. While 
such carbon nanotube sensors were shown to detect target oligonucleotides in simple 
buffer conditions with a modest shift in emission wavelength, the optical change upon 
detection could be greatly enhanced by the presence of sodium 
dodecylbenzenesulfonate (SDBS). This was found to be due to changes in the 
nanotube surface area after hybridization that allows for SDBS to bind to the nanotube 
and induce changes in its optical emission. The enhancement from SDBS was found to 
persist in biofluids such as serum and urine and enabled detection of short DNA 
oligonucleotides and microRNA13. 
Herein, we describe another means for hybridization enhancement that only occurs in 
protein-rich biological solutions. By itself, protein-rich solutions such as serum 
prevent detection of target oligonucleotide. We found that the addition of a different 
surfactant, sodium dodecylsulfate (SDS), which does little on its own to enhance the 
solvatochromic change after hybridization with target oligonucleotide, provides 
greatly enhanced solvatochromism when combined with serum. To deduce the 
mechanism of this enhancement, purified proteins of different molecular weight and 
character, such as bovine serum albumin, γ-globulins, casein, and hydrolyzed casein 
peptides, were tested with and without SDS. From these studies we conclude that 
hydrophobic pockets of the SDS-denatured protein interact with the nanotube upon 
hybridization, leading to a greatly enhanced blue-shift. Finally, we demonstrate the 
potential for clinical application by detecting single-strand viral RNA from an intact 
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lentivirus model using a nanotube-sensor for a specific for a region of the lentiviral 
RNA and lysing the virus with SDS. 
 
5.3 Results and discussion 
Using a carbon nanotube-based sensor for miR-19 microRNA sequence as previously 
described (GT15mir19)13, we characterized the effect of serum proteins on detection 
using a single-stranded DNA target strand. In buffer only conditions, the detection of 
target DNA produces a blue-shift in nanotube emission for most chiralities. However, 
the addition of a small amount of fetal bovine serum (10%), abrogated any wavelength 
changes in response to target oligonucleotide (Figure 5.1a). Two-dimensional 
excitation/emission photoluminescence spectroscopy (PL plot) was used to assay 
optical changes for 11 different nanotube chiralities incubated with FBS after addition 
of target oligonucleotide or a non-complementary control strand. For every chirality 
measured, FBS ablated any optical changes in response to target oligonucleotide 
(Figure 5.1b). To better understand the effect of FBS on the sensor’s baseline 
fluorescence, we measured the optical changes of the sensor as a dose-response to 
dilutions of FBS in the absence of any hybridization. Increasing concentrations of FBS 
induced steady red-shifting, as well as a concurrent increase in intensity (Figure 5.2). 
Because nanotube solvatochromism occurs in response to changes in the local 
dielectric environment of the nanotube, we interpret this red-shift and intensity 
increase to mean that material from the serum is either closely associating with the 
bare-regions of the DNA coated nanotubes, electrostatically interacting with the 
phosphate backbone to induce DNA conformation changes, or some combination 
thereof.  
 
 
180 
 
Figure 5.1 Impact of serum on carbon nanotube oligonucleotide sensor function. a, 
Wavelength shift of GT15mir19 nanotube sensor after overnight incubation with 1 uM 
target DNA (orange) or control DNA (purple) in either PBS or 10% FBS. b, 
Wavelength shift after overnight incubation with 1 uM target DNA (orange) or control 
DNA (purple) for the indicated nanotube chiralities in fetal bovine serum (FBS). 
 
 
Figure 5.2 Dose-dependent effects of serum on nanotube sensor baseline 
fluorescence. a, Center wavelength of the (9,4) chirality as a function of added fetal 
bovine serum (FBS) incubated overnight. b, Intensity of the (9,4) chirality as a 
function of added fetal bovine serum (FBS) incubated overnight 
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In an attempt to reduce this apparent FBS-induced fouling of the sensor, we 
hypothesized that an anionic detergent, sodium dodecyl sulfate (SDS) may associate 
with bare-regions of the nanotube and block non-specific binding of serum 
components. SDS can be used to suspend carbon nanotubes14, due to hydrophobic 
interactions between the nanotube surface and the 12-carbon long alkyl chain20. We 
first tested whether addition of SDS would change the baseline fluorescence of the 
GT15mir19 sensor. Dilutions ranging from 0.1% to 1% wt/vol SDS showed no 
significant changes in emission wavelength (Figure 5.3a) or intensity (Figure 5.3b). 
When hybridization of target DNA was measured in the presence of SDS via PL plots, 
only slight enhancement was observed for some chiralities compared to the buffer 
only condition (Figure 5.4). Although SDS seemed to have little effect on the DNA-
wrapped nanotube baseline fluorescence and changes during hybridization, we 
hypothesized that SDS may at least preserve hybridization detection under serum 
conditions. GT15mir19 sensor was added to whole FBS with target or control 
oligonucleotide, followed by addition of concentrated SDS to a final concentration of 
1%. After 4h, PL plots were acquired to measure the nanotube optical response. 
Surprisingly, every nanotube showed a greatly enhanced solvatochromic response to 
target oligonucleotide, with emission blue-shifting from 3 to 9 nanometers depending 
on chirality (Figure 5.5a) as well as an increase in emission intensity (Figure 5.5b). 
Excitation wavelengths also shifted, indicating change in the ground state-absorption 
(Figure 5.6). When the concentration of target oligonucleotide was varied, the sensor 
retained dose-dependent blue-shifting behavior for quantitative detection of target 
oligonucleotide (Figure 5.7). 
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Figure 5.3 Baseline effects of SDS. a, Center wavelength of GT15mir19 nanotube 
sensor after overnight incubation with the indicated concentration of SDS, shown for 
the (9,4) nanotube chirality. Intensity of GT15mir19 nanotube sensor after overnight 
incubation with the indicated concentration of SDS, shown for the (9,4) nanotube 
chirality. Error bars represent standard deviation of technical triplicates 
 
Figure 5.4 Effect of SDS on hybridization. Wavelength shift after overnight 
incubation with 1 uM target DNA (orange) or control DNA (purple) for the indicated 
nanotube chiralities in 1% SDS. 
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Figure 5.5Effect of serum with SDS on wavelength and intensity after hybridization 
a, Wavelength shift of GT15mir19 nanotube sensor after overnight incubation with 1 
uM target DNA (orange) or control DNA (purple) for the indicated nanotube 
chiralities in FBS treated with 1% SDS. b, Intensity fold change of GT15mir19 
nanotube sensor after overnight incubation with 1 uM target DNA (orange) or control 
DNA (purple) for the indicated nanotube chiralities in FBS treated with 1% SDS  
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Figure 5.6 Changes in excitation and emission after hybridization in serum with 
SDS. Plots of excitation and emission wavelength shifts in response to target DNA 
and control (R23) in serum treated with 1% SDS. Nanotubes treated with target DNA 
are labeled by chirality, while the nanotubes treated with R23 control DNA have 
labels omitted for clarity. Colors indicate mod type of the nanotube. Error bars 
represent standard deviation of technical triplicates. 
 
Figure 5.7 Dose-response behavior of target oligonucleotide in serum with SDS. 
Wavelength shift of GT15mir19 nanotube sensor after overnight incubation with 
indicated concentrations of target DNA (orange) or control DNA (purple) in FBS 
treated with 1% SDS. In all cases 2 mg/L GT15mir19 was used. Error bars represent 
standard deviation of technical replicates. 
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We next measured the kinetics of wavelength shifting for the (8,6) nanotube after 
addition of target DNA and non-complementary control DNA in both PBS buffer and 
serum, with and without SDS (Figure 5.8). Addition of SDS to buffer only conditions 
had little effect compared to the buffer control, and there was no detection of target in 
untreated serum. The combination of serum and SDS produced a greatly enhanced 
blue-shift that became apparent after about 30m. Compared to the buffer conditions, 
the shape of the kinetic trace was sigmoidal with an inflection point around 2h that 
reached a minimum by 3h.  
Figure 5.8 Dynamics of the carbon nanotube oligonucleotide sensor under different 
hybridization conditions with different additives. Each condition depicts 2 mg/L 
GT15mir19 nanotube sensor treated with 1 uM target DNA (orange in PBS, light 
green in serum) or control DNA (purple in PBS, dark green in serum) added at time 0 
and measured every 10m for 4h. 
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We have previously reported hybridization-induced enhancement of solvatochromic 
changes using sodium dodecylbenzene sulfonate (SDBS), which also enabled 
detection in serum conditions13. We compared the kinetics of SDS + serum to the 
enhancement provided by SDBS in both buffer and serum upon hybridization with 
target DNA. SDBS-enhanced blue-shifting kinetics upon hybridization produced a 
similar line shape regardless of buffer or serum conditions, characterized by a blue-
shift that approaches a maximum overtime with pseudo-first order kinetics (Figure 
5.9a). This similarity in kinetics suggests a similar mechanism in both conditions, 
which we have previously reported to be due to SDBS interacting with newly exposed 
regions of the nanotube after hybridization. When the kinetics of hybridization-
induced enhancement in SDS + serum is compared to SDBS, there is a long lag period 
followed by a gentler slope (Figure 5.9b). Although slower than SDBS, the SDS + 
serum combination produces a final blue-shifted value of greater magnitude (Figure 
5.9c and d). The kinetics of emission intensity displays a more complicated pattern, 
with initial quenching, a short period of apparent stabilization, and then steady 
intensity increase that extends beyond baseline. When the kinetics of intensity change 
is plotted on the same graph as wavelength shift, it appears that the inflection point for 
the wavelength shifting is also where the intensity begins to increase (Figure 5.10). 
Because SDS only provides enhancement in the presence of serum, and because of the 
relatively complex kinetics of SDS + serum enhancement compared to SDBS, we 
hypothesized that SDS-denatures a component of the serum that binds to the newly 
exposed regions upon hybridization to provide an enhanced blue-shift. 
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Figure 5.9 Comparison of hybridization-induced enhancement dynamics a, 
Normalized ( 0 to -1, with -1 being most blue-shifted) wavelength shift of GT15mir19 
nanotube sensor over time with 1 uM target DNA in 0.2% sodium 
dodecylbenzenesulfonate (SDBS) in PBS (green) or FBS (blue). b, Wavelength shift 
of GT15mir19 nanotube sensor over time with 1 uM target DNA in serum with 0.2% 
SDBS (blue) or serum with 1% SDS (red). c and d, Dynamics of wavelength shift for 
GT15mir19 in serum with 0.2% SDBS or 1% SDS treated with 1 uM target or control 
DNA. 
Figure 5.10 Overlay of wavelength shifting and intensity dynamics. Overlay of 
wavelength shift (blue, left axis) and intensity fold enhancement (red, right axis) 
overtime after addition of 1 uM target DNA in serum treated with 1% SDS. Vertical 
dotted line indicates approximate time where intensity beings to increase 
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Serum is a complex biological fluid with many protein and non-protein components21. 
Because non-polar compounds tend to blue-shift nanotubes22, 23, we hypothesized that 
lipoproteins, which transport non-polar fats24, may be the component of serum 
responsible for SDS-induced hybridization enhancement. GT15mir19 sensor was 
spiked into human lipoprotein-deficient serum (LPDS) or standard FBS with different 
concentrations of target DNA, followed by addition of concentrated SDS to a final 
concentration of 1% wt/vol. The dose-response behavior and magnitude of blue-shift 
upon hybridization with target oligonucleotide was largely indistinguishable between 
the two serum conditions (Figure 5.11), suggesting that lipoproteins only play a minor 
role.  
 
Figure 5.11 Wavelength shift response of GT15mir19 to dilutions of target DNA or 
control DNA in fetal bovine serum (FBS) treated with 1% SDS or human 
lipoprotein-deficient serum treated with 1% SDS after incubation overnight. 
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The most abundant macromolecule component of serum is albumin, which ranges 
from 35 mg/mL to 50 mg/mL in healthy individuals25. Using purified bovine serum 
albumin (BSA), we tested the high end of the normal range, 50 mg/mL, with SDS to 
see if this purified component of serum would enhance hybridization in the absence of 
other serum components. A serial dilution of target DNA produced dose-dependent 
enhanced blue-shifting, indicating that BSA + SDS provided enhancement of blue-
shifting in a hybridization dependent manner (Figure 5.12). We next kept the 
concentration of target DNA and SDS constant at 1 uM and varied the concentration 
of BSA. For most chiralities, there was a highly dose-dependent pattern in blue-
shifting and intensity enhancement (Figure 5.13), although some chiralities displayed 
less shifting at the highest protein concentration (Figure 5.14). Interestingly, even in 
these cases, the intensity enhancement was still dose-dependent. Finally, we kept the 
concentration of BSA and target oligonucleotide constant and varied the SDS 
concentration. We escalated the concentration from 0 to 6% in 1% increments, but 
observed no additional enhancement above 2% SDS (Figure 5.15). Narrowing the 
tested percentages between 0 and 1% in 0.1% increments however revealed that blue-
shifting was dose-dependent in this range. The critical micelle concentration (CMC) of 
SDS is approximately 0.23 % wt/vol; just below the CMC, at 0.2% wt/vol, SDS did 
not have any enhancement effect. These data support our hypothesis that SDS-
denatured protein is a major causative agent in serum for the observed hybridization-
induced blue-shift enhancement.  
 
 
 
190 
 
Figure 5.12 Dose-response in BSA with serum. Wavelength shift of the (9,4) 
nanotube after treatment with the indicated concentration of target or control DNA in 
50 mg/mL BSA treated with 1% SDS. Incubation proceeded for 4h. Error bars 
represent standard deviation. 
 
Figure 5.13 Assessment of albumin and SDS contribution to hybridization-induced 
blue-shifting a, Wavelength shift of GT15mir19 nanotube sensor after treatment with 
1 uM target DNA or control DNA in PBS with 1% SDS and the indicated 
concentration of bovine serum albumin (BSA). b, Intensity fold-change of GT15mir19 
nanotube sensor after treatment with 1 uM target DNA or control DNA in PBS with 1% 
SDS and the indicated concentration of BSA 
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Figure 5.14 Chirality specific behavior from BSA + SDS enhanced hybridization. 
Wavelength shift (top) and intensity fold change (bottom) of GT15mir19 nanotube 
sensor for three additional chiralities after treatment with 1 uM target DNA or control 
DNA in PBS with 1% SDS and the indicated concentration of bovine serum albumin 
(BSA).  
Figure 5.15 Role of SDS in BSA + SDS enhanced hybridization. Wavelength shift of 
GT15mir19 nanotube sensor after overnight incubation with 50 mg/mL BSA and 1 
uM of target (orange) or control (purple) DNA and escalating concentrations of SDS . 
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Considerable effort has been put forth in understanding the microstructure and 
mechanism of SDS denaturation of proteins, including the relative contribution of 
hydrophobic interactions versus ionic interactions26-28. The currently accepted view is 
that below the critical micelle concentration of SDS, there is protein tertiary structure 
unfolding to a protein chain29, and at micellular concentrations chain expansion drives 
complete denaturation. The interaction is predominantly hydrophobic at submicellular 
concentrations, and exclusively hydrophobic at micellar concentrations. In this model, 
the chain expansion is driven by micelle nucleation on hydrophobic patches of the 
protein chain30. Based on our experimental observations and this model, we propose 
the following mechanism for SDS-denatured protein enhancement of hybridization-
induced blue-shifting: hybridization with target oligonucleotide leads to partial 
desorption of DNA from the nanotube, exposing the hydrophobic surface to the 
solvent conditions13. SDS-driven loss of tertiary structure and exposure of 
hydrophobic patches on the protein chain, which would typically be coated by an SDS 
micelle31, have a stronger affinity for the newly-exposed nanotube surface than with 
SDS, leading to preferential binding of the hydrophobic patch to the nanotube surface. 
The competition between SDS and the bare nanotube surface for the hydrophobic 
patch may explain the relatively slow kinetics and complicated shape compared to 
SDBS (Figure 5.9). The binding of the peptide chain hydrophobic patch decreases the 
local dielectric environment around the nanotube, producing the observed blue-shift in 
emission. The rest of the DNA-coated nanotube is protected due to charge-charge 
repulsion between the negatively charged SDS-denatured protein chain and the 
negatively charged DNA phosphate backbone. Because SDS does not change baseline 
fluorescence (Figure 5.3) and produces almost no enhancement of blue-shifting after 
hybridization with the target (Figure 5.4), we conclude that free SDS itself makes little 
contribution to the observed blue-shift. Protein by itself red-shifts the nanotube and 
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largely prevents hybridization (Figure 5.1), possibly due to electrostatic interactions 
with the DNA-suspended nanotube32 that are eliminated by SDS coating the protein 
chain. The hybridization conditions and resulting optical outputs are summarized in 
Figure 5.16. 
Figure 5.16 Summary of components added to GT15mir19 nanotube sensor, the 
observed optical effects, and models of hypothesized structures. Grey cylinders 
represent the carbon nanotube, and suspending DNA is represented by blue (GT15 
portion) and orange (complementary region to target oligonucleotide) ribbon.  
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We next tried to understand the impact of the protein size and tertiary character on 
SDS-denatured protein enhancement of hybridization-induced blue-shifting. Using the 
relatively large γ-globulins (1200 kDa compared to albumin, 66.5 kDa), a subset of the 
second most abundant protein class in serum after albumin, we tested if SDS 
denaturation would lead to enhanced blue-shifting upon hybridization. A solution of γ-
globulins at 35 mg/mL was tested with 2% wt/vol SDS with target or control DNA. In 
this case, although we found that SDS-denatured γ-globulins were relatively slow, 
there was a similar equilibrium blue-shift compared to BSA (Figure 5.17a). Unlike 
BSA, SDS-denatured γ-globulins did not lead to increased intensity upon 
hybridization (Figure 5.17b). Another protein, casein, the main protein component of 
milk, is not found in serum but has a micellular tertiary structure as a distinguishing 
characteristic33. Hydrolyzed casein, which is casein that has been digested into smaller 
peptide and protein fragments, was also tested to compare the effect of protein 
fragmentation. We tested whether SDS + casein would recapitulate the results seen for 
BSA and immunoglobulins, and whether SDS + hydrolyzed casein would produce any 
enhancement due to the fragmentation from partial digestion. Casein and hydrolyzed 
casein were prepared at 35 mg/mL and SDS was added to 2% wt/vol, followed by 
target or control DNA. For most chiralities, SDS + casein enhanced hybridization 
induced blue-shifting and intensity increase, while hydrolyzed casein provided only 
modest benefit over controls (Figure 5.17c, d). This is consistent with work showing 
that the degree of hydrolysis of casein is correlated with loss of hydrophobicity34. 
However, we noted that some chiralities showed significant hybridization-induced 
blue-shift enhancement with SDS + hydrolyzed casein, sometimes exceeding the 
enhancement produced by SDS + casein (Figure 5.18). These results suggest that most 
proteins, independent of their tertiary structure, combined with SDS will lead to 
hybridization-induced enhancement with a similar magnitude at equilibrium. A 
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relatively long protein chain appears to be important, as most chiralities did not 
respond well to SDS + hydrolyzed casein as an enhancing agent. Two chiralities were 
notable exceptions, where SDS + hydrolyzed casein performed better than full length 
casein. Chirality-dependent selectivity to analytes has been reported13, 35, 36, but the 
mechanism for chirality selectivity observed here requires further study. 
 
Figure 5.17 Effect of tertiary character and integrity of protein as part of 
hybridization conditions a, Wavelength shift of GT15mir19 nanotube sensor after 
treatment with 1 uM target DNA or control DNA in PBS buffer, 2% SDS, 35mg/mL 
γ-globulins, and 2% SDS with 35 mg/mL overnight. b, Intensity fold change 
corresponding to experiment in part a. c, Wavelength shift of GT15mir19 nanotube 
sensor after treatment with 1 uM target DNA or control DNA in PBS, 2% SDS, 
35mg/mL casein, 2% SDS with 35 mg/mL casein, 35 mg/mL hydrolyzed casein 
peptides, and 2% SDS with 35 mg/mL hydrolyzed casein peptides overnight. d, 
Intensity fold change corresponding to experiment in part c. 
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Figure 5.18 Chirality differences in response to peptide length. Wavelength shift 
(top) and intensity fold change (bottom) of GT15mir19 nanotube sensor for two 
additional chiralities after overnight incubation with 1 uM target DNA or control DNA 
in PBS, 2% SDS, 35 mg/mL casein, 2% SDS plus 35 mg/mL casein, 35 mg/mL 
hydrolyzed casein, or 2% SDS plus 35 mg/mL hydrolyzed casein. 
 
Finally we tested whether the single-strand RNA genome37 of intact lentivirus could 
be detected using SDS to both liberate the genome and denature proteins for 
hybridization-induced enhancement of a nanotube sensor. A sensor was constructed 
for the poly A tail of the virus genome by using (GT)15-(T)15 DNA to suspend carbon 
nanotubes. As a control, a sensor for a poly-T sequence, which does not exist in the 
virus genome, was similarly constructed with (GT)15-(A)15 DNA. The functionality 
of both sensors was first assessed with short strands of DNA target and 0.2% SDBS. 
The sensor for poly-A sequences, (GT)15-(T)15, showed a rapid (complete in 90m) 
and robust blue-shift when treated with (A)15, but no change was observed after 
treatment with (T)15, which served as a control for non-specific oligonucleotide 
binding (Figure 5.19a). To test the sensor with intact virus, we synthesized lentivirus 
according to molecular biology protocols intended for gene transduction. A lentiviral 
vector was chosen as a model virus due to its similar structure and function to 
wildtype lentivirus, but such vectors can be produced in high-yield and have been 
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engineered to be replication incompetent for safety38. Concentrated viral stocks were 
treated with 1% SDS and (GT)15(T)15, the sensor for the poly A tail, or with 
(GT)15(A)15, to serve as a control for non-specific interactions. The center 
wavelength of the (8,6) nanotube was measured every 10m over 180m. The sensor for 
poly-A sequences, (GT)15(T)15, began to blue-shift within 20m, and by 180m had 
shifted about 3 nm. The kinetics displayed a sigmoidal shape, suggesting enhancement 
from denatured viral proteins. The control sensor, (GT)15(A)15, blue-shifted by about 
0.5 nm over 180m, indicating some non-specific interactions (Figure 5.19b). We 
present a model for such detection in Figure 5.19c; here, intact lentivirus is treated 
with SDS and a carbon nanotube sensor. The SDS denatures the lentivirus envelope 
and protein structure, releasing the single-strand RNA genome. Hybridization with the 
poly A tail enables binding by the detergent-denatured protein, leading to a blue-shift 
of the nanotube emission. 
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Figure 5.19 Detection of viral RNA using a lentivirus model. a, Kinetics of 
wavelength shift for (GT)15-T(15) suspended (8,6) with 1 uM of target 
oligonucleotide, (A)15, or non-target control, (T)15, using 0.2% SDBS and blue-shift 
enhancing agent. b, Kinetics of the (8,6) center wavelength for (GT)15-T(15) 
suspended nanotubes or (GT)15-A(15) suspended nanotubes with concentrated 
lentivirus and 2% SDS. c, model depicting how lentivirus RNA can be detected with a 
carbon nanotube sensor and SDS. The virus is ruptured and denatured by SDS, 
liberating the RNA genome, which hybridizes to the sensor. Denatured viral proteins 
provide enhanced blue-shifting upon hybridization. 
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5.4 Conclusions 
Here, we have shown how SDS-treated serum can interact with carbon nanotubes to 
enhance blue-shifting due to hybridization induced removal of DNA from the 
nanotube surface. In understanding why SDS-treated serum provided such 
enhancement, we tested lipoprotein deficient serum as well as purified serum proteins 
to identify the causative agent. Lipoprotein depleted serum behaved nearly identically 
as untreated serum, suggesting that lipoproteins play little role. Purified protein treated 
with SDS could largely recapitulate the enhancement seen with serum, but not with 
the same magnitude of blue-shift. This may be due to a combinatorial effect of several 
proteins present in serum, or a non-protein factor that we could not identify. Serum is 
a complex biological fluid, containing all the proteins not involved in clotting as well 
as electrolytes, lipids, vitamins and minerals, and hormones21. The enhancement to 
hybridization-induced blue-shifting by SDS-treated protein was quite unexpected due 
to the fact that SDS alone does very little to DNA-suspended nanotubes, and protein 
alone red-shifts DNA-suspended nanotubes. Based on the current understanding of 
SDS-induced protein denaturation and the mechanism of the DNA-carbon nanotube 
sensor, we propose a model where hydrophobic patches from the SDS-denatured 
protein bind to newly exposed nanotube surface after hybridization, leading to the 
enhancement in blue-shifting.  
 
For clinical applications, we believe that in vitro diagnostics based on detection of 
short oligonucleotides in protein rich environments such as serum could benefit from 
the use of carbon nanotube-based sensors with SDS. We have previously reported the 
use of another detergent, SDBS, to enhance detection of oligonucleotides in serum. In 
serum, we believe that SDBS and SDS operate with two distinct mechanisms, where 
SDBS interacts with the nanotube directly after hybridization while SDS only 
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functions to expose hydrophobic centers in denatured proteins, which then interacts 
with the nanotube. Although SDBS produces a faster response in serum, SDS 
produces a shift with a greater magnitude, and thus may be better suited for in vitro 
applications. SDS is also a standard molecular biology agent with wide availability 
and well-understood properties and applications. As a proof-of-principle for direct 
optical detection of virus, we have shown here how SDS can be combined with a 
DNA-nanotube sensor to liberate lentiviral RNA from a complete virus structure, and 
provide enhanced blue-shifting from SDS-denatured viral proteins detection after 
hybridization. Such detection could take place directly in serum samples where point 
of care detection is desirable. The DNA-nanotube sensor solution and SDS are both 
highly stable and can be stored at room temperature. While we have used laser 
excitation and an InGaAs array camera for detection, cheaper LEDs could also be used 
for excitation and some nanotubes, such as the (8,4) and (6,5), can be detected by 
standard CCD cameras. An LED/CCD camera detection apparatus could be a 
relatively simple, affordable, and portable device for deployment in regions lacking 
critical biomedical infrastructure. For example, Ebola is a virus with a single-strand 
RNA genome that may be amenable to detection with our method; direct optical 
detection without the need for purification, amplification, labeling, or the use of 
perishable reagents such as antibodies could be beneficial for controlling future 
outbreaks. While we have shown here an application with a lentivirus model, we 
believe that SDS could also be applied to detection of single-strand oligonucleotides in 
other viruses and pathogen types, as well as in circulating cancer cells. 
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5.5 Materials and Methods 
5.5.1 DNA-suspension of carbon nanotubes 
Carbon nanotubes produced by the HiPco process (Unidym, Sunnyvale, CA) were 
mixed with DNA oligonucleotides (IDT DNA, Coralville, IA) at a 2:1 mass ratio in 1 
mL of PBS buffer (Thermo Fisher Scientific Waltham, MA) and ultrasonicated for 30 
minutes at 40% amplitude (Sonics & Materials, Inc.). The DNA sequences used for 
suspension were 
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTCAGTTTTGCATAGATTTGCAC
A (GT15mir19)13, 
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTTTTTTTTTTTTTTT  
((GT)15-T(15)), and 
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTAAAAAAAAAAAAAAA ((GT)15-
A(15)) all purchased from IDT (Coralville, IA). Following ultrasonication, the 
dispersions were ultracentrifuged (Sorvall Discovery 90SE) for 30 minutes at 280,000 
x g and the top 80% of the supernatant was collected. Absorbance spectra were 
acquired using a UV/Vis/nIR spectrophotometer (Jasco V-670, Tokyo, Japan). The 
concentration for HiPco samples was calculated using the extinction coefficient Abs910 
= 0.02554 L mg-1cm-1. Excess DNA was removed via 100 kDa Amicon centrifuge 
filters (Millipore). The DNA-nanotube complexes were re-suspended in PBS (Thermo 
Fisher Scientific Waltham, MA).  
 
5.5.2 Fluorescence spectroscopy measurements of carbon nanotubes 
Fluorescence emission spectra from aqueous nanotube solutions were acquired with a 
home-build spectroscopy system as described13. Briefly, carbon nanotube samples 
were assayed in a 96 well plate format on an inverted microscope using a tunable 
white-light laser (NKT Photonics) coupled to a variable bandpass filter. Emission light 
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was directed into a spectrometer with a focal length of 320 mm and aperture ratio of 
f/4.6 (Princeton Instruments IsoPlane SCT 320) and InGaAs array camera (Princeton 
Instruments 640 × 512 pixel NIRvana). For all experiments, measurements were taken 
in triplicate across three wells. Following spectra acquisition, custom code written in 
Matlab applied spectral corrections and background subtraction as described13. 
Corrected spectra were used to fit the data with Voigt functions. Error bars and linear 
fits were computed with GraphPad Prism 6. 
 
5.5.3 Hybridization conditions 
Concentrated sodium dodecyl sulfate (Sigma-Aldrich) was prepared in PBS buffer and 
added to samples to the final concentration indicated, or 1% wt/vol where not 
indicated; control samples had an equivalent volume of PBS added. Carbon nanotubes 
were used at a final concentration of 2 mg/L for all experiments. Fetal bovine serum 
(FBS) (Life Technologies) and human lipoprotein deficient serum (LPDS) (J65516 
Lipoprotein Deficient Serum, human, BT-931 from Alfa Aesar) were used for serum-
based experiments, and had concentrated nanotubes or SDS added directly to the 
whole serum. Bovine serum albumin, bovine γ-globulins, casein, and hydrolyzed 
casein (all from Sigma-Aldrich) were resuspended in PBS to the indicated 
concentrations. Concentrated target DNA (TGTGCAAATCTATGCAAAACTGA) 
complementary to the DNA-nanotube sensor or non-complementary control DNA 
(TCGGTCAGTGGGTCATTGCTAGT) (both from IDT DNA, Coralville, IA) was 
added to the indicated final concentration. Non-treated controls received an equivalent 
volume of PBS. Hybridization was allowed to proceed overnight for equilibrium 
measurements. Kinetics were measured immediately after addition of target. 
Assessment of (GT)15-T(15) and (GT)15-A(15) used 0.2% SDBS (Sigma-Aldrich) as 
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described13 to verify expected behavior with AAAAAAAAAAAAAAA or 
TTTTTTTTTTTTTTT (IDT DNA, Coralville, IA).  
 
5.5.4 Lentivirus production 
Lentivirus was produced from transfected packaging cells (293T) using 100 ng 
pLX304 plasmid39, 100 ng of packaging plasmid (psPAX2) and 10 ng of envelope 
plasmid (VSV-G). Virus was collected 48 and 70 h after transfection and concentrated 
10-fold. 
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CHAPTER 6 A CUMULATIVE SENSOR FOR IN VIVO DOXORUBICIN 
EXPOSURE 
 
6.1 Abstract 
Doxorubicin is a highly successful chemotherapy drug with indications for many 
cancers, but cumulative dose-toxicity leads to cardiomyopathy. Experimentally, 
doxorubicin is also being applied as part of intraperitoneal delivery methods. For 
monitoring doxorubicin exposure, an implantable, optically-based cumulative sensor 
could help provide personalized care and improve experimental therapies. Using 
DNA-suspended carbon nanotubes, we have discovered that the polycyclic aromatic 
hydrocarbon pyrene, when derivatized to be soluble, induces a large and uniform red-
shift in carbon nanotube emission. We have ascribed this to be a property of DNA-
intercalating agents, including doxorubicin. Sensing of doxorubicin was obtained in 
buffer, serum, intracellularly, and from single nanotubes on a surface covered with 
buffer or serum. Doxorubicin adsorption to the DNA-suspended nanotubes did not 
displace DNA and could not be reversed, and we calculate approximately 180 
molecules bound to a typical 166nm long nanotube as we have prepared. Several 
implantable devices were tested, and doxorubicin was found to be detectable in a 
cumulative way. Real time, in vivo detection of doxorubicin injected into the 
peritoneum was obtained, as well as compartment specific measurements. The robust 
and cumulative sensing of doxorubicin suggests suitability for clinical and 
experimental applications. 
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6.2 Introduction 
Many clinically useful drugs for chemotherapy are based on interactions with DNA, 
which can be covalent, electrostatic, or intercalating interactions1. DNA intercalation 
is a non-covalent interaction driven by hydrophobic and π- π interactions between a 
planar, aromatic polycyclic compound that is approximately the size of two DNA 
bases2. Intercalation often distorts the DNA3 to prevent replication or other essential 
cell functions4, which is therapeutically useful for halting cell-division in cancer cells5 
but can also be highly toxic to normally dividing cells6. DNA intercalating agents have 
additionally found wide-spread use in molecular biology to visualize DNA. Some 
intercalating agents undergo a solvatochromic change in the DNA microenvironment 
that enables fluorescence7. Ethidium bromide is the most common and well-studied of 
such dyes8, with safer alternatives also on the market7. Other compounds, such as 
Hoechst stains, are used in live cells to visual DNA in real-time9. Although several 
intercalating drugs have proven clinically useful in cancer chemotherapy, some 
pollutants are also recognized to be intercalating agents with carcinogenic potential. 
Polycyclic aromatic hydrocarbons result from incomplete combustion of organic 
material and form a class of mutagenic and carcinogenic pollutants due in part to their 
DNA intercalating ability10. The first experimentally induced cancers were driven by 
benz[a]anthracene, a PAH found in soot11. Rapid optical detection of PAH could be 
beneficial for environmental monitoring12, 13 or other toxicology applications. 
Drugs based on DNA intercalating agents include the anthracyclines, a powerful class 
of drugs that are used for a variety of solid and blood based malignancies. Major drugs 
in this class include daunorubicin, doxorubicin, epirubicin, idarubicin, and valrubicin14. 
Doxorubicin in particular has become one of the most widely used chemotherapy 
drugs, often in combination with other drugs. Doxorubicin has indications for breast 
cancer, acute lymphoblastic leukemia, bladder cancer, Ewing sarcoma, Hodgkin 
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lymphoma, non-Hodgkin lymphoma, osteosarcoma, recurrent small cell lung cancer, 
and soft tissue sarcomas. Doxorubicin also has off-label uses for advanced 
endometrial carcinoma, multiple myeloma, thymomas, uterine sarcoma, and 
Waldenstrom macroglobulinemia15. Despite the broad efficacy of doxorubicin, its 
administration must be closely monitored due to dose-limiting cardiotoxicity, which 
limits both acute and lifetime dosing. The cardiotoxicity is cumulative and irreversible. 
Based on retrospective analyses of clinical events, the incidence of cardiotoxicity is 
about 7.5% at a lifetime dose of 550 mg/m2,16 which has become the recommended 
upper-limit. While the exact mechanism of cardiotoxicity is still controversial17, most 
hypotheses are related to an increase in reactive oxygen species18, 19. Establishment of 
550 mg/m2 as an upper limit for a lifetime dose is pragmatic from an epidemiological 
perspective; because the mechanism is not completely understood, it is not yet 
possible to predict patient specific life-time dose limits. Doxorubicin is typically 
administered intravenously, but is also used as part of hyperthermic intraperitoneal 
chemotherapy (HIPEC) for certain cancers restricted to the peritoneum20, 21. An 
ongoing clinical trial is assessing the highest tolerable dose of heated doxorubicin for 
unresectable or refractory pelvic and abdominal rhabdomyosarcoma and 
undifferentiated sarcomas in children (NCT03111069). For both traditional IV 
administration and administration as part of HIPEC, an implantable optical sensor 
could be useful for assessing drug distribution in particular anatomic sites in real time. 
A cumulative sensor near the heart or within cardiac tissue could also provide precise 
information on patient-specific exposure to doxorubicin, and eventually enable better 
control of life-time exposure to doxorubicin and prevention of cardiomyopathy. 
Like DNA intercalating drugs, single-walled carbon nanotubes also strongly interact 
with single-stranded DNA22. Single-walled carbon nanotubes are composed entirely of 
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sp2 hybridized carbon, and can be qualitatively thought of as a polycyclic aromatic 
carbon sheet like graphene rolled into a cylinder with a diameter between about 0.8 
nm to 1.2 nm23, depending on preparation. Because the surface of the carbon nanotube 
is composed entirely of π electrons, DNA bases are driven to interact with the surface 
based on the many of the same forces as DNA intercalating agents. π-π stacking 
between the bases and the nanotube surface drives adsorption, and flexibility in the 
single-strand DNA backbone enables wrapping around the nanotube so that all bases 
can bind, providing a high avidity interaction22, 24. The negatively charged phosphate 
backbone then serves to prevent re-aggregation through electrostatic repulsion25, 
making single-strand DNA an effective dispersant for preparing colloidal solutions of 
carbon nanotubes. Also like some DNA intercalating agents, single-walled carbon 
nanotubes are fluorescent26, but do not photobleach27. The fluorescence is in the near-
infrared range, which is highly penetrant to tissue28. Single-walled carbon nanotubes 
undergo solvatochromic changes depending on their local dielectric environment29, 30, 
which can be utilized for selective sensing of chemical and biological analytes31, 32. 
Stable fluorescence in the tissue-penetrating near-infrared range and sensitivity to 
analytes make carbon nanotube based sensors outstanding candidates for implantable 
optical sensors. Sensors based on DNA-suspended nanotubes have been shown to be 
feasible for in vivo detection of some analytes33, 34.  
Previous reports show that some polycyclic aromatic hydrocarbons, such as pyrene, 
have strong affinity for nanotubes35 and can utilized as part of a non-covalent 
functionalization scheme36. Other work has shown that doxorubicin also has affinity 
for carbon nanotubes that have been non-covalently functionalized with lipid-PEG37. 
This was later demonstrated to be a viable method of drug delivery38. However, the 
impact of these molecules on the photoluminescence of the nanotubes was not 
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assessed. We have shown that DNA-suspended nanotubes can be combined with some 
amphiphilic molecules in a way where the optical character from both the DNA and 
amphiphilic molecule can be discerned in the spectrum, and found that the amphiphile 
binds to the free space on the nanotube34. Given the strong affinity of polycyclic 
aromatic hydrocarbons and doxorubicin for carbon nanotubes, we hypothesized that 
DNA-suspended nanotubes may be made into a sensor for these agents that might 
have utility as an implantable device. 
Herein, we have explored the impact of a soluble pyrene derivative and DNA 
intercalating agents on the optical properties of DNA-suspended carbon nanotubes. 
We found that a soluble pyrene derivative greatly red-shifted the emission and 
excitation of DNA-suspended nanotubes, but not surfactant suspended nanotubes. This 
red-shift was unexpected, as molecules that bind to the nanotube and displace water 
tend to blue-shift nanotubes. In testing a panel of DNA-intercalating agents, we found 
that these agents also red-shifted DNA-suspended nanotubes, and often quenched the 
emission intensity to varying degrees. One such agent, doxorubicin, was selected as a 
target analyte due to the utility of a carbon nanotube-based sensor. Doxorubicin was 
found to elicit dose-dependent red-shifting and intensity quenching in both buffer and 
serum conditions with rapid kinetics. Like pyrene, doxorubicin did not affect 
surfactant suspended nanotubes. In exploring the mechanism we found that the 
suspending DNA is not displaced, and calculated about 180 molecules of doxorubicin 
bind strongly to a DNA wrapped nanotube of average length (166nm), and could not 
be reversed by washing or dialysis. We also found that single nanotubes on a surface 
can detect doxorubicin in both buffer and serum conditions, and when averaged 
largely recapitulate the shifts seen in solution. Three modalities of implantable devices 
were tested in vitro; two hydrogels, agarose and alginate, and a heat-sealable 
215 
 
semipermeable membrane. Using the semipermeable membrane based device, we 
show that in vitro sensing is cumulative. Implantation into the mouse peritoneum 
allowed for detection of injected doxorubicin, and kinetics measurements show this 
detection to be rapid. Finally two devices were surgically implanted in anatomically 
distinct sites separated by a thin layer of fascia. After injection with doxorubicin, we 
found that it did not appreciably pass through the fascia, giving us anatomically 
specific sensing. 
6.3 Results and Discussion 
Recent work has shown that some amphiphilic molecules with affinity for carbon 
nanotubes can be combined with DNA-suspended nanotubes to form a stable “co-
surfactant” system and impart new or enhanced functionality to DNA-suspended 
nanotube-based sensors34. We hypothesized that pyrene may be an effective agent in 
binding free sites on DNA-suspended nanotubes. To make a soluble form of pyrene, 1-
pyrenebutyric acid was activated with N-Hydroxysuccinimide (NHS) and combined 
with excess polyethylene glycol 100 with a terminal primary amine. The resulting 
solution was water soluble, producing a dark yellow-brown solution. A fluorescence 
scan between 350nm and 650nm showed sharp peaks between 350nm and 400nm, 
characteristic of pyrene monomers, and a large peak centered at approximately 480 nm, 
indicative of excimer formation 39 (Figure 6.1a), suggesting that the PEG reaction with 
NHS-activated 1-pyrenebutyric acid produced a water soluble product (Pyrene-PEG).  
Pyrene-PEG was added to a DNA-suspended nanotube-based sensor for short 
oligonucleotides34 and compared to other amphiphilic molecules, sodium 
dodecylbenzene sulfonate (SDBS) and sodium deoxycholate (SDC). SDBS is known 
to associate with the nanotube tube surface without displacement of the suspending 
DNA producing a moderately blue-shifted emission. SDC also has high affinity for the 
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nanotube surface, but is known to displace the suspending DNA, producing a greater 
blue-shift in emission40. The blue-shift from both of these agents is understood to be 
due to the exclusion of water from the nanotube surface, and the resulting decrease in 
the local dielectric environment29, 30, 34. Based on this mechanism, we hypothesized 
that pyrene-PEG would also produce a blue-shift in the nanotube emission. To our 
surprise, the addition of pyrene-PEG greatly red-shifted the DNA-suspended 
nanotubes, while SDBS blue-shifted a modest degree and SDC greatly blue-shifted the 
nanotube emission (Figure 6.1b). The speed at which these red-shifts occurred was 
remarkable; within approximately 5 minutes, the nanotubes were nearly maximally-
red-shifted (Figure 6.1c). The red-shift induced by pyrene-PEG was universal across 
all measured nanotube chiralities (Figure 6.1d), and produced a consistent red-shift 
between of about 12-16 nm with no apparent dependence on chirality (Figure 6.1e). 
There was additionally a consistent red-shift in the excitation wavelength of about 5 
and 7 nm, also apparently independent of chirality (Figure 6.1f). This pyrene-PEG 
induced red-shift is unique to DNA-suspended nanotubes, as addition to SDC-
suspended nanotubes did not produce any change (Figure 6.1g). 
 
 
 
 
 
 
217 
 
 
Figure 6.1 Optical effects of Pyrene-PEG on DNA-suspended nanotubes. a, 
Polyethylene glycol solubilized pyrene-derivative (pyrene-PEG) fluorescence scan 
between 350nm and 650nm with 317 nm excitation. b, Quantified center wavelengths 
of DNA-suspended nanotubes treated with buffer control (PBS), pyrene-PEG, sodium 
dodecylbenzenesulfonate (0.2% wt/vol), and sodium deoxycholate (0.2% wt/vol) after 
overnight incubation. c, Quantified center wavelength overtime for two DNA-
suspended nanotube chiralities, (9,4) and (8,6), after addition of pyrene-PEG 
(indicated by arrow). d, PL plots depicting buffer treated DNA-suspended nanotubes 
(top) and pyrene-PEG treated nanotubes (bottom). Colors indicate intensity (arbitrary 
units). Black vertical lines drawn to aid comparison. e, quantified emission 
wavelength shift for 11 chiralities after treatment with pyrene-PEG. f, quantified 
excitation wavelength shift for 11 chiralities after treatment with pyrene-PEG. g, 
Intensity normalized emission spectra of SDC-suspended nanotubes excited with 
730nm laser after treatment with buffer or pyrene-PEG. Error bars represent standard 
deviation of technical replicates. 
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The functionality of the DNA-suspended nanotube-based sensor was assessed in 
buffer or serum conditions with the addition of pyrene-PEG. The nanotube sensor is 
based on hybridization with target oligonucleotides and partial desorption from the 
nanotube surface34, so we hypothesized that pyrene-PEG may enhance optical changes 
due to hybridization with target. In both buffer and serum, with all tested conditions, 
pyrene-PEG greatly red-shifted the nanotubes and prevented any further optical 
changes from the target oligonucleotide, control non-complementary oligonucleotides, 
or proteins in the serum (Figure 6.2). The relative affinity of pyrene-PEG for the 
nanotube surface was tested by pre-treating DNA-suspended nanotubes with SDBS, 
which produces a distinct blue-shifted shoulder in the emission spectra, followed by 
addition of pyrene-PEG. The presence of SDBS did not impact the red-shift due to 
pyrene-PEG (Figure 6.3a), producing similar final emissions as the buffer treated 
control. There again was no apparent dependence on nanotube chirality (Figure 6.3 b-
d). 
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Figure 6.2 Impact of Pyrene-PEG on a DNA-suspended nanotube sensor for a 
specific oligonucleotide. Quantified center wavelength for the three indicated 
chiralities of a DNA-suspended nanotube sensor for a specific oligonucleotide 
sequence treated with target DNA, a non-complementary control sequence, or buffer 
only vehicle in buffer conditions or whole serum after addition of pyrene-PEG. Error 
bars represent standard deviation of technical replicates. 
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Figure 6.3 Relative affinity of Pyrene-PEG and SDBS. a, Spectra of the (9,4) 
chirality after treatment with buffer overnight followed by addition of pyrene-PEG 
(top) or treatment with 0.2% SDBS overnight followed by pyrene-PEG (bottom). 
Intensity is normalized. b, PL plots of buffer or 0.2% SDBS pre-treatment overnight 
followed by addition buffer control (top panels) or pyrene-PEG (bottom panels). 
Colors indicate intensity (arbitrary units). Black vertical lines drawn to aid comparison. 
c, quantified wavelength shift after pyrene-PEG addition to buffer or 0.2% SDBS pre-
treated nanotubes for 10 chiralities. d, intensity fold change after pyrene-PEG addition 
to buffer or 0.2% SDBS pre-treated nanotubes.  
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Pyrene is a common by-product of partial combustion of organic material, but does 
not have the same carcinogenicity as closely related compounds such as 
benzo[a]pyrene. Benzo[a]pyrene, with one additional fused benzene ring, is 
metabolized to diol epoxide that intercalates in DNA and covalently binds 
nucleophilic guanine bases41. Pyrene is also observed to be an intercalating agent 
when made to be water soluble42. Because of the strong and rapid affinity of pyrene-
PEG for DNA-suspended nanotubes, but not for SDC-suspended nanotubes, we 
hypothesized that the observed red-shifting from pyrene-PEG may be due to its 
intercalating properties. To test this, a panel of other known DNA intercalating agents 
was tested in equi-molar amounts with DNA-suspended nanotubes (Figure 6.4a). 
Three of the compounds, ethidium bromide, SYBR green, and Hoechst 33258 are used 
to measure DNA content by fluorescent changes after intercalating. Doxorubicin, a 
chemotherapy drug, is an effective agent against rapidly dividing cells due in part to 
its affinity for DNA. Pyrene-PEG was included as reference. Each agent produced 
greatly red-shifted emission similar to pyrene-PEG, except for Hoechst 33258 which 
was slightly less effective (Figure 6.4b). The emission intensity for most agents was 
reduced to varying degrees, with doxorubicin and ethidium bromide producing the 
greatest loss of intensity (Figure 6.4c). 
Because of the potential clinical utility of an optical sensor for doxorubicin, we 
focused on doxorubicin to further characterize its interaction. We tested whether 
DNA-suspension is necessary for detection by adding doxorubicin to SDC-suspended 
nanotubes. Like pyrene-PEG, there was no change (Figure 6.4d). We next tested the 
relative affinity by again pre-treating DNA-suspended nanotubes with SDBS and 
adding doxorubicin. The SDBS effectively prevented red-shifting by doxorubicin, and 
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the spectral emission character from bound SDBS persisted (Figure 6.4e). We 
conclude that compared to pyrene-PEG, the affinity of doxorubicin is not as strong. 
 
Figure 6.4 Interaction of DNA intercalating agents with DNA-suspended nanotubes. 
a, structures of the five DNA-intercalating agents tested. b, wavelength shift relative to 
a buffer treated control for three chiralities after addition of 1 uM of the indicated 
compound. c, corresponding intensity fold change relative to buffer treated control for 
three chiralities after addition of 1 uM of the indicated compound. d, Intensity 
normalized emission spectra of SDC-suspended nanotubes excited with 730nm laser 
after treatment with buffer or doxorubicin. e, Intensity normalized emission spectra of 
0.2% SDBS pre-treated DNA-suspended nanotubes after treatment with buffer or 
doxorubicin. Error bars represent standard deviation of technical triplicates.  
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Quantitative sensing behavior was assessed by measuring DNA-suspended nanotube 
emission changes from a serial dilution of doxorubicin. For most chiralities, there was 
dose-dependent red-shifting from 500 nM to 50 uM, after which there was no 
additional red-shift (Figure 6.5a). Intensity quenching closely matched the wavelength 
shifting behavior, but for most chiralities quenching was detectable before any major 
red-shifting (Figure 6.5b). The kinetics of wavelength shifting and intensity change 
was measured for three nanotube chiralities after addition of doxorubicin at time 0m 
(Figure 6.5c). The kinetics of wavelength shifting was relatively rapid, with the 
majority of the changes taking place before the spectra could be acquired. Intensity 
changes were almost immediate, with most of the dynamics unable to be captured. We 
next tested if quantitative sensing of doxorubicin was possible in complex biological 
solutions such as serum. We have previously reported that serum non-specifically red-
shifts nanotubes and prevents functionality of a DNA-suspended nanotube sensor, due 
to electrostatic interactions with serum proteins. Using serum, we repeated the dose-
response experiment to see if doxorubicin could still be detected. For the measured 
chiralities, dose-dependent red-shifting (Figure 6.5d) and intensity quenching (Figure 
6.5e) were observed, although with less sensitivity compared to buffer only conditions. 
This may be due to doxorubicin binding serum proteins 43. 
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Figure 6.5 Sensitivity and kinetics of doxorubicin-induced optical changes. a, 
Quantified center wavelength shift of 5 nanotube chiralities as a function of 
doxorubicin concentration in buffer conditions. b, intensity fold change relative to 
buffer treated control for 5 nanotube chiralities as a function of doxorubicin 
concentration in buffer conditions. c, Kinetics of wavelength shifting (top panels) and 
intensity changes (bottom panels) for the three indicated nanotube chiralities after 
addition of the four indicated concentrations of doxorubicin at time 0 minutes. d, 
Quantified center wavelength shift of 5 nanotube chiralities as a function of 
doxorubicin concentration in whole serum. e, Intensity fold change relative to buffer 
treated control for 5 nanotube chiralities as a function of doxorubicin concentration in 
whole serum. Error bars represent standard deviation of technical triplicates. 
 
225 
 
Mechanistic studies were undertaken to better understand how doxorubicin may be 
eliciting the observed optical changes. In buffer conditions, added doxorubicin 
produces visible flocculation. Dynamic light scattering of the DNA-suspended 
nanotubes in buffer alone or with doxorubicin show that with doxorubicin, the 
correlation of signal takes a longer time to decay. By the time the correlation 
coefficient decays to 0 for the buffer treated control, the correlation coefficient for the 
doxorubicin treated sample is just beginning to change, consistent with the presence of 
large aggregates (Figure 6.6a). We hypothesized that the quenching of intensity may 
be due to aggregation with metallic nanotubes, which can provide a non-radiative 
decay pathway excited nanotubes26. Using (8,4) chirally pure, (GT)20 suspended 
nanotubes44, which do not contain metallic nanotubes, we measured the optical 
response after addition of doxorubicin. Severe quenching was observed, making 
background fluorescence from doxorubicin prominent in the spectra (Figure 6.6b, left); 
however, enough nanotube emission was collected to reveal a red-shift of 
approximately 8 nm (Figure 6.6c). Reducing agents such as the soluble vitamin E 
analog Trolox have been reported to increase the fluorescent intensity of DNA-
suspended single-walled carbon nanotubes45. Using a concentrated solution of Trolox, 
we spiked some into the doxorubicin treated sample. After allowing 15 minutes of 
equilibration, spectra was again acquired revealing modest intensity restoration from 
the doxorubicin quenched nanotubes (Figure 6.6b, right). Trolox had negligible effect 
on the center wavelength (Figure 6.6c). An absorbance spectrum from 400 nm to 1350 
nm was measured for the buffer treated control and the doxorubicin treated sample 
(Figure 6.6d). Doxorubicin absorbs strongly at 500 nm, complicating analysis of the 
E22 transition. The peak corresponding to E11 showed red-shifting and bleaching46 
after treatment with doxorubicin. We conclude that metallic nanotubes are not a likely 
source of quenching, even though doxorubicin causes flocculation. 
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Figure 6.6 Assessment of the role of flocculation and purity of nanotube 
preparations on optical changes. a, Correlation coefficient overtime as calculated 
from dynamic light scattering for three trials of buffer treated and doxorubicin treated 
DNA-suspended nanotubes. b, GT20 suspended, (8,4) purified chirality after treatment 
with buffer (top panels) or 50 uM doxorubicin without the reducing agent Trolox 
(bottom left) or addition of Trolox (0.2 mg/mL) (bottom right). Colors indicate 
intensity (arbitrary units). Black vertical lines drawn to aid comparison. c, quantified 
wavelength of GT20 suspended purified (8,4) after treatment with buffer, 0.2 mg/mL 
Trolox, 50 uM doxorubicin, or 50 uM doxorubicin with 0.2 mg/mL Trolox. d, 
Absorbance scan of buffer or 50 uM doxorubicin treated GT20 suspended purified 
(8,4), with inset depicting the center wavelength of the absorbance peak. Error bars 
represent standard deviation 
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We hypothesized that DNA intercalating agents such as doxorubicin displace the DNA 
suspending the nanotube by competing for interaction with the adsorbing nucleotide 
bases. To measure DNA displacement, we treated DNA-suspended nanotubes with 
buffer, doxorubicin, or SDC, followed by spin filtration through 100 kDa membranes 
to allow flow through of displaced DNA but not of nanotubes. The flow through was 
then measured for absorbance at 260 nm to quantify the amount of DNA present 
(Figure 6.7a). The sample treated with buffer produced no signal with the absorbance 
spectrometer. SDC, which is known to displace DNA40, was included as a positive 
control and produced detectable levels of DNA. Doxorubicin also produced some 
signal, but comparison of the complete absorbance spectra revealed a large degree of 
noise. To overcome the difficulty in measuring the intrinsic absorbance of DNA, we 
suspended carbon nanotubes with Cy5-labeled DNA. Cy5 is a fluorophore that 
absorbs strongly at 650nm and appears blue to the naked eye. After suspending 
nanotubes with the Cy5-conjugated DNA, we added doxorubicin and measured 
nanotube emission to verify that Cy5 did not impact nanotube sensitivity to 
doxorubicin. As expected, the nanotubes red-shifted with doxorubicin (Figure 6.7b), 
up to 17 nm in some cases (Figure 6.7c). We subjected the Cy5-DNA suspended 
nanotubes to buffer, doxorubicin, or SDC treatment followed by spin filtration. The 
sample treated with SDC resulted in a flow through that had a blue-appearance, while 
the buffer treated sample was clear (Figure 6.7d). The doxorubicin treated sample had 
a slight red tint, likely from unbound doxorubicin. Absorbance scans were taken to 
measure Cy5 absorbance from the flow through in all three conditions (Figure 6.7e). 
The SDC treated sample produced a strongly absorbing peak centered at 650nm. The 
buffer and doxorubicin treated samples did not produce any peak. Finally we treated 
Cy5-DNA suspended nanotubes with doxorubicin, and measured the flow through. 
We then added SDC directly to the doxorubicin treated nanotubes, and again measured 
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the flow through (Figure 6.7f). We again observed that only after treatment with SDC 
did the flow through produce the characteristic Cy5 absorbance peak. Control 
experiments were run to assess the effect of SDC and doxorubicin on Cy5 absorbance 
by using a pure sample of Cy5-conjugated DNA mixed with each component. Both 
SDC (Figure 6.7g) and doxorubicin (Figure 6.7h) had only a minor effect on the 
absorbance, validating our approach. We conclude that doxorubicin does not displace 
the DNA suspending the nanotube to a significant degree. 
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Figure 6.7 Stability studies of DNA suspended nanotubes treated with doxorubicin. 
a, Absorbance measurements at 260 nm for flow through after treatment of DNA-
suspended nanotubes with buffer, 125 uM doxorubicin, or 2.5% SDC. Buffer treated 
sample flow through could not be quantified. b, Emission spectra of Cy5- DNA 
suspended nanotubes after treatment with buffer or treatment with 500 uM 
doxorubicin. c, Normalized intensity and wavelength shift of buffer treated sample 
versus 500 uM doxorubicin treated sample. Different (17nm) is indicated between the 
peaks. d, Appearance of flow through after treatment of Cy5-DNA-suspended 
nanotubes with buffer, 125 uM doxorubicin, or 2.5% SDC. e, Absorbance scan of flow 
through depicted in panel d. f, Absorbance of flow through from same sample treated 
first with buffer, then with 125 uM doxorubicin, then with 2.5% SDC. g, absorbance 
scan of pure Cy5-DNA and Cy5-DNA with 2.5% SDC. h, absorbance scan of pure 
Cy5-DNA and Cy5-DNA with 500 uM doxorubicin. 
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We next attempted to measure the quantity of doxorubicin that binds to DNA-
suspended nanotubes. A known mass of (GT)15 suspended nanotubes was added to 
500 uM doxorubicin, and an equal volume of buffer was added to a control. After 
incubation, the samples were centrifuged to pellet the flocculated nanotubes (Figure 
6.8a), and a sample of the supernatant was assayed for doxorubicin using an 
absorbance scan (Figure 6.8b). The difference in absorbance was compared to a 
doxorubicin standard curve (Figure 6.8c), and used to estimate the mass of 
doxorubicin lost from solution due to binding the nanotubes. From this data we 
estimate that 1 ug of (GT)15 suspended nanotubes binds to 0.95 ug of doxorubicin. 
This is less than previous reports of doxorubicin loading on phospholipid-PEG 
suspended nanotubes, which calculated a 4:1 ratio of doxorubicin to carbon nanotube 
by mass37. Here, they estimated the phospholipid-PEG coating to cover only 10% of 
the nanotube surface, which may explain the difference we observed with DNA. We 
next attempted to wash away the bound doxorubicin by pelleting the sample, 
aspirating the supernatant, and adding 100 uL of buffer and vortexing. This was 
performed three times, with the supernatant extracted for absorbance measurements 
after each wash (Figure 6.9a). The first wash released some doxorubicin from the 
nanotubes, giving the supernatant a red hue. The following washes did not change 
color, but the nanotube pellet appeared to have a red tint. Based on comparing the 
absorbance of the supernatant from each wash (Figure 6.9b) to the standard curve, we 
calculated that about 0.35 ug of doxorubicin was returned to solution by washing. We 
conclude that 0.6 ug of doxorubicin binds to 1 ug of (GT)15 suspended nanotubes 
strongly enough to resist desorption from pelleting and washing. The average length of 
carbon nanotubes that results from our suspension process is 166 nm47. The mass of 
nanotube this length (estimated using the (6,5)) is 3x10-19 g48. Thus, for one nanotube, 
we calculate that approximately 180 molecules of doxorubicin bind strongly. The 
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emission spectra from the nanotubes after treatment with buffer, 500 uM dox, or 500 
uM dox followed by three washes was acquired to assess the impact of washing on the 
nanotube optical response to doxorubicin (Figure 6.9c). We observed that the emission 
spectrum was largely unaltered by washing as compared to the sample that received 
500 uM dox without pelleting and washing (Figure 6.9d). We conclude that 0.6 ug of 
dox binds nearly irreversibly to 1 ug of (GT)15 suspended nanotubes, and is 
responsible for the observed nanotube emission changes. Additional doxorubicin that 
is less strongly bound does not appear to contribute further to the optical changes, as 
removal of the less strongly bound doxorubicin had little impact on the nanotube 
emission. 
 
Figure 6.8 Quantitative measurements of doxorubicin affinity for DNA-suspended 
nanotubes. Image of 500 uM doxorubicin with DNA-suspended nanotubes or buffer 
vehicle after centrifugation. b, Absorbance of supernatant from buffer treated 
doxorubicin sample and nanotube-treated doxorubicin sample for three independent 
measurements. Error bars represent standard deviation. Significance determined with 
t-test; p = 0.0354 c, Standard curve of doxorubicin absorbance as a function of 
concentration. Measurements taken in triplicate. Black solid line represents fit to linear 
regression Y = 0.002424*X + 0.0212. Error bars representing standard deviation were 
too small to render. 
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Figure 6.9 Persistence of spectral changes after washing. a, images of supernatant of 
doxorubicin treated DNA-suspended nanotubes after centrifugation and washing with 
100 uL of buffer. b, absorbance scan of the wash supernatant corresponding to the 
image in panel a. c, Emission spectra of DNA-suspended nanotubes with buffer 
treatment (blue), 500 uM doxorubicin (red), or 500 uM doxorubicin after three washes 
(green). d, Quantified center wavelength of the (9,4) chirality after treatment with 
buffer (blue), 500 uM doxorubicin (red) or 500 uM doxorubicin followed by three 
washes (green). Error bars represent standard deviation. 
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Single-nanotube responses to doxorubicin were assessed in buffer conditions and in 
serum conditions. DNA-suspended nanotubes were added to a lysine-coated glass 
bottom plate and allowed to incubate for 10m before washing and replacing the buffer. 
Single-nanotubes were apparent on the surface according to broadband image 
acquisition (as diffraction limited dots) and hyperspectral measurements (Figure 
6.10a). Spectra of the (9,4) nanotubes were acquired before and after addition of a 
buffer vehicle control or concentrated doxorubicin to a final concentration of 50 uM. 
After 10m of incubation the spectra were acquired again and the shift of each 
individual nanotube calculated. Treatment with doxorubicin produced a significant 
(****) wavelength shift of 11.6 nm ± 1.5 nm (Figure 6.10b). The spectra from buffer 
treated and doxorubicin treated single nanotubes were averaged together into a 
composite spectrum (Figure 6.10c, d). The average spectra of the single nanotubes 
largely recapitulated the spectra seen in solution phase, with a magnitude of shift 
approaching that seen in solution (15.6 nm in solution compared to 11.6 nm when 
single nanotubes are averaged). We next measured the before and after spectra of 
single (9,4) nanotubes after treatment with buffer or doxorubicin in whole serum. The 
shift of each measured nanotube was calculated before and after treatment with buffer 
or doxorubicin. A significant (****) shift compared to buffer was again observed, 
with an average red-shift magnitude of 7.7 ± 0.9 nm (Figure 6.10e). The averaged shift 
from single nanotubes closely recapitulates the shift seen in solution phase with serum 
of 7.8 nm. 
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Figure 6.10 Single-nanotube measurements after doxorubicin treatment in buffer 
and whole serum. a, representative image of carbon nanotubes on the surface of a 
lysine-coated glass bottom plate in buffer before any treatment. b, Wavelength shift of 
single nanotubes in buffer treated with buffer or 50 uM doxorubicin. Differences were 
pooled for each condition in the box and whisker plot. Statistical significance 
calculated with unpaired t-test. Buffer n=36, 50 uM dox treatment n=19. c, composite 
spectra of all single nanotube spectra before and after buffer. d, composite spectra of 
all single nanotube spectra before and after 50 uM dox. E, Wavelength shift of single 
nanotubes in whole serum treated with buffer or 50 uM doxorubicin. Differences were 
pooled for each condition in the box and whisker plot. Statistical significance 
calculated with unpaired t-test. Buffer n= 18, 50 uM doxorubicin n = 28. 
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Because doxorubicin is able to elicit an optical response in complex protein 
environments, we tested whether doxorubicin could be detected by nanotubes inside of 
cells. (GT)15 suspended nanotubes were incubated with the RAW 264.7 murine 
macrophage cell line overnight. Nanotubes are internalized via phagocytosis49, and the 
nanotubes remain localized in phagocytic vesicle in the cell. Cell viability is 
unaffected by this treatment50, 51. White light images showed normal cell morphology 
(Figure 6.11a), and broadband images revealed punctate spots of nanotube filled 
vesicles inside most of the cells (Figure 6.11b). Three cohorts of cells were treated 
with 500 uM doxorubicin or buffer control and incubated 1h, after which the 
nanotubes were measured via hyperspectral cubes, focusing on the (9,4) chirality. 
Spectra from the three cohorts in each condition were averaged and quantified. 
Treatment with 500 uM dox elicited a red-shift of approximately 7.9nm (Figure 6.11c). 
This is less than what would be expected in solution phase in serum (~14nm), and may 
be due to sequestration of doxorubicin to other cell material. 
 
Figure 6.11 Response of internalized nanotubes after treatment with doxorubicin. a, 
White light image of macrophage cell line on glass surface. b, broadband nanotube 
emission under 730 nm excitation corresponding to the region of interest depicted in 
panel a. c, Averaged spectra after selecting nanotube emissive spots in cells treated 
with buffer or treated with 500 uM doxorubicin. Each condition represents three 
separate runs and approximately 50 cells. 
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To make an implantable sensor for doxorubicin, three different materials with 
precedent for use were tested. We first tested a suspension of DNA-suspended 
nanotubes in an agarose gel. Testing in vitro showed that the kinetics were unaffected 
by gel encapsulation, with maximal red-shifting and intensity quenching by 10 
minutes. Agarose gel is known to prevent nanotubes from aggregating52, providing 
additional evidence that aggregation is not the source of the quenching. The 
doxorubicin treated agarose gel (about 20 uL volume) was dialyzed in 50 mL of DI 
water with three changes, where the last change was allowed to proceed overnight. 
The red-shift was not reversed by the dialysis, consistent with the inability to wash 
away doxorubicin in previous experiments (Figure 6.12a). Another hydrogel, alginate, 
was tested due to its ease of use and precedent for use in vivo with suspended 
nanotubes for sensing applications33. Again, we observed red-shifting and quenching 
in response to doxorubicin, making this hydrogel a potential implantation material 
(Figure 6.12b). Lastly, we tested an implantable membrane where a nanotube solution 
can be heat-sealed inside as we have previously reported34. An in vitro dose-response 
assessment produced a surprising pattern, where concentrations above 5 uM 
doxorubicin red-shifted and recovered some of the intensity loss, even to levels 
brighter than baseline for some chiralities (Figure 6.12c). When the dialysis 
membranes were tested again in vitro in whole serum, we noted a similar phenomenon, 
but with the maximal quenching taking place at 50 uM rather than 5 uM, consistent 
with the penalty in sensitivity from detection in solution phase in serum (Figure 6.12d). 
To better understand the surprising restoration of intensity with higher concentrations 
of doxorubicin using the dialysis membrane, more concentrations were tested closer to 
5 uM and more dilute than 5 uM. We observed that the wavelength did not shift at 
concentrations less than 1 uM. However, before the red-shift could be detected, the 
intensity begins to drop. Beyond about 5 uM, the intensity begins to restore to levels 
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comparable to untreated controls (Figure 6.13a). While analyzing the wavelength shift 
of carbon nanotubes has several advantages as a sensor output for an implantable 
sensor, it is also possible to make use of ratiometric intensity changes to control for 
factors that could change absolute intensity, such as tissue irregularities. Thus, we 
measured the intensity ratio of two nanotubes, the (9,4) and the (8,7), to test if 
ratiometric quenching could be measured in concentration regimes below 5 uM. 
Indeed, we found that ratiometric sensing could improve our threshold of detection to 
between 50 and 500 nM (Figure 6.13b). 
Figure 6.12 Hydrogel and dialysis based device responsivity in vitro. a, DNA-
suspended nanotubes cast in 4% wt/vol agarose gel before treatment with doxorubicin, 
10 minutes after treatment with 50 uM doxorubicin, and 120 minutes after treatment 
with 50 uM doxorubicin. Red line represents spectra after dialysis overnight with three 
dialysate changes. b, Alginate spheres (6% wt/vol) with DNA-suspended nanotubes 
after overnight treatment with buffer or 50 uM doxorubicin. c, Emission spectra from 
DNA-suspended nanotubes in a heat sealed implantable semi-permeable membrane 
after overnight incubation with escalating doses of doxorubicin in buffer. d, Emission 
spectra from DNA-suspended nanotubes in a heat sealed implantable semi-permeable 
membrane after overnight incubation with escalating does of doxorubicin in whole 
serum (FBS). A control sample was incubated in buffer only (blue). 
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Figure 6.13 Wavelength shifting and intensity changes of DNA-suspended 
nanotubes as part of an implantable membrane tested in vitro. Center wavelength 
(red line, left y-axis) and intensity fold change (blue, right y-axis) of the (9,4) 
nanotube in a heat sealed implantable semi-permeable membrane after overnight 
incubation with the indicated concentration of doxorubicin. b, Intensity ratio of the 
(9,4) and (8,7) nanotube in a heat sealed implantable semi-permeable membrane for 
concentrations less than 5 uM doxorubicin. All error bars represent standard deviation 
of three implants tested in vitro. Test of significance was done using t-test. Only non-
statistically significance differences are labeled in b; 500 nM and 5 uM are 
significantly different than the buffer treated control. 
 
 
Because earlier experiments suggest that doxorubicin binding is largely irreversible, 
an implantable carbon nanotube-based sensor may be useful for cumulative sensing. 
We hypothesized that the optical changes from overnight incubation in 10 mL of 5 uM 
will be equivalent to overnight incubation in 1 mL of 50 uM, since in both cases the 
total mass of doxorubicin is 29 ug. We prepared DNA-suspended nanotubes in 
implantable devices and incubated them overnight in 1 mL of buffer, 1 mL of 5 uM 
doxorubicin, or 1 uL of 50 uM doxorubicin to serve as controls. Concurrently, we 
incubated devices overnight in 1 mL of 5 uM doxorubicin and 10 mL of 5 uM for an 
experimental group. The controls behaved as expected, where 5 uM doxorubicin 
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treatment induced red-shifting and maximal quenching while 50 uM dox further red-
shifted the nanotubes and restored intensity (Figure 6.14a). In the experimental group, 
5 uM dox in 1 mL again induced red-shifting and maximal quenching; however, 5 uM 
in 10 mL produced a spectrum that was nearly identical to incubation in 1 mL of 50 
uM doxorubicin (Figure 6.14b). We quantified the center wavelength (Figure 6.14c) 
and intensity (Figure 6.14d) for the (9,4) nanotube and found that the values were not 
different in a statistically significant way. 
 
Figure 6.14 Test of cumulative sensing in vitro. A, emission spectra of DNA-
suspended nanotubes in implantable membrane device after incubation in 1 mL of 
buffer, 5 uM doxorubicin, or 50 uM doxorubicin. b, Emission spectra of DNA-
suspended nanotubes in implantable membrane device after overnight incubation in 1 
mL of buffer, 1 mL of 5 uM doxorubicin, or 10 mL of 5 uM doxorubicin. c, 
Quantification of the (9,4) center wavelength from spectra in panels a and b with 
doxorubicin concentration, volume, and total mass doxorubicin listed below. d, 
Intensity corresponding to the data in panel c. No significant difference in intensity 
between incubation in 1 mL of 50 uM doxorubicin or 10 mL of 5 uM doxorubicin. 
Error bars represent standard deviation of three measurements. 
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Using the dialysis membrane device for implantation, we surgically placed the device 
into the peritoneum of mice as previously described34. After allowing the animals to 
awaken and become ambulatory for an hour, they were again anaesthetized with 
isoflurane and fluorescence measurements of the implanted carbon nanotubes were 
taken through the skin with a laser probe apparatus as previously described34. 
Following measurement, an intraperitoneal injection of 1 mL of doxorubicin was 
administered, and the mice were again allowed to awaken and become ambulatory. 
After 30m, the mice were again anaesthetized and the nanotube implant was measured. 
Injected doxorubicin produced the expected red-shift and intensity quenching (Figure 
6.15a, representative spectra).  
We next repeated the experiment, but measured the carbon nanotube implant 
continuously (with 0.5s exposures) to measure the kinetics of doxorubicin binding 
immediately after injection. Initial spectra were acquired, followed by injection of 
doxorubicin into peritoneum. The (8,6) nanotube was monitored over the course of the 
experiment. Initial quenching was observed (Figure 6.15b), followed by red-shifting 
(Figure 6.15c) at approximately 4 minutes. The mouse was periodically monitored 
(gaps in data) for any laser induced damage to the skin, but none was noted. The 
threshold of detection in vivo was measured by surgically implanting the nanotube 
sensor device into four mice, and injecting either buffer, 5 uM dox, 50 uM dox, or 500 
uM dox. For both the (9,4) and (8,6) nanotube, significant red-shifting was observed 
for both the 50 uM and 500 uM doxorubicin injection, but not for 5 uM (Figure 6.16a, 
b). An examination of the implantable devices ex vivo corroborates the in vivo data 
(Figure 6.16c, d). Detection of 50 uM doxorubicin, but not 5 uM doxorubicin, is 
consistent with the dose response data taken in whole serum. 
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Figure 6.15 Implanted sensor response and kinetics to injected doxorubicin. 
Emission spectrum of implanted membrane device before injection of doxorubicin and 
30m after intraperitoneal injection of 1 uL uM doxorubicin. b, Intensity of implanted 
nanotube device measured for the (8,6) in real-time after intraperitoneal injection of 1 
mL doxorubicin at time 0 minutes. c, center wavelength of the (8,6) nanotube device 
measured in real-time after intraperitoneal injection. Kinetics data was taken every 0.5 
second for the duration of the experiment. Gaps in data are from periodic monitoring 
of the mouse.  
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Figure 6.16 Dose-escalation of doxorubicin in vivo. a, Center wavelength of the (9,4) 
nanotube from implanted membrane devices after injection with 1 mL of buffer, 5 uM 
dox, 50 uM dox, or 500 uM dox. b, Center wavelength of the (8,6) nanotube from 
implanted membrane devices after injection with 1 mL of buffer, 5 uM dox, 50 uM 
dox, or 500 uM dox. c, Center wavelength of the (9,4) from membrane devices ex vivo 
after removal from the mouse. d, Center wavelength of the (8,6) from membrane 
devices ex vivo after removal from the mouse. Error bars represent standard deviation 
from 3 measurements per mouse per condition.  
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Finally we tested whether implanted carbon nanotube sensor devices could be used to 
obtain anatomic compartment specific measurement of doxorubicin. We surgically 
implanted two carbon nanotube devices separated by the peritoneal membrane. The 
peritoneal membrane defines the peritoneal cavity, and separates it from the skin. One 
device was placed in the peritoneum, while the other device was implanted under the 
skin but over the peritoneal membrane. Whole mouse imaging in the custom built 
hyperspectral imager modeled after an IVIS system was used to assess implant 
placement. Two white light images show the mouse before surgery and after, with one 
of the implantable devices visible protruding under the skin. Broadband imaging with 
730 nm illumination show the nanotube emission from the two implanted devices. The 
suture is also slightly auto fluorescent and apparent near the incision (Figure 6.17a). 
Doxorubicin was injected in the peritoneum, and intensity of the nanotube 
fluorescence from the implanted devices monitored (Figure 6.17b). The mouse imager 
showed quenching of the device in the peritoneum, but not of the device under the 
skin (Figure 6.17c). Hyperspectral imaging was attempted; the implant under the skin 
however showed no wavelength changes (Figure 6.17d, e) but the emission was too 
quenched to collect spectral data from the peritoneal implant (Figure 6.17f). The 
mouse was then imaged under the probe, where each of the devices was measured. 
Compared to the device implanted outside the peritoneum, the device inside red-
shifted and quenched a large degree (Figure 6.17g). Measurement of the devices ex 
vivo confirmed the red-shift observed in vivo (Figure 6.17h). Using two implantable 
devices, we found that doxorubicin was restricted to the inside of the peritoneum for 
the course of this experiment, giving us anatomic location specific sensing of the drug. 
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Figure 6.17 Differential response of implanted sensors in anatomically distinct 
locations. a, Image of the mouse before surgery (left), after implantation of devices in 
peritoneum and under skin (center), and broadband emission under 730nm 
illumination (right). b, Broadband emission of implanted devices in peritoneum 
(device on left) and under skin (device on right) before injection (left image) and 20m 
after injection (right image). c, quantification of intensity from the images in b. d, 
Section of hyperspectral cube corresponding to intensity at 1124 nm before injection 
(left image) and after injection (right image). e, spectral data of the implant under the 
skin before and after injection of doxorubicin. f, Spectral data of the implant in the 
peritoneum before and after injection of doxorubicin. g, Emission spectra from the 
device under the skin (blue, outside peritoneum) and inside the peritoneum (red) as 
measured with probe apparatus. h, emission spectra of the device under the skin (blue, 
outside peritoneum) and inside the peritoneum (red) taken ex vivo after the experiment.  
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6.4 Conclusions and outlook 
Although pyrene-derivatives have been previously reported to be effective agents in 
non-covalently modifying carbon nanotubes, their interaction has been henceforth 
restricted to structural applications36. Some reports have looked at fluorescence 
changes of the pyrene derivative itself upon adsorption to the nanotube53, but the 
impact of pyrene-derivatives on the intrinsic fluorescence of carbon nanotubes has not 
been addressed. Pyrene is a convenient molecule to study as it is one of the simplest 
polycyclic aromatic hydrocarbons, and derivatives such as 1-pyrenebutyric acid are 
readily available for functionalization. Polycyclic aromatic hydrocarbons as a whole 
are often carcinogenic pollutants formed from incomplete combustion of organic 
material. Part of their carcinogenicity is related to their planar, aromatic structure that 
is conducive to DNA intercalation. Using methoxypolyethylene glycol, a common 
material for imparting hydrophilicity to insoluble compounds, we were able to 
solubilize pyrene to test its effect on DNA-suspended nanotubes. We found a 
surprising effect—a large and rapid red-shift in carbon nanotube emission. Generally 
speaking, amphiphilic molecules that bind strongly to carbon nanotubes and provide a 
hydrophobic environment protected from water blue-shift the emission of nanotubes54-
56. Compared to other surfactants, DNA-suspended nanotubes are typically relatively 
red-shifted due to incomplete coverage of the surface56. This feature has been useful 
for many sensing applications using DNA-suspended nanotubes34. We had 
hypothesized that pyrene-PEG would strongly adsorb to free surface area on DNA-
suspended carbon nanotubes and exclude more water, leading to a blue-shift like the 
surfactants SDBS and SDC. Instead, pyrene-PEG red-shifted nearly 15 nm in some 
cases, matching the magnitude with which SDC blue-shifts DNA-wrapped nanotubes. 
Theoretical ab initio calculations predict that pyrene should have little impact on the 
electronic structure of nanotubes57. The apparent independence of chiral identity was 
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also surprising, as the environmental effects on nanotube optical properties are usually 
sensitive to chirality and mod type of the nanotube58. The strength with which pyrene-
PEG associates with DNA-suspended nanotubes was also unexpected, blocking the 
interaction of SDBS and serum with the nanotube. However, the lack of effect of 
pyrene-PEG on SDC-suspended nanotubes suggests that the DNA-suspension is 
critical to sensitivity. It is still unknown if this is because of the sparse coverage 
provided by DNA, or a DNA-specific interaction with pyrene-PEG. Because of the 
large and rapid effect on DNA-suspended nanotube fluorescence, we believe that 
DNA-suspended nanotubes may be useful as sensors for other polycyclic aromatic 
hydrocarbons59 in the environment as part of monitoring efforts.  
The unexpected optical effects of pyrene-PEG led us to discover that other DNA-
intercalating agents also largely recapitulate the impact on DNA-suspended nanotube 
fluorescence. Importantly, the ability to detect doxorubicin in this case could help 
address the issue of dose-monitoring for cumulative toxicity in patients by 
incorporating DNA-suspended nanotubes into an implantable device. One unfortunate 
effect doxorubicin had on DNA-suspended nanotubes was intensity quenching. 
Compared to other materials, the quantum yield of DNA-suspended nanotubes is 
already quite poor60, making intensity quenching potentially problematic. Although 
other nanotube sensors have been reported based on quenching upon contact with an 
analyte61, this mode of sensing is not ideal for in vivo applications, where a strong 
signal is required. Indeed, in the current study the quenching was below the threshold 
of detection for one mode of detection, although with a probe-based measurement the 
red-shift and intensity quenching was clearly detectable. We were able to rule out 
DNA-displacement and flocculation (with or without metallic nanotubes present) as 
the origin of this intensity loss from doxorubicin, and found that reducing agents were 
moderately useful in restoring some loss of intensity. At physiological pH, 
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doxorubicin is positively charged; it is possible that the electron-withdrawing 
character creates non-radiative decay sites on the nanotube sidewall, leading the 
observed intensity loss62, 63. This is supported by the partial intensity restoration by the 
reducing agent Trolox. For reasons that are still not clear, incorporation of the 
nanotubes into the implantable dialysis membrane enables high doses of doxorubicin 
to restore some intensity. This was repeated several times in vitro, and observed ex 
vivo after removal of the implant after several hours post doxorubicin exposure. The 
hydrogels displayed a similar effect, suggesting some kind of doxorubicin-mediated 
interaction with the implant substrate. Further work to reveal the exact mechanism for 
this may enable future implantable sensors for doxorubicin to be brightly fluorescent. 
As an applied sensor material for doxorubicin, DNA-suspended nanotubes displayed 
several qualities that make them outstanding candidates. The optical response to 
doxorubicin was quite robust, even in the complex protein environment of whole 
serum and within cells. We have also shown that doxorubicin-responsive DNA-
suspended nanotubes can be incorporated in hydrogels and semipermeable membranes 
for implantation without losing responsiveness to doxorubicin. The inability to reverse 
doxorubicin-induced red-shifting and the cumulative sensing behavior could make this 
particularly useful for human clinical applications, where dose-related toxicity of 
doxorubicin to patients is cumulative. We envision a possible sensing device to part of 
a small stent that could be placed near the heart in a minimally invasive manner 
through arteries. For research purposes, an implantable sensor could also be useful for 
doxorubicin as part of hyperthermic intraperitoneal chemotherapy (HIPEC) 
procedures, where site-specific measurement of doxorubicin can take place in live 
animals or patients64. This could help provide more precise therapy by accounting for 
patient-to-patient variation in doxorubicin distribution. In experimental model systems, 
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it may also be possible to introduce DNA-suspended nanotubes into specific cells of 
target organs to study doxorubicin accessibility in live organisms. This may be 
especially helpful in understanding cancer resistance to doxorubicin as cell intrinsic 
processes or extrinsic processes in the context of the live animal. 
 
6.5 Materials and methods  
 
6.5.1 Preparation of PEGylated pyrene derivative 
Excess N-Hydroxysuccinimide (NHS) active 1-pyrenebutyric acid (1-Pyrenebutyric 
acid N-hydroxysuccinimide ester, Sigma Aldrich) was incubated with 
methoxypolyethylene glycol amine, M.W. 1,000 (PEG 1000, Alfa Aesar) in DMSO at 
room temperature overnight while vortexing. A centrifugal vacuum evaporator was 
used to remove DMSO, and the pellet was resuspended in deionized water. The 
sample was again centrifuged to pellet non-soluble 1-pyrenebutryic acid that did not 
conjugate to PEG. A fluorescence scan from 350 nm to 650 nm using 317 nm 
excitation was taken of the soluble Pyrene-PEG using the Tecan Infinite M1000 plate 
reader (Tecan Group Ltd, Switzerland).. The spectra contained evidence of excimer 
formation consistent with other reports of solubilized pyrene derivatives65. 
 
6.5.2 Suspension of carbon nanotubes 
For DNA suspension, carbon nanotubes produced by the HiPco process (Unidym, 
Sunnyvale, CA) were mixed with DNA oligonucleotides (IDT DNA, Coralville, IA) at 
a 2:1 mass ratio in 1 mL of saline-sodium citrate (SSC) buffer and ultrasonicated for 
30 minutes at 40% amplitude (Sonics & Materials, Inc.). For sodium deoxycholate 
(SDC) suspension, 1 mg of HiPco nanotubes were similarly sonicated in 2% wt/vol 
SDC prepared in water. Following ultrasonication, the dispersions were 
249 
 
ultracentrifuged (Sorvall Discovery 90SE) for 30 minutes at 280,000 x g. To remove 
free DNA, 100 kDa Amicon centrifuge filters (Millipore) were used. The DNA-
nanotube complexes were re-suspended in saline-sodium citrate buffer (G Biosciences, 
St. Louis, MO). The top 80% of the supernatant was collected. Absorbance spectra for 
all dispersions were acquired using a UV/Vis/nIR spectrophotometer (Jasco V-670, 
Tokyo, Japan). The concentration was calculated using the extinction coefficient 
Abs910 = 0.02554 L mg-1cm-1. 
The DNA sequences used for suspension were: 
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTCAGTTTTGCATAGATTTGCAC
A 
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGT 
GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGT 
CTTCCCTTC-Cy5 
all purchased from IDT (Coralville, IA). Purification of the (8,4) nanotube chirality 
suspended in (GT)20 was performed as previously described44. 
 
6.5.3 Fluorescence spectroscopy of carbon nanotubes in solution 
Fluorescence emission spectra from aqueous nanotube solutions were acquired using a 
home-built apparatus consisting of a tunable white light laser source, inverted 
microscope, and InGaAs nIR detector. The SuperK EXTREME supercontinuum white 
light laser source (NKT Photonics) was used with a VARIA variable bandpass filter 
accessory capable of tuning the output 500 – 825 nm with a bandwidth of 20 nm. The 
light path was shaped and fed into the back of an inverted IX-71 microscope 
(Olympus) where it passed through a 20x nIR objective (Olympus) and illuminated a 
50-100 µL nanotube sample in a 96-well plate (Corning). The emission from the 
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nanotube sample was collected through the 20x objective and passed through a 
dichroic mirror (875 nm cutoff, Semrock). The light was f/# matched to the 
spectrometer using several lenses and injected into an Isoplane spectrograph 
(Princeton Instruments) with a slit width of 410 µm which dispersed the emission 
using an 86 g/mm grating with 950 nm blaze wavelength. The spectral range was 930 
– 1369 nm with a resolution of ~0.7 nm. The light was collected by a PIoNIR InGaAs 
640 x 512 pixel array (Princeton Instruments). A HL-3-CAL-EXT halogen calibration 
light source (Ocean Optics) was used to correct for wavelength-dependent features in 
the emission intensity arising from the spectrometer, detector, and other optics. A 
Hg/Ne pencil style calibration lamp (Newport) was used to calibrate the spectrometer 
wavelength. Background subtraction was conducted using a well in a 96-well plate 
filled with DI H2O. Following acquisition, the data was processed with custom code 
written in Matlab which applied the aforementioned spectral corrections, background 
subtraction, and was used to fit the data with Lorentzian functions. 
 
6.5.4 Solution phase experimental conditions 
Unless otherwise noted, the concentration of nanotubes used for all experiments was 1 
mg/L. Doxorubicin hydrochloride salt (LC labs) was prepared in a concentrated stock 
solution of 5 mM in deionized water and added to samples to the indicated final 
concentrations. Control sample received a volume-matched addition of water. 
Ethidium bromide, SYBR green, and Hoechst 33258 (all from ThermoFisher) were 
added to a final concentration of 1 uM. Experiments in serum used fetal bovine serum 
(ThermoFisher) with concentrated nanotubes added for a negligible increase in 
volume. Sodium dodecylbenzenesulfonate (Sigma Aldrich) was used at a final 
concentration of 0.2% wt/vol, prepared from a stock solution at 4% wt/vol. 
Hybridization experiments were conducted with 1 mg/L of the GT15mir19 sensor in 
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saline-sodium citrate buffer at room temperature. Concentrated target DNA was 
introduced to reach a final concentration of 1 uM target DNA 
(TGTGCAAATCTATGCAAAACTGA) complementary to the DNA-nanotube sensor 
or non-complementary control DNA (TCGGTCAGTGGGTCATTGCTAGT) (both 
from IDT DNA, Coralville, IA). Samples were incubated for 4 hours. 
 
6.5.5 DNA-displacement, flocculation, and doxorubicin accumulation 
measurements 
Measurement of DNA-displacement used 100 kDa Amicon centrifuge filters 
(Millipore) to separate displaced DNA. Absorbance of unmodified DNA was 
measured using the NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific). 
DNA modified with Cy5 was measured using the Tecan Infinite M1000 plate reader 
(Tecan Group Ltd, Switzerland) taking absorbance scans with 2nm steps. Experiments 
measuring the loss of doxorubicin in 100 uL of 500 uM doxorubicin after incubation 
with 20 mg/L GT15 nanotubes were performed by centrifugation at maximum speed 
(21130 RCF) for 5 minutes, then extraction of the supernatant. The supernatant was 
subjected to absorbance scans from 350 nm to 700 nm using 2 nm steps, and 
compared to an identically treated control sample without addition of nanotubes. A 
standard curve was constructed with known concentrations of doxorubicin to calculate 
mass of doxorubicin that was lost due to the presence of nanotubes. The pellet of 
nanotubes was then washed in an attempt to liberate bound doxorubicin, which was 
again assessed by an absorbance scan of the supernatant and comparison to the 
standard curve. Quantification of flocculation was done using dynamic light scattering 
(Zetasizer Nano ZS, Malvern Instruments) for three independent runs. 
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6.5.6 Single-nanotube measurements 
Single-nanotube measurements were performed by incubating GT15 suspended 
nanotubes on a poly-D-lysine coated glass bottom plate (Mattek, Ashland, MA) for 10 
minutes before washing with 20 mM HEPES buffer three times and adding 1 mL of 
20mM HEPES buffer containing (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-
carboxylic acid (Trolox) at 2 mg/mL. Hyperspectral cubes were obtained as described 
before and after addition of 50 uM doxorubicin. Three independent runs were 
performed. Data was processed with ImageJ software. Peaks were fit to Voigt 
functions using custom Matlab code to obtain center wavelength values, and the 
differences of each nanotube from each condition was pooled to make an average 
spectra and construct box and whisker plots. 
 
6.5.7 Measurement of nanotube response to doxorubicin in cells 
A murine macrophage cell line (RAW 264.7, TIB-71 obtained from ATCC) was 
propagated at 37˚C and 5% CO2 in DMEM with 10% heat-inactivated FBS, 2.5% 
HEPES, 1% glutamine, and 1% penicillin/streptomycin (all from Gibco). Cells were 
plated on glass bottom petri-dishes (Mattek) and treated with 1mg/mL GT15 
nanotubes added directly to the medium overnight. Cells were washed in warm PBS 
three times before hyperspectral measurements. For both the buffer treated and 
doxorubicin treated cells, regions of interest (ROIs) were selected using ImageJ 
software over approximately 50 cells in each condition. Reported spectra are based on 
the average of all ROIs. 
 
6.5.8 Hyperspectral microscopy 
Hyperspectral microscopy was performed by illuminating the sample with a 
continuous wave 730 nm diode laser (output power = 2 W) via a multimode fiber. A 
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custom beam shaping module was used to produce a top hat intensity profile with a 
maximum of 20% variation at the sample surface. Shaped laser emission was reflected 
into an Olympus IX-71 inverted microscope modified for near infrared transmission 
and focused onto the sample with a 100X (UAPON100XOTIRF, NA=1.49) oil 
objective (Olympus, USA) via a longpass dichroic mirror with a cut-on wavelength of 
880 nm. Spatially resolved, near-infrared emission from the sample was fed into a 
volume Bragg grating (VBG) where specific wavelength components of the 
polychromatic light was diffracted and passed again through the VBG resulting in a 
monochromatic beam, which was collected by a 256 x 320 pixel InGaAs array 
(Photon Etc.). Data was compiled as a continuous stack of images for the indicated 
wavelength ranges (hyperspectral cubes) wherein every pixel of a near-infrared image 
was spectrally resolved.  
 
6.5.9 Device implantation and in vivo spectroscopy 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee at Memorial Sloan Kettering Cancer Center. KrosFlo Implant Membranes 
(500 kD MWCO) were obtained from Spectrum Labs (Rancho Dominguez, CA). The 
membrane was cut to about 1 cm in length and filled with approximately 15 uL of 1 
mg/L GT15 nanotubes. Each end was heat sealed. All mice used were NU/J (nude) 
from Jackson Labs, and anesthetized with 2% isoflurane for surgeries and spectra 
acquisition. Initial assessment or responsivity in vivo used three mice with 1 mL 
injection of 500 uM doxorubicin. Dose-escalation studies used one mouse per 
condition. Kinetics of after injection of doxorubicin and whole mouse hyperspectral 
imaging of anatomic compartment specific sensing is reported for one mouse each. 
Probe-based measurements were taken using a custom-built reflectance probe-based 
spectroscopy system. The system consisted of a continuous wave 1 watt 730 nm diode 
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laser (Frankfurt). The laser light was injected into a bifurcated fiber optic reflection 
probe bundle. The sample leg of the bundle included one 200 µm, 0.22 NA fiber optic 
cable for sample excitation located in the center of six 200 µm, 0.22 NA fiber optic 
cables for collection of the emitted light. Emission below 1050 nm was filtered using 
longpass filters, and the light was focused into the slit of a Czerny-Turner 
spectrograph with 303 mm focal length (Shamrock 303i, Andor). The slit width of the 
spectrograph was set at 410 µm. The light was dispersed using an 85 g/mm grating 
with 1350 nm blaze wavelength and collected with an iDus InGaAs camera (Andor). 
Spectra were fit to Voigt functions using custom Matlab code. Whole mouse 
hyperspectral imaging of nanotubes in vivo was performed using a preclinical 
hyperspectral mouse imaging system (Photon Etc., Montreal). Two continuous wave 
730 nm diode lasers each with an output power of 2 W were reflected off optical 
mirrors and distributed over the entire mouse, resulting in a maximum power density 
of 340 mW/cm2. Emission light was filtered through an 1100 nm longpass filter to 
reduce autofluorescence. Intensity from broadband imaging was quantified with 
custom software (PhySpec, Photon Etc.). Hyperspectral cubes were obtained via a 
volume Bragg grating (VBG) analogous to the system used for hyperspectral 
microscopy of cells and single nanotubes.  
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APPENDIX 
 
 
Supplementary Tables for Chapter 2 
 
Table S1: List of amphipathic molecules used to study the enhancement of the sensor 
response. 
 
 
 
 
 
Table S2. GT15mirX sequences used in this work. 
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Table S3. Analyte/target sequences used in this work. 
 
 
 
 
 
Table S4. Truncated miR analyte sequences designed to hybridize to the middle of miRNA 
capture sequence. 
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Table S5. Truncated miR analyte sequences designed to hybridize to the 5’ end of miRNA 
capture sequence. 
  
 
Table S6. Elongated analyte sequences used in this work. 
 
 
